CURRICULUM VITAE
Kareem Mohamed Abu-Elmagd, M.D., Ph.D., FACS
DATE FEBRUARY 9TH, 2023
PERSONAL INFORMATION
Name:
Kareem M. Abu-Elmagd, M.D., Ph.D.
Date of Birth:
June 16, 1952
Place of Birth:
Mansoura, Egypt
Citizenship:
USA
Marital Status:
Married
Children:
2
Office Address:
9500 Euclid Avenue, A100, Cleveland, OH 44195
Home Address
12911 Lakeshore Blvd. Bratenahl, OH 44108
Office Phone:
216-445-8876
Cell Phone:
216-385-7837
Office E-mail:
[email protected]
Facsimile:
216-636-7060
EDUCATION
Undergraduate
School:
Mansoura University, School of Science, Mansoura, Egypt
Degree:
BA
Dates:
10/70-9/1971
Graduate
School:
Mansoura University, School of Medicine, Mansoura, Egypt
Degree:
M.B.B.Ch. (MD)
Dates:
10/71-12/76
Post-Graduate (Master Degree in General Surgery)
Institution:
Mansoura University School of Medicine, Mansoura, Egypt
Degree:
M.S. in Surgery
Thesis Title:
Evaluation of Renal Functions after Lienorenal Shunt
Date:
1981
Post-graduate (Ph.D.)
Institute:
Emory University School of Medicine/ Mansoura University School of Medicine
Degree:
Ph.D.
Thesis Title:
Clinical, Hemodynamic,and Metabolic Effects of Selective Shunt in Variceal Bleeders with Schistosomal and Nonschistosomal Portal Hypertension
Committee:
Farouk A. Ezzat, M.D., FRCS (Egypt), Dean W. Warren, M.D., FACS (USA),
and Atef A. Salam, M.D., Ph.D. (USA)
Date:
1986
TRAINING
Dates Attended
Name & Location of Institution
Name of Program Director-Discipline
3/77-2/78
Mansoura University, Mansoura, Egypt
Mohamed Sobh, M.D., Ph.D.-Intern
3/78-6/79
Hurghada General Hospital, Hurghada, Egypt
Osama El-Adawy, M.D., FRCS
Military Medical Services
Surgical Resident
7/79-4/82
Mansoura University Hospital, Mansoura, Egypt
Mohamed S. Ibrahim, M.D., FRCS
Farouk A. Ezzat, M.D., FRCS
Surgical Resident
2/83-8/83
Wayne State University, Department of Pathology
Detroit, MI USA
Margarita Palutke, M.D.
Research Fellow, Immunology
5/84-2/86
Emory University School of Medicine
Department of Surgery
Dean W. Warren, M.D., FRCS
Atef A. Salam, M.D., Ph.D.
Kareem Abu-Elmagd, M.D., PhD. 2
Atlanta, GA USA
Clinical Research Fellow, Surgery
6/89-11/90
University of Pittsburgh Department of Surgery
Pittsburgh, PA USA
Thomas E. Starzl, M.D., Ph.D.
Clinical Fellow, Transplantation
7/95-6/97
University of Pittsburgh Department of Surgery
Pittsburgh, PA USA
Richard Simmons, M.D., FACS
Marshall Webster, M.D., FACS
Senior and Chief Resident, Surgery
PROFESSIONAL APPOINTMENTS
Position/Rank:
Institution/Department:
Dates:
Position/Rank:
Institution/Department:
Dates:
Position/Rank:
Institution/Department:
Dates:
Position/Rank:
Adjunct Professor, Cairo University, Cairo, Egypt
General Surgery Department, Department in the Faculty of Medicine
3/11/2017
Staff Appointment, Broward Hospital, Miami Florida
Department of Surgery/Transplant Center
01/2016 to present
Staff Appointment, Cleveland Clinic Weston
Department of Surgery/Transplant Center
2014 to present
Director, Cleveland Clinic Transplant Center
Institution/Department:
Digestive Disease Institute/Department of Surgery/Transplant Center
Dates:
8/2012 to present
Position/Rank:
Director, Center for Gut Rehabilitation & Transplantation
Institution/Department:
Digestive Disease Institute/Department of Surgery/Transplant Center
Dates:
8/2012 to present
Position/Rank:
Director, Intestinal Rehabilitation & Transplant Center
Institution/Department:
UPMC/Department of Surgery/Thomas E. Starzl Transplant Institute
Dates:
01/2001-07/2012
ACADEMIC APPOINTMENTS
Position/Rank:
Professor of Surgery
Institution/Department:
Lerner College of Medicine, Case Western Reserve University
Dates:
1/2013 to present
Position/Rank:
Professor of Surgery – Tenure
Institution/Department:
UPMC/Department of Surgery/Thomas E. Starzl Transplant Institute
Dates:
8/2006 – 8/2012
Position/Rank:
Professor of Surgery
Institution/Department:
UPMC/Department of Surgery/Thomas E. Starzl Transplant Institute
Dates:
1/2002-7/2006
Position/Rank:
Associate Professor of Surgery
Institution/Department:
UPMC/Department of Surgery/Thomas E. Starzl Transplant Institute
Dates:
7/1997-12/2001
Position/Rank:
Assistant Professor of Surgery
Institution/Department:
UPMC/Department of Surgery/Transplant Division
Dates:
12/1990-6/1995
Position/Rank:
Professor of Surgery (Joint appointment)
Institution/Department:
Mansoura University school of Medicine, Mansoura, Egypt
Dates:
12/98- 10/2006
Position/Rank:
Associate Professor of Surgery (Joint appointment)
Institution/Department:
Mansoura University school of Medicine, Mansoura, Egypt
Dates:
5/92-11/1998
Position/Rank:
Assistant Professor of Surgery (Joint appointment, 1/1991 – 4/1992)
Institution/Department:
Mansoura University school of Medicine, Mansoura, Egypt
Kareem Abu-Elmagd, M.D., PhD. 3
Dates:
3/1987-4/1992
Position/Rank:
Clinical Instructor in Surgery
Institution/Department:
Mansoura University school of Medicine, Mansoura, Egypt
Dates:
5/1982-2/1987
CERTIFICATION AND LICENSURE
ECFMG
01/1990
FLEX
01/1993
American Board of Surgery
01/1998
American Board of Surgery (Recertification)
01/2006
12/2017-2029
Licensure State/Number:
Date Issued:
Pennsylvania/43372
9/1998 (active)
Licensure State/Number:
Date Issued:
Florida/ME118155
11/2013 (active)-1/31/2020
Licensure State/Number:
Date Issued:
Ohio/099999
8/2012 (active)
Licensure State/Number:
Date Issued:
Pennsylvania/MD048249L
10/27/1993 (active)-12/31/18
Licensure Number:
Date Issued:
DEA/BA3863809
Expires 6/30/2020
MEMBERSHIP IN PROFESSIONAL SOCIETIES
The Society of Egyptian Surgeons
1982 - Present
American Association for the Study of Liver Diseases (AASLD)
1992 - Present
American Medical Association (AMA)
1993 - Present
American Society of Transplant Surgeons (ASTS)
1994 - Present
International College of Surgeons (ICS)
1994 - Present
International Liver Transplant Society (ILTS)
1995 - Present
American College of Surgeons (ACS)
1995 - Present
American Society of Transplantation (AST)
1997 - Present
Pittsburgh Surgical Society
1998 - Present
International Society of Transplantation
1998 - Present
American College of Gastroenterology
1998 - Present
The Society for Surgery of the Alimentary Tract
1999 - Present
American Surgical Association
2002 - Present
HONORS AND AWARDS
Sadat National Prize for Medical Science as the Best Surgical Resident (Egypt)
1980
Visiting Professor at the Military Medical Academy, Belgrade, Yugoslavia
1998
Health Care Heroes Finalist, Pittsburgh Business Times (Pittsburgh, USA)
2000
Nation’s Best Physician - Pittsburgh Magazine (Pittsburgh, PA, USA)
2002-2012
Nation’s Best Physician - Cleveland Magazine (Cleveland, Ohio, USA)
2013-2015
Visiting Professor at Duke University
2003 Muslin Society of Greater Pittsburgh & Association of Pakistani Physicians of North America
2003
ACG Governors Award for Excellence in Clinical Research
2006
Visiting Professor at Cario University, Cairo, Egypt
Visiting Professor of Surgery at Mansoura University, Mansoura, Egypt
Visiting Professor of Surgery at Al- Azhar University, Cairo, Egypt
2011
2018
2018
PUBLICATIONS
I-Peer Reviewed Articles (Refereed)
Kareem Abu-Elmagd, M.D., PhD. 4
1. Warren WD, Millikan WJ, Henderson JM, Abu-Elmagd KM, Galloway JR, Shire GT III, Richards WO, Salam AA, Kutner MH. Splenopancreatic disconnection: Improved selectivity of distal splenorenal shunt. Ann Surg 204(4):346-355, 1986.
2. Ezzat FA, Abu-Elmagd KM, Aly IY, Aly MA, Fathy OM, El-Barbary MH, Bahgat OO, Salam AA, Kutner MH. Distal splenorenal shunt for management of variceal bleeding in patients with schistosomal hepatic fibrosis. Ann Surg 204(4):566-573, 1986.
3. Ezzat FA, Abu-Elmagd KM, Sultan AA, Aly MA, Fathy OM, Bahgat OO, El-Fily AM, El-Barbary MH, Mashhor N. Schistosomal versus nonschistosomal variceal bleeders - Do they respond differently to selective shunt (DSRS)? Ann Surg 209(4):489-500, 1989.
4. Ezzat FA, Abu-Elmagd, KM, Aly MA, Fathy OM, El-Ghawlby NA, El-Fiky AM, El-Barbary MH. Selective shunt versus nonshunt surgery for management of both schistosomal and nonschistosomal variceal bleeders. Ann Surg 212(1):97-108, 1990.
5. Salam AA, Ezzat FA, Abu-Elmagd KM. Selective shunt in schistosomiasis in Egypt. Am J Surg 160:90-92,1990.
6. Abu-Elmagd KM, Ezzat FA, Fathy OM, El-Ghawlby NA, Aly MA, El-Fiky AM, El-Barbary MH, El-Ebady GE, El-Hak NG. Should both schistosomal and nonschistosomal variceal bleeders be disconnected? World J Surg 15:389-398, 1991.
7. Iwaki Y, Starzl TE, Yagihasi A, Taniwaki S, Abu-Elmagd K, Tzakis A, Fung J, Todo S. Replacement of donor lymphoid tissue in small bowel transplants. Lancet 337:818-819, 1991.
8. Starzl TE, Todo S, Tzakis A, Alessiani M, Casavilla A, Abu-Elmagd K, Fung JJ. The many faces of multivisceral transplantation. Surg Gynecol Obstet 172:335-344, 1991 (lead article).
9. Abu-Elmagd K, Fung JJ, Alessiani M, Jain A, Venkataramanan R, Warty VJ, Takaya S, Todo S, Shannon WD, Starzl TE. The effect of graft function on FK 506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation 52:71-77, 1991.
10. Steeves M, Abdallah HY, Venkataramanan R, Burckart GJ, Ptachcinski RJ, Abu-Elmagd K, Jain AK, Fung J, Todo S, Starzl TE. In-vitro interaction of a noval immunosuppressant, FK 506 and antacids. J Pharmacol 43:574-577, 1991.
11. Uknis ME, Block G, Abu-Elmagd KM, Suwan S, Van Thiel D, Duquesnoy R, Zeevi A. Sterilization of human small intestine allograft biopsies for later immunologic studies. Transplantation 52:558-559, 1991.
12. Fung JJ, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Jordan M, Armitage J, Jain A, Martin M, Bronsther O, Stieber A, Kormos R, Selby R, Gordon R, Starzl TE. FK506 in clinical organ transplantation. Clin Transplant 5:517-522, 1991.
13. Todo S, Tzakis AG, Abu-Elmagd K, Reyes J, Fung JJ, Casavilla A, Nakamura K, Yagihashi A, Jain A, Murase N, Iwaki Y, Demetris AJ, Van Thiel DH, Starzl TE. Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation 53:369-376, 1992.
14. Takaya S, Bronsther O, Iwaki Y, Nakamura K, Abu-Elmagd K, Yagihashi A, Demetria AJ, Kobayashi M, Todo S, Tzakis AG, Fung JJ, Starzl TE. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 53:400-406, 1992.
15. Sakr M, Hassanein T, Gavaler J, Abu-Elmagd K, Fung J, Gordon R, Starzl T, Van Thiel D. Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation: Incidence, location, and severity in cyclosporine and FK506-treated patients. Transplantation 53:786-791, 1992.
16. Casavilla A, Selby R, Abu-Elmagd K, Tzakis A, Todo S, Reyes J, Fung J, Starzl TE. Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg 216 (5):605-609, 1992.
Kareem Abu-Elmagd, M.D., PhD. 5
17. Jegasothy BV, Ackerman CD, Todo S, Fung JJ, Abu-Elmagd K, Starzl TE. Tacrolimus (FK506)-A new therapeutic agent for severe recalcitrant psoriasis. Ann Derm 128:781-785, 1992.
18. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, Alessiani M, Abu-Elmagd K, Van Thiel DH, Starzl TE. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy-A clinicopathologic study of 96 patients. Transplantation 53:1056-1062, 1992.
19. Todo S, Tzakis AG, Abu-Elmagd K, Reyes J, Nakamura K, Casavilla A, Selby R, Nour BM, Wright H, Fung JJ, Demetris AJ, Van Thiel DH, Starzl TE. Intestinal transplantation in composite visceral grafts or alone. Ann Surg 216:223-234, 1992.
20. El-Ebiedy G, Sultan A, El-Hak NG, El-Fiky A, El-Ghawalby N, Abdel Wahab M, Fathy O, El-barbary M, Abu-Elmagd K, Ezzat F. Primary hepatic Tumors: Clinical and histopathological evaluation. Mansoura J Medical 13-14/2 1992.
21. Przeipiorka D, Abu-Elmagd K, Huaringa A, Luna M, van Besian K, Starzl TE, Fung JJ. Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506. Bone Marrow Transplant 11:502-508, 1993.
22. Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs other liver diseases. AJR 161:297-300, 1993.
23. Abu-Elmagd K, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, Demetris AJ, Krom RAF, Van Thiel DH, Starzl TE. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 177:335-344, 1993.
24. Abu-Elmagd KM, Van Thiel DH, Jegasothy BV, Jacobs JC, Carroll P, Rilo H, Ackerman CD, Fung JJ, Starzl TE. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506) treatment. Ann Intern Med 119(7):595-598, 1993.
25. Tzakis AG, Todo S, Reyes J, Nour B, Abu-Elmagd K, Selby R, Casavilla A, Kocoshis S, Demetris AJ, Yunis E, Van Thiel DH, Starzl TE. Intestinal transplantation in children under FK 506 immunosuppression. J Pedtr Surg 28(8):1040-1043, 1993.
26. Abu-Elmagd KM, Aly MA, Fathy OM, El-Ghawlby NA, El-Fiky AM, El-Barbary MH, El-Hak NG, El-Ebady GE, Sultan A, Baghut SO, Ezzat FA. Ten years of experience with chronic active liver disease variceal bleeding: Ablative versus selective decompressive therapy. Surgery 114(5):868-881, 1993.
27. Campbell WL, Abu-Elmagd K, Federle MP, Thaete FL, Furukawa H, Tzakis AG, Todo S. Contrast examination of the small bowel in patients with small-bowel transplants: findings in 16 patients. AJR 161:969-974, 1993.
28. Thomson AW, Woo J, Lemster B, Irish W, Huang LL, Carroll PB, Rilo HR, Abu-Elmagd K, Eidelman B. Incidence of CD4+ IL-2R+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy. Ann NY Acad Sci 696:245-249, 1993.
29. Jain AB, Abu-Elmagd K, Abdallah H, Warty VJ, Fung J, Todo S, Starzl TE, Venkataramanan R. Pharmacokinetics of FK 506 in liver transplant recipients following continuous intravenous infusion. J Clin Pharmacol 33:606-611, 1993.
30. El-Barbary MH, Fathy O, Elfiky A, Wahab MA, Abu-Elmagd K, El-Hak NG, El-Ebiedy G, Ezzat F. Parietal cell vagotomy (P.C.V.) 15 years experience. Benha Med J 10(2):135-145, 1993.
31. El-Hak NG, Wahab MA, Shady M, Fathy O, Elbarbary M, Abu-Elmagd K, Elebeidy G, Ezzat F. Evaluation of esophageal function after Heller’s myotomy for treatment of achalasia. Benha Med J 10(3), 1993.
32. El-Fiky A, Fathy O, Abdel Wahab M, El-Barbary MH, Abu-Elmagd K, El-Hak NG, El-Ebaidy G, Ezzat FA. Ulcerative colitis in Mansoura Provence “Egypt” epidemiological study. Benha Med J 10(3), 1993.
Kareem Abu-Elmagd, M.D., PhD. 6
33. Abdel Wahab M, El-Barbary MH, El-Ebady G, El-Ghawalby N, Sultan A, El-Fiky A, Fathy OM, El-Hak NG, Abu-Elmagd K, Ezzat FA. Recurrent ulcer following different surgical modalities for treatment of duodenal ulcer. Benha Med J 10(3), 1993.
34. Campbell WL, Sheng R, Zajko AB, Abu-Elmagd K, Demetris AJ. Intrahepatic biliary strictures after liver transplantation. Radiology 191:735-740, 1994.
35. Wilson, JR, Conwit RA, Eidelman BH, Starzl TE, Abu-Elmagd K. Sensorimotor neuropathy resembling CIDP in patients receiving FK 506. Muscle Nerve 17:528-532, 1994.
36. Todo S, Tzakis A, Reyes J, Abu-Elmagd K, Furukawa H, Nour B, Casavilla A, Nakamura K, Fung J, Demetris AJ, Starzl T. Small intestinal transplantation in humans with or without colon. Transplantation 57(6):840-848, 1994.
37. Fontes P, Rao AS, Demetris AJ, Zeevi A, Trucco M, Carroll P, Rybka W, Rudert WA, Ricordi C, Dodson F, Shapiro R, Tzakis A, Todo S, Abu-Elmagd K, Jordan M, Fung JJ, Starzl TE. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 344:151-155, 1994.
38. Eghtesad B, Bronsther O, Irish W, Casavilla A, Abu-Elmagd K, Van Thiel D, Tzakis A, Fung JJ, Starzl TE. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 20(Suppl1):56-62, 1994.
39. Casavilla A, Selby R, Abu-Elmagd K, Reyes J, Nakamura K, Wright HI, Tzakis A, Todo S, Demetris AJ, Fung JJ, Van Thiel DH, Starzl TE. Early clinical and histologic viability of human liver-small intestinal allografts after implantation. Clin Transplant 8:49-53, 1994.
40. Todo S, Fung JJ, Starzl TE, Tzakis A, Doyle H, Abu-Elmagd K, Jain A, Selby R, Bronsther O, Marsh W, Ramos H, Reyes J, Gayowski T, Casavilla A, Dodson F, Furukawa H, Marino I, Pinna A, Nour B, Jabbour N, Mazariegos G, McMichael J, Kusne S, Venkataramanan R, Warty V, Murase N, Demetris AJ, Iwatsuki S. Single-center experience with primary orthotopic liver transplantation under FK 506 immunosuppression. Ann Surg 220(3):297-309, 1994.
41. Abu-Elmagd K, Todo S, Tzakis A, Reyes J, Nour B, Furukawa H, Fung JJ, Demetris A, Starzl TE. Three years clinical experience with intestinal transplantation. J Am Coll Surg 179:385-400, 1994.
42. Lemster B, Huang LL, Irish W, Woo J, Carroll PB, Abu-Elmagd K, Rilo HR, Johnson N, Russell-Hall R, Fung JJ, Starzl TE, Eidelman B, Thomson AW. Influence of FK 506 (Tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. Autoimmunity 19:89-98, 1994.
43. Carroll PB, Rilo HL, Abu-Elmagd K, Johnson N, Carter C, Wright H, Jegasothy B, Starzl TE, Van Thiel DH. Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: Rationale and preliminary results. Arch Dermatol 130 (11):1457-1458, 1994.
44. Ramos HC, Reyes J, Abu-Elmagd K, Zeevi A, Reinsmoen N, Tzakis A, Demetris AJ, Fung JJ, Flynn B, McMichael J, Ebert F, Starzl TE. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 59:212-217, 1995.
45. Todo S, Tzakis A, Abu-Elmagd K, Reyes J, Furukawa H, Nour B, Fung JJ, Demetris A, Starzl TS. Abdominal multivisceral transplantation. Transplantation 59:234-240, 1995.
46. Pham SM, Keenan RJ, Rao AS, Fontes PA, Kormos RL, Abu-Elmagd K, Zeevi A, Kawai A, Hattler BG, Hardesty RL, Demetris AJ, Trucco MM, Rosner GL, Fung JJ, Starzl TE, Griffith BP. Perioperative donor bone marrow augments chimerism in heart and lung transplant recipients. Ann Thorac Surg 60:1015-1020, 1995.
47. Manez R, Kusne S, Green M, Abu-Elmagd K, Irish W, Reyes J, Furukawa H, Tzakis A, Fung JJ, Todo S, Starzl TE. Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 59(7):1010-1014, 1995.
Kareem Abu-Elmagd, M.D., PhD. 7
48. Todo S, Reyes J, Furukawa H, Abu-Elmagd K, Lee RG, Tzakis A, Rao AS, Starzl TE. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 222(3): 270-282, 1995.
49. Van Thiel DH, Carroll P, Abu-Elmagd K, Rodriquez-Rilo H, Irish W, McMichael J, Starzl TE. Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis. Results of an open-label preliminary trial. Am J Gastroenterol 90(3):455-459, 1995.
50. Tzakis AG, Nour B, Reyes J, Abu-Elmagd K, Furukawa H, Todo S, Starzl TE. Endorectal pull-through of transplanted colon as part of intestinal transplantation. Surgery 117:451-453, 1995.
51. Van Thiel DH, Wright HI, Carroll P, Abu-Elmagd K, Rodriguez-Rilo H, McMichael J, Irish W, Starzl TE. Tacrolimus: A potential new treatment for autoimmune chronic active hepatitis. Results of an open-label preliminary trial. Am J Gastroenterol 90(5):771-776, 1995.
52. Furukawa H, Reyes J, Abu-Elmagd K, Todo S. Clinical intestinal transplantation. Clin Nutrition 15:45-52, 1996.
53. Lee RG, Nakamura K, Tsamandas AC, Abu-Elmagd K, Furukawa H, Hutson W, Reyes J, Tabasco-Minguillan JS, Todo S, Demetris AJ. Pathology of human intestinal transplantation. Gastroenterology 110:1820-1834, 1996.
54. Kusne S, Manez R, Frye BL, George K, Abu-Elmagd K, Tabasco-Minguillan J, Fung JJ, Todo S, Rinaldo C, Ehrlich GD. Use of DNA amplification for the diagnosis of Cytomegalovirus enteritis after intestinal transplantation. Gastroenterology 112:1121-1128, 1997.
55. Reyes J, Todo S, Green M, Yunis E, Skoner D, Kocoshis S,, Furukawa H, Abu-Elmagd K, Tzakis A,, Bueno J, Starzl TE.. Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant 11:345-348, 1997.
56. Bueno J, Green M, Kocoshis S, Furukawa H, Abu-Elmagd K, Yunis E, Irish W, Todo S, Reyes J, Starzl TE. Cytomegalovirus infection after intestinal transplantation in children. Clin Inf Dis 25:1078-1083, 1997.
57. Reyes J, Bueno J, Kocoshis S, Green M, Abu-Elmagd K, Furukawa H, Barksdale E, Strom S, Fung JJ, Todo S, Irish W, Starzl TE. Current status of intestinal transplantation in children. J Pediatr Surg 33:243-254, 1998.
58. Abu-Elmagd K, Reyes J, Todo S, Rao A, Lee R, Irish W, Furukawa H, Bueno J, McMichael J, Fawzy AT, Murase N, Demetris J, Rakela J, Fung JJ, Starzl TE. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 186:512-527, 1998.
59. Furukawa H, Kusne S, Sutton DA, Manez R, Carrau R, Nichols L, Abu-Elmagd K, Skedros D, Todo S, Rinaldi MG. Acute invasive sinusitis due to Trichoderma Longibrachiatum in a liver and small bowel transplant recipient. Clin Infect Dis 26(2):487-489, 1998.
60. Reyes J, Fishbein T, Bueno J, Mazariegos G, Abu-Elmagd K. Reduced-size orthotopic composite liver-intestinal allograft. Transplantation 66(4):489-492, 1998.
61. Rovera GM, DiMartini A, Schoen RE, Rakela J, Abu-Elmagd K, Graham TO. Quality of life of patients after intestinal transplantation. Transplantation 66(9):1141-1145, 1998.
62. DiMartini A, Rovera GM, Graham TO, Furukawa H, Todo S, Funovits M, Lu S, Abu-Elmagd KM. Quality of life after intestinal transplantation and among home parenteral nutrition patients. JPEN 22(6):357-62, 1998.
63. Bueno J, Ohwada S, Kocoshis S, Mazariegos GV, Dvorchik I, Sigurdsson L, DiLorenzo C, Abu-Elmagd K, Reyes J, Factors impacting on the survival of children with intestinal failure referred for intestinal transplantation. J Ped Surg 34(1):27-33, 1999.
64. Idoate MA, Martinez AJ, Bueno J, Abu-Elmagd K, Reyes J. The neuropathology of intestinal failure and small bowel transplantation. Acta Neuropathologica 97:502-508, 1999.
Kareem Abu-Elmagd, M.D., PhD. 8
65. Grant D, Abu-Elmagd K. Intestinal transplantation: 1997 report of the international registry. Transplantation 67:1061-1064, 1999.
66. Oddis CV, Sciuraba FC, Abu-Elmagd KM, Starzl TE. Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 353:1762-1763, 1999.
67. Salgar S, Shapiro R, Dodson F, Corry R, McCurry K, Zeevi A, Pham S, Abu-Elmagd K, Reyes J, Jordan M, Keenan R, Griffith B, Sesky T, Ostrowski L, Starzl TE, Fung JJ, Rao AS. Infusion of donor leukocyes to induce tolerance in organ allograft recipients. J Leukoc Biol 66(2):310-314, 1999.
68. Sigurdsson L, Reyes J, Kocoshis SA, Mazariegos G, Abu-Elmagd KM, Bueno J, DiLorenzo C. Intestinal transplantation in children with chronic intestinal Pseudo-obstruction. GUT 45(4):570-574, 1999.
69. Jain A, Reyes J, Kashyap R, Rohal S, Abu-Elmagd K, Starzl T, Fung J. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg 230(3):441-449, 1999.
70. Bueno J, Abu-Elmagd K, Mazariegos G, Madariaga J, Fung J, Reyes J. Composite liver-small bowel allografts with preservation of donor duodenum and hepatic biliary system in children. J Ped Surg 35(2):291-296, 2000.
71. Green M, Bueno J, Rowe D, Mazariegos G, Qu L, Abu-Elmagd K, Reyes J. Predictive negative value of persistent low EBV viral load after intestinal transplantation in children. Transplantation 70(4):593-596, 2000.
72. Sigurdsson L, Reyes J, Kocoshis SA, Mazariegos G, Abu-Elmagd K, Green M. Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. Transplantation 70(2):302-305, 2000.
73. Eskandari MK, Makaroun MS, Abu-Elmagd K, Billiar TR. Endovascular treatment of an aortoduodenal fistula: A complication of an extragonadal germ cell tumor. J Endovasc Ther 7(4):328-332, 2000.
74. Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, Abu-Elmagd K, Marsh W, Madariaga J, Mazariegos G, Geller D, Bonham CA, Gayowski T, Cacciarettl T, Fontes P, Starzl TE, and Fung J. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann of Surg 232(4):490-500, 2000.
75. Abu-Elmagd KM, Fung JJ, Bueno J, Martin D, Madariaga JR, Mazariegos G, Bond GJ, Molmenti E, Corry RJ, Starzl TE, Reyes J. Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor. Ann of Surg 232(5):680-687, 2000.
76. Murase N, Ye Q, Nalesnik MA, Demetris AJ, Abu-Elmagd K, Reyes J, Ichikawa N, Okuda T, Fung JJ, Starzl TE. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation 70(11):1632-1641, 2000.
77. Bueno J, Gutierrez J, Mazariegos G, Abu-Elmagd K, Madariaga J, Ohwada S, Reyes J. Analysis of patients with longitudinal intestinal lengthening procedure referred for evaluation for intestinal transplantation. J Ped Surg 36(1):178-183, 2001.
78. Abu-Elmagd K, Reyes J, Bond G, Mazariegos G, Wu T, Murase N, Sindhi R, Martin D, Colangelo J, Zak M, Janson D, Ezzelarab M, Dvorchik I, Parizhskaya M, Deutsch M, Demetris A, Fung J, Starzl T. Clinical intestinal transplantation: A decade of a single center experience. Ann of Surg 234(3):404-417, 2001.
79. Dvorchik I, Subotin M, Demetris AJ, Fung JJ, Starzl TE, Wieand S, Abu-Elmagd KM. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology 35(2):380-384. 2002.
Kareem Abu-Elmagd, M.D., PhD. 9
80. Demetris AJ, Ruppert K, Dvorchik I, Jain A, Minervini M, Nalesnik MA, Randhawa P, Wu T, Abu-Elmagd KM, Fontes P, Cacciarelli T, Marsh W, Geller D, Fung. Real time monitoring of acute liver allograft rejection using the Banff Schema. Transplantation 74(9):1290-1296, 2002.
81. Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, Eghtesad B, Marsh W, Cacciarelli T, Fontes P, Abu-Elmagd K, Sindhi R, Demetris J, Fung J. Post-transplant lymphoproliferative disorders (PTLD) in liver transplantation (LTX): A twenty-year experience. Ann of Surg 236(4):429-36, 2002.
82. Turler A, Kalff JG, Heeckt P, Abu-Elmagd KM, Schraut WH, Bond GJ, Moore VA, Brunagel G, Bauer AJ. Molecular and functional observations on the donor intestinal muscularis during human small bowel transplantation. Gastroenterology 122:1886-1897, 2002.
83. Han PKJ, Arnold R, Bond G, Janson D, Abu-Elmagd K. Myoclonus secondary to withdrawal from transdermal fentanyl: Case report and literature review. Journal of Pain and Symptom Management 23(1):66-72, 2002.
84. Reyes J, Mazariegos GV, Bond G, Green M, Dvorchik I, Kosmach-Park B, Abu-Elmagd K. History of pediatric organ transplantation: Pediatric intestinal transplantation: Historical notes, principles and controversies. Ped Transplantation (6):193-207, 2002.
85. Parizhskaya M, Redondo C, Demetris A, Jaffe R, Reyes J, Ruppert K, Martin L, Abu-Elmagd K. Chronic rejection of small bowel grafts: A pediatric and adult study of risk factors and morphologic progression. Ped & Dev Path 6(3):240-250. 2003.
86. Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, Corry RJ, Jordan ML, Fontes P, Gayowski T, Bond G, Scantlebury VP, Potdar S, Randhawa P, Wu T, Zeevi A, Nalesnik MA, Marcos A, Trucco M, Demetris AJ, Fung JJ. Tolerogenic immunosuppression for organ transplantation. Lancet 361(9368):1502-10, 2003.
87. Rovera GM, Schoen RE, Goldbach B, Janson D, Bond G, Rakela J, Graham TO, O’Keefe S, Abu-Elmagd, K. Intestinal and Multivisceral Transplantation: Dynamics of Nutritional Management and Functional Autonomy. JPEN J Parenter Enteral Nutri 27(4):252-9, 2003.
88. Rhee J, Demetris AJ, Abu-Elmagd K, Rabinovitz M. Suprahepatic Budd-Chiari syndrome treated with thrombectomy and cavoplasty. Dig Dis Science 48(8):1637-41, 2003.
89. Wu T, Cieply K, Nalesnik MA, Randhawa PS, Sonzongni A, Bellamy C, Abu-Elmagd K, Michalopolous GK, Jaffe R, Kormos RL, Gridelli B, Fung JJ, Demetris AJ. Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts. Am J Transplant 3(9):1173-1181, 2003.
90. Macedo C, Popescu I, Logar A, Abu-Elmagd K, Shapiro R, Reyes J. Repertoire, memory subsets, and function of EBV-specific CD8+T cells in peripheral blood from stable solid organ transplant patients. Hum Immunol 64:S41, 2003.
91. Metes D, Logar A, Rudert WA, Zeevi A, Woodward J, Demetris AJ, Abu-Elmagd K, Eghtesad B, Shapiro R, Fung JJ, Trucco M, Starzl TE, Murase N. Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Human Immunology, 64(8):787-95, 2003.
92. Vilchez RA, Shapiro R, McCurry K, Kormos, R, Abu-Elmagd KM, Fung J, Kusne S. Longitudinal Study of Cryptococcosis in Adult Solid Organ Transplant Recipients. Transplantation Int 16:336-340, 2003.
93. Wu T, Abu-Elmagd K, Bond G, Nalesnik MN, Radhawa P, Demetris AJ. A schema for histological grading of allograft small intestine acute rejection. Transplantation 75(8):1241-8, 2003.
94. Starzl TE, Murase N, Demetris A, Trucco, Abu-Elmagd K, Gray E, Eghtesad B, Shapiro R, Marcos A, Fung J. Lessons of organ-induced tolerance learned from history. Transplantation 22; 7(6): 926-29, 2004.
Kareem Abu-Elmagd, M.D., PhD. 10
95. Abu-Elmagd KM, Zak M, Stamos J, Bond G, Jain A, Youk A, Ezzelarab M, Costa G, Wu T, Nalesnik M, Mazariegos G, Sindhi R, Marcos A, Demetris A, Fung J, Reyes J. De novo malignancies after intestinal and multivisceral transplantation. Transplantation 15; (11): 1719-25, 2004.
96. Wu T, Abu-Elmagd K, Bond G, Demetris A. A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies. Human Path 35(11): 1332-39, 2004.
97. Mazariegos GV, Abu-Elmagd K, Jeffe R. Bond G, Martin L, Macedo C, Peters J, Sindhi R, Reyes J. Graft versus host disease in intestinal transplantation. American Journal of Transplantation 4(9): 1459-65, 2004.
98. Thai N., Abu-Elmagd K., Khan A., Bond G., Basu A., Tom K., Mazariegos G., Sindhi R., Reyes J., Tan H., Marcos A., Starzl T., Shapiro R. Pancreatic Transplantation at the University of Pittsburgh. 205-214, 2004.
99. Buchman, Alan, Kotler, Donald, Abu-Elmagd, Kareem, Practical Approach to the Management of Short-Bowel Syndrome. Gastroenterology & Endoscopy News, 1-12, July 2004
100. Grant D, Abu-Elmagd K, Reyes J, Tzakis A, Langnas A, Fishbein T, Goulet O, Farmer D. 2003 Report of the intestine transplant registry: A new era has dawned. Annals of Surgery 241(4): 607-613, 2005.
101. Zeevi A, Britz J, Bentlejewski C, Guaspari D, Tong, Bond G, Murase N, Harris C, Zak M, Martin D, Post D, Kowalski R, Abu-Elmagd K. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transplant Immunology 15: 17-24, 2005.
102. Reyes J, Mazariegos G, Abu-Elmagd K, Macedo C, Bond G, Murase N, Peters J, Sindhi R, Starzl T E. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (Thymoglobulin). American Journal of Transplantation 5: 1430-1436, 2005
103. Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J. Evolutionary experience with immunosuppression in pediatric intestinal transplantation. Journal of Pediatric Surgery 40(1): 274-280, 2005.
104. Macedo C, Popescu I, Abu-Elmagd K, Reyes J, Shapiro R, Zeevi A, Mueller Berghaus J, Wang L, Lu L, Thomson A, Storkus W, Fung J, Metes D. Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients. Transplantation 79 (4): 451-459, 2005.
105. Flynn B, Kosmach Park B, McGhee W, Mazariegos G, Bond G, Sindhi R, Reyes J, Abu-Elmagd K, Immunosuppressive strategies for intestinal transplantation: a tolerogenic regime using recipient induction therapy pre-transplant and tacrolimus monotherapy post-transplant. Progress in Transplantation 15(1): 60-64, 2005.
106. Matarese LE, O’Keefe SJ, Kandil HM, Bond G, Costa G, Abu-Elmagd K. Comprehensive care of the patient with intestinal failure. Japanese Journal of Clinical Nutrition 106(6): 804-809, 2005.
107. Matarese LE, O’Keefe SJ, Kandil HM, Bond G, Costa G, Abu-Elmagd K. Short bowel syndrome: Clinical guidelines for nutrition management. Nutrition in Clinical Practice 20(10): 493-502, 2005.
108. Matarese LE, Abu-Elmagd K. Somatropin for the treatment of short bowel syndrome. Expert Opinion Pharmacotherapy 6(10): 1741-1750, 2005.
109. Macedo C, Sindhi R, Mazariegos GV, Abu-Elmagd K, Bond GJ, Reyes J. Sclerosing peritonitis after intestinal transplantation in children. Pediatr Transplantation 9(2):187-191, 2005.
110. Lang E, Reyes J, Faintuch S, Smith A, Amesur N, Abu-Elmagd K. Central venous recannalization and restoration of candidacy for intestinal and multivisceral transplantation: An innovative radiologic approach. J Vasc Interv Radiol 16(9): 1203-1213, 2005.
111. Abu-Elmagd KM, Bond G, Matarese L, Costa G, Koritsky D, Laughlin K, Soltys K, Kandil H, Sindhi R, O’Keefe S, Mazariegos G. Gut rehabilitation and intestinal transplantation. Therapy 2(6): 853-864, 2005.
Kareem Abu-Elmagd, M.D., PhD. 11
112. Nato JS, Macedo C, Jaffe R, Mazariegos GV, Sindhi R, Bond GJ, Abu-Elmagd K, Reyes J. Carcinoma of donor origin after liver-intestine transplantation in a child. Pediatr Transplant 9(2):244-248, 2005.
113. Macedo C, Donnenberg A, Popescu I, Reyes J, Abu-Elmagd K, Shapiro R, Zeevi A, Fung JJ, Storkus WJ, Metes D. EBV-specific CD8+ T cell phenotype and function in stable solid organ transplant patients. Transplant Immunology 14:109-116, 2005.
114. Mendes O, Kanal E, Abu-Elmagd K, McFadden K, Thomas S, Bond G, Zivkovic S. Granulomatous amebic encephalitis in a multivisceral transplant recipient. European Journal of Neurology 13:292-295, 2006.
115. Matarese LE, Abu-Elmagd K. Can growth hormone and glutamine reduce parenteral nutrition in patients with short bowel syndrome? Nature Clinical Practice Gastroenterology & Hepatology 3(4):194-195, 2006.
116. Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LM, Abu-Elmagd K, Connor J. Distal splenorenal shunt versus transjugular intrahepatic portal systemic shunt for variceal bleeding: a randomized trial. Gastroenterology, 130(6): 1643-1651, 2006.
117. Boucek CD, Abu-Elmagd KM. Alternative route transfusion for transplantation surgery in patients lacking accessible veins. Anesthesia & Analgesia 102(5): 1591-1592, 2006.
118. Wu T, Bond G, Martin D, Nalesnik M, Demetris A, Abu-Elmagd K. Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab. American Journal of Gastroenterology 101(7): 1617-1624, 2006.
119. Kowalski R, Post D, Mannon R, Sebastian A, Wright H, Sigle G, Burdick J, Abu-Elmagd K, Zeevi A, Lopez-Cepero M, Daller J, Gritsch HA, Reed E, Jonnson J, Hawkins D, Britz J. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 82(5): 663-668, 2006.
120. Peleg AY, Husain S, Kwak EJ, Silveira FP, Magdaline N, Tran J, Shutt KA, Shapiro R, Thai N, Abu-Elmagd K, McCurry KR, Marcos A, Paterson DL. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monocloncal CD-52 antibody. Clin Infect Dis 44(2):204-212, 2006.
121. Silveira FP, Marcos A, Kwak EJ, Husain S, Sharpiro R, Thai N, McCurry KR, Abu-Elmagd K, Paterson DL. Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. J Infect 53(4):241-247, 2006.
122. O’Keefe SJD, Emerling M, Koritsky D, Martin D, Stamos J, Kandil H, Matarese L, Bond G, Abu-Elmagd K. Nutrition and quality of life following small intestinal transplantation. Am J Gastro 102(5):1093-1100, 2007.
123. Popescu J, Macedo C, Abu-Elmagd K, Shapiro R, Thomson AW, Morellis AE, Storkus WW, Metes D. EBV-specific CD8+ T cells reactivation from transplant patients results in expansion of CD8+ Type-1 tregs. Am J Transplant 7(5):1215-1223, 2007.
124. Schaefer N, Tahara K, Schmidt J, Wehner S, Kalff J, Abu-Elmagd K, Hirner A, Turler A. Resident macrophages are involved in intestinal transplantation associated inflammation and motoric dysfunction of the graft muscularis. Am J Transplant 7(5):1062-1070, 2007.
125. McMahon C, Abu-Elmagd K, Bontempo FA, Kant JA, Swerdlow SH. JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses. Am J Clin Pathol 127:736-743, 2007.
126. Harary AM, Abu-Elmagd K, Thai N, Shapiro R, Todo A, Fung JJ, Starzl TE. World’s longest surviving liver-pancreas recipient. Liver Transplantation 13:957-960, 2007.
127. Matarese L, Costa G, Bond G, Stamos J, Koritsky D, O’Keefe SJD, Abu-Elmagd K. Therapeutic efficacy of intestinal and multivisceral transplantation: survival and nutritional outcome. Nature Clinical Practice 22(5):474-481, 2007.
Kareem Abu-Elmagd, M.D., PhD. 12
128. Akhavan A, Jackman SV, Costa G, Davies B, Wu T, Bond G, Abu-Elmagd K. Urogenital disorders associated with gut failure and intestinal transplantation. J Urol 178(5):2067-2072, 2007.
129. Abu-Elmagd KM. Preservation of the native spleen, duodenum, and pancreas in patients with multivisceral transplantation: Nomenclature, dispute of origin, and proof of premise. Transplantation 84(9):1208-1209, 2007.
130. Boyer TD, Henderson JM, Heerey AM, Arrigain S, Konig V, Connor J, Abu-Elmagd K, Galloway J, Rikkers LF, Jeffers L. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. Journal of Hepatology 48(3):407-414, 2007.
131. Zivkovic SA, Costa G, Bond G, Abu-Elmagd KM. Treatment of tardive dyskinesia with levetiracetam in a transplant patient. Acta Neurol Scand 115(5):351-353, 2008.
132. Adeyi OA, Randhawa PA, Nalesnik MA, Ochoa ER, Abu-Elmagd KM, Demetris AJ, Wu T. Posttransplant adenoviral enteropathy in patients with small bowel transplantation. Arch Pathol Lab Med 132(4):703-705, 2008.
133. Schaefer N, Tahara K, Schuchtrup S, Websky MV, Overhaus M, Schmidt J, Wirz S, Abu-Elmagd KM, Kalff JC, Hirner A, Turler A. Perioperative glycine treatment attenuates ischemia/reperfusion injury and ameliorates smooth muscle dysfunction in intestinal transplantation. Transplantation 85(9):1300-1310, 2008.
134. Schaefer N, Tahara K, von Websky M, Koscielny A, Pantelis D, Kalff JC, Abu-Elmagd K, Hirner A, Turler A. Acute rejection and the muscularis propria after intestinal transplantation: The alloresponse, inflammation, and smooth muscle function. Transplantation 85(10):1465-1475, 2008.
135. Sanghavi SK, Abu-Elmagd K, Keightley MC, St. George K, Lewandowski K, Boes SS, Bullotta A, Dare R, Lassak M, Husain S, Kwak EJ, Paterson DL, Rinaldo CR. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients. J Clin Virol 42(4):335-342, 2008.
136. Schaefer N, Tahara K, von Websky M, Wehner S, Pech T, Tolba R, Abu-Elmagd K, Kalff JC, Hirner A, Turler A. Role of resident macrophages in the immunologic response and smooth muscle dysfunction during acute allograft rejection after intestinal transplantation. Transpl Int 21(8):778-791, 2008.
137. Mazariegos G, Soltys K, Bond G, Girnita, Machaidze A, Zeevi A, Green M, Martin D, Jaffe R, Squires R, Perez G, Abu-Elmagd K, Sindhi R. Pediatric intestinal re-transplantation: Techniques, management and outcomes. Transplantation 86(12):1777-1782, 2008.
138. Schaefer N, Tahara K, Pech T, Websky MV, Fujishiro J, Pantelis D, Abu-Elmagd K, Kalff JC, Hirner A, Turler A. Inducible nitric oxide synthase expression in the intestinal muscularis mediates severe smooth muscle dysfunction during acute rejection in allogenic rodent small bowel transplantation. J Surg Res 150(2):159-168, 2008.
139. Matarese LE, Dvorchik I, Costa G, Bond GJ, Koritsky DA, Ferraris RP, Touger-Decker R, O’Sullivan-Maillet JK, Abu-Elmagd KM. Pyridoxal-5’-phosphate deficiency after intestinal and multivisceral transplantation. Am J Clin Nutr 89(1):204-209, 2008.
140. El Hajj II, Khalid A, Schoedel KE, Abu-Elmagd KM, McGrath KM, Fasanella KE. EUS-guided FNA diagnosis of primary splenic lymphoma. Gastrointest Endosc 69(3): 585-588, 2009.
141. Talukdar AJ, Ashokkumar C, Wilson P, Gupta A, Sun Q, Boig L, Abu-Elmagd K, Mazariegos G, Green M, Sindhi R. Lymphocyte subset reconstitution patterns in children with small bowel transplantation induced with steroid-free rabbit anti-human thymocyte globulin. Pediatr Transplant 13(3): 353-359, 2009.
142. Ashokkumar C, Gupta A, Sun Q, Ningappa M, Higgs BW, Mazariegos G, Fazzolare T, Remaley L, Soltys K, Bond G, Abu-Elmagd K, Sindhi R. Allospecific CD154+ T-cells identify rejection-prone recipients after pediatric small bowel transplantation. Surgery 146(2):166-173, 2009.
Kareem Abu-Elmagd, M.D., PhD. 13
143. Hilmi I, Kellum JA, Planinsic R, Foster D, Abdullah A, Damian D, Gligor S, Klein D, Abu-Elmagd K. Endotoxemia is common following abdominal organ transplantation and is associated with reperfusion and rejection. Journal of Organ Dysfunction iFirst article:1-7, 2009.
144. Abu-Elmagd KM, Costa G, Bond GJ, Soltys K, Sindhi R, Wu T, Koritsky D, Schuster B, Martin L, Cruz R, Murase N, Zeevi A, Irish W, Ayyash MO, Matarese L, Humar A, Mazariegos G. Five hundred intestinal and multivisceral transplantation at a single center: Major advances with new challenges. Ann of Surg 250(4):567-581, 2009.
145. Abu-Elmagd KM, Mazariegos G, Costa G, Soltys K, Bond G, Sindhi R, Green M, Jaffe R, Wu T, Koritsky D, Matarese L, Schuster B, Martin L, Dvorchik I, Nalesnik M. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: Improved outcome with new outlook. Transplantation 88(7):926-934, 2009.
146. Sidjabat HE, Silveira FP, Potoski BA, Abu-Elmagd KM, Adams-Haduch JM, Paterson DL. Interspecies spread of klebsiella pneumoniae carbapenemase gene in a single patient. Clinical Infectious Diseases 49(11):1736-1738, 2009.
147. Shapiro R, Basu A, Tan HP, Morgan C, Sharma V, Blisard D, Randhawa PS, Dvorchik I, McCauley J, Ellis D, Marsh JW, Webber S, Kurlnad G, McCurry KR, Abu-Elmagd K, Mazariegos G, Starzl TE. Kidney after nonrenal transplantation – the impact of alemtuzumab induction. Transplantation 88(6):799-802, 2009.
148. Gupta A, Ashokkumar C, Ningappa M, Sun Q, Higgs BW, Snyder S, Johnson M, Zeevi A, Abu-Elmagd KM, Thomson AW, Mazariegos GV, Sindhi R. Elevated myeloid: Plasmacytoid Dendritic cell ration associates with early acute cellular rejection in pediatric small bowel transplantation. Transplantation 89(1):55-60, 2010.
149. Nayyar N, Mazariegos G, Ranganathan S, Soltys K, Bond G, Jaffe R, Sun Q, Nucci A, Kosmach B, Squires R, Abu-Elmagd K, Sindhi R. Pediatric small bowel transplantation. Seminars in Pediatric Surgery 19(1):68-77, 2010.
150. Zivkovic SA, Eidelman BH, Bond G, Costa G, Abu-Elmagd KM. The clinical spectrum of neurological disorders after intestinal and multivisceral transplantation. Clin Transplant 24(2):164-168, 2010.
151. Ashokkumar C, Gupta A, Sun Q, Higgs BW, Ningappa M, Snyder S, Johnson M, Mazariegos G, Soltys K, Bond G, Abu-Elmagd K, Sindhi R. Proliferative alloresponse of T-cytotoxic identifies rejection-prone children with small-bowel transplantation. Transplantation 89(11):1371-1377, 2010.
152. Sindhi R, Ashokkumar C, Mazariegos G, Nayyar N, Ningappa M, Soltys K, Bond G, Sun Q, Humar A, Abu-Elmagd K, Zeevi A. Immune monitoring in small bowel transplantation. Curr Opin Organ Transplant 15(3):349-356, 2010.
153. Fujishiro J, Pech TC, Finger TF, Praktinjo M, Stoffels B, Standop J, Abu-Elmagd K, Tuerler A, Himer A, Kalff JC, Schaefer N. Influence of immunosuppression on alloresponse, inflammation and contractile function of graft after intestinal transplantation. Am J Transplant 10(7):1545-1555, 2010.
154. Eid K, Costa G, Bond G, Cruz R, Rubin E, Bielefeldt K, Koritsky D, Abu-Elmagd K. An innovative sphincter preserving pull-through technique with en bloc colon and small bowel transplantation. Am J Transplant 10(8):1940-1946, 2010.
155. Resnick J, Gupta N, Wagner J, Costa G, Cruz R, Martin L, Koritsky D, Perera S, Matarese L, Schuster B, Eid K, Roberts M, Greenspan S, Abu-Elmagd K. Skeletal integrity and visceral transplantation. Am J Transplant 10(10):2331-2340, 2010.
156. Cruz RJ, Costa G, Bond GJ, Soltys K, Stein WC, Wu G, Martin L, Koritsky D, McMichael J, Sindhi R, Mazariegos G, Abu-Elmagd KM. Modified liver-sparing multivisceral transplant with preserved native spleen, pancreas and duodenum: Technique and long-term outcome. J Gastrointest Surg 14(11):1709-1721, 2010.
Kareem Abu-Elmagd, M.D., PhD. 14
157. Pech T, Finger T, Fujishiro J, Praktiknjo M, Ohsawa I, Abu-Elmagd K, Limmer A, Himer A, Kalff JC, Schaefer N. Perioperative infliximab application ameliorates acute rejection associated inflammation after intestinal transplantation. Am J Transplant 10(12):2431-2441, 2010.
158. Ashokkumar C, Bentlejewski C, Sun Q, Higgs BW, Snyder S, Mazariegos GV, Abu-Elmagd K, Zeevi A, Sindhi R. Allospecific CD154+ B cells associate with intestine allograft rejection in children. Transplantation 90(11):1226-1231, 2010.
159. Adeyi OA, Costa G, Abu-Elmagd KM, Wu T. Rotavirus infection in adult small intestine allografts: A clinicopathological study of a cohort of 23 patients. Am J Transplant 10(12):2683-2689, 2010.
160. Abu-Elmagd KM. The small bowel contained allografts: Existing and proposed nomenclature. Am J Transplant, 11(1):184-185, 2010.
161. Ningappa M, Higgs BW, Weeks DE, Ashokkumar C, Duerr RH, Sun Q, Soltys KA, Bond GJ, Abu-Elmagd K, Mazariegos GV, Alissa F, Rivera M, Rudolph J, Squires R, Hakonarson H, Sindhi R. NOD2 gene polymorphism rs2066884 associates with need for combined liver-intestine transplantation in children with short-gut syndrome. Am J Gastroenterol 106(1):157-165, 2011.
162. Cruz RJ, Costa G, Bond G, Soltys K, Rubin E, Humar A, Abu-Elmagd K. Modified multivisceral transplantation and spleen-preserving pancreaticoduodenectomy for patients with familial adenomatous polyposis “Gardner’s Syndrome”. Transplantation 91(12):1417-1423, 2011.
163. Papachristou GI, Abu-Elmagd KM, Bond G, Costa G, Mazariegos GV, Sanders MK, Slivka A. Pancreaticobiliary complications after composite visceral transplantation: Incidence, risk, and management strategies. Gastrointest Endo 73(6):1165-1173, 2011.
164. Ashokkumar C, Ningappa M, Ranganathan S, Higgs BW, Sun Q, Schmitt L, Snyder S, Dobberstein J, Branca M, Jaffe R, Zeevi A, Squires R, Alissa F, Shneider B, Soltys K, Bond G, Abu-Elmagd K, Humar A, Mazariegos G, Hakonarson H, Sindhi R. Increased expression of peripheral blood leukocyte genes implicate CD14(+) tissue macrophages in cellular intestinae allograft rejection. Am J Pathol 179(4):1929-1938, 2011.
165. Pech T, Fujishiro J, Finger T, von Websky M, Stoffels B, Wehner S, Abu-Elmagd K, Kalff JC, Schaefer N. Effects of immunosuppressive therapy after experimental small bowel transplantation in rats. Transpl Immunol 25(2-3):112-118, 2011.
166. Abu-Elmagd KM and Mazariegos G. Intestinal transplantation and the European implication: Impact of experience and study design. GUT, 60:17-25, 2011.
167. Sakai T, Matsusaki T, Abu-Elmagd K, Amesur N, Thaete FL, Zak MF, Aggarwal S. The role of ultrasonography in determining central venous patency in patients undergoing bowel transplantation. Clin Transplant 26(1):E78-E83, 2012.
168. Pech T, Fujishiro J, Finger T, Ohsawa I, Praktiknjo M, von Websky M, Wehner S, Abu-Elmagd K, Kalff JC, Schaefer N. Perioperative infliximab application has marginal effects on ischemis-reperfusion injury in experimental small bowel transplantation in rats. Arch Surg 397(1):131-140, 2012.
169. Sindhi R, Ashokkumar C, Higgs BW, Gilbert PB, Sun Q, Ranganathan S, Jaffe R, Snyder S, Ningappa M, Soltys KA, Bond GJ, Mazariegos GV, Abu-Elmagd K, Zeevi A. Allospecific CD154 + T-cytotoxic memory cells as potentital surrogate for rejection risk in pediatric intestine transplantation. Pediatr Transplant 16(1):83-91, 2012.
170. Pech T, Fujishiro J, Finger T, Ohsawa I, Praktiknjo M, Abu-Elmagd K, vonWebsky M, Overhaus M, Kalff JC, Schaefer N. Combination therapy of tacrolimus and infliximab reduces inflammatory response and dysmotility in experimental small bowel transplantation in rats. Transplantation 93(3):249-256, 2012.
171. Matsusaki T, Sakai T, Boucek CD, Abu-Elmagd K, Martin LM, Amesur N, Thaete FL, Hilmi IA, Planinsic RM, Aggarwal S. Central venous thrombosis and perioperative vascular access in adult intestinal transplantation. Br J Anaesth 108(5):776-783, 2012.
Kareem Abu-Elmagd, M.D., PhD. 15
172. Peck T, Von Websky M, Ohsawa I, Kitamura K, Praktiknjo M, Jafari A, Vilz T O, Wehner S, Abu-Elmagd K, Kalff JC, Schaefer N. Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. Am J Transplan 12: S9-S17, 2012,
173. Abu-Elmagd K, Wu G, Costa G, Lunz J, Murase N, Martin L, Koritsky D, Irish W, Zeevi A. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant, 2012 November 12 (11): 3047-60.
174. Abu-Elmagd KM, Kosmach-Park B, Costa G, Zenati MS, Martin L, Koritsky DA, Emerling M, Murase N, Bond GJ, Soltys K, Sogawa H, Lunz J, Al Samman MM, Sindhi R, Mazariegos GV. Long-term survival, nutritional autonomy, and quality of life after intestinal and multivisceral transplantation. Ann Surg, 256(3):494-508, 2012.
175. O’Keefe S, El Hajj I, Wu Tong, Martin D, Mohanned K, Abu-Elmagd KM. Endoscopic evaluation of small intestine transplant grafts. Transplantation 94(7):1-6, 2012.
176. Hilmi IA, Planinsic RM, Nicolau-Raducu R, Damian D, Al-Khafaji A, Sakia T, Abu-Elmagd K. Isolated Small Bowel Transplantation: 8-Years Outcome Study for Single Transplant Center. World Journal of Transplanation. 2013 December; 24 3(4): 127-133.
177. Berger M, Zeevi A, Farmer DG, Abu-Elmagd KM. Immunologic Challenges in Small Bowel Transplantation. Am J Transplantation 2012; 12: S2-S8.
178. Pech T., Praktiknjo M., Overhaus M., Wehner S., von Websky M., Abu-Elmagd K., Echten-Deckert G., Kalff JC, Schaefer N. A natural tetrahydropyrimidine, ectoine, ameliorates ischemia reperfusion injury after intestinal transplantation in rats. Department of Surgery, University of Bonn, Bonn, Germany. Pathbobiology, 80(2): 102-110, 2012.
179. Ningappa M., Ashokkumar C., Ranganathan S., Schmitt L, Higgs BW., Sun Q., Branca M., Mazariegous G., Zeevi A., Abu-Elmagd K., Squires R., Rudolph J., Alissa F., Hakonarson H., Sindhi R., Mucosal Plasma Cell Barrier Disruption During Intestine Transplant Rejection: December 2012: 94(12): 1236-42
180. Kundu N, Watson M, Coppa C, Djohan R, Hashimoto K, Eghtesad B, Grandhi N, Abu-Elmagd K, Quintini C. Role of tissue expanders in patients with loss of abdominal domain awaiting intestinal transplantation. Transplant International. 2013 Dec; 26 (12): 1184-90.
181. Amesur NB. Zajko AB. Costa G. Abu-Elmagd KM. Combined surgical and interventional radiologic management strategies in patients with arterial pseudo-aneurysms after multivisceral transplantation. Transplantation. 97(2):235-44, 2014 Jan 27.
182. Hilmi I., Planinsic R., Nicolau-Raducu R., Damian D., Al-Khafaji A., Sakai T., Abu-Elmagd K. Small Bowel Transplantation: An Outcome Study. World Journal of Transplantation, Isolated Small Bowel Transplantation Outcomes and the Impact of Immunosuppresants: Experience of a Single Transplant Center. World Journal of Transplanation 2013 Dec 24: 3(4): 127-33.
183. Hara H, Bentall A, Long C, Fang G, Andreyev O, Lunz J, Ezzelarab M, Abu-Elmagd K, Shapiro R, Ayares D, Stegall M, Cooper DK. Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study. Xenotransplanation 2013 Nov-Dec; 20(6): 429-37.
184. Nickkholgh A., Contin P, Abu-Elmagd K., Golriz M, Gotthardt D, Morath C., Schemmer P, Mehrabi A. Intestinal Transplantation: Review of operative techniques. Clinical Transplantation 27: 56-65, 2013.
185. Hilmi I., Planinsic R, Nicolau-Raducu R, Damian D, Al-Khafaji S, Sakai T., Abu-Elmagd K. Isolated small bowel transplantation outcomes and the impact of immunosuppresessants: Experience of a single transplant center. World Journal of Transplantation, December 2013; 3(4): 1-000
186. Watson MJ, Kundu N, Coppa C, Djohan R, Hashimoto K, Eghtesad B, Fujiki M, Diago Uso T, Gandhi N, Nassar A, Abu-Elmagd K, Quintini C. Role of tissue expanders in patients with loss of abdominal domain awaiting intestinal transplantation. Transpl Int. 2013 Dec;26(12):1184-90
Kareem Abu-Elmagd, M.D., PhD. 16
187. Waghray A, Nassar A, Hashimoto K, Eghtesad B, Aucejo F, Krishnamurthi V, Uso TD, Srinivas T, Steiger E, Abu-Elmagd K, Quintini C. Combined intestine and kidney transplantation in a patient with encapsulating peritoneal sclerosis: case report. Am J Transplant. 2013 Dec;13(12):3274-7.
188. Websky, Mv., Fujishiro J., Ohsawa I, Praktiknjo M, Wehner S, Abu-Elmagd K, Kitamura K, Kalff JC, Schaefer N, Pech T. The novel Quanylhydrazone CPSI-2364 ameliorates ischemia reperfusion injury after experimental small bowel transplantation: 2013 June 15:95 (11):1315-23.
189. Hara H, Bentall A, Long C, Fang J, Andreyev O, Lunz J, Ezzelarab M, Abu-Elmagd KM, Shapiro R, Ayares D, Stegall M, Cooper DK . Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study. Xenotransplantation 2013 Nov-Dec;20(6):429-37.
190. Hilmi IA, Planinsic RM, Nicolau-Raducu R, Damian D, Al-Khafaji A, Sakai T, Abu-Elmagd K. Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center. World J Transplant 2013 Dec 24;3 (4):127-33.
191. Florescu, Diana, Abu-Elmagd K. An International Survey of Cytomegalovirus Prevention and Treatment Practices in Intestinal Transplantation. Transplanation. 2014 Jan 15: 97(1):78-82.
192. Amesur NB, Zajko AB, Costa G, Abu-Elmagd KM. Combined surgical and interventional radiologic management strategies in patients with arterial pseudo-aneurysms after multivisceral transplantation. Transplantation. 2014 Jan 27;97(2):235-44.
193. Nassar A, Hashimoto K, Shay-Downer C, Bollinger J, Uso TD, Fujiki M, Askar M, Steiger E, Eghtesad B, Abu-Elmagd K, Quintini C. Sequential split liver followed by isolated intestinal transplant: the "liver-first" approach: report of a case. Transplantation 2014 Feb 15;97 (3).
194. Nassar A, Liu Q, Farias K, D'Amico G, Tom C, Grady P, Bennett A, Diago Uso T, Eghtesad B, Kelly D, Fung J, Abu-Elmagd K, Miller C, Quintini C. Ex Vivo Normothermic Machine Perfusion Is Safe, Simple, and Reliable: Results From a Large Animal Model.Surg Innov.2014 Apr 2.
195. Liu Q, Nassar A, Farias K, Buccini L, Baldwin W, Mangino M, Bennett A, O'Rourke C, Okamoto T, Uso TD, Fung J, Abu-Elmagd K, Miller C, Quintini C. Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers. Liver Transpl. 2014 Aug; 20(8):987-99.
196. Borhani AA, Dasyam AK, Papachristou G, Furlan A, Almusa O, Abu-Elmagd K, Costa G, Slivka A, Bae KT. Radiologic features of pancreatic and biliary complications following composite visceral transplantation. Abdom Imaging. 2014 Dec 31.
197. Grant D, Abu-Elmagd K, Mazariegos G, Vianna R, Langnas A, Mangus R, Farmer DG, Lacaille F, Iyer K, Fishbein T. Intestinal Transplantation Registry Report: Global Activity and Trends. On behalf of the Intestinal Transplant Association. Am J Transplant. 2015 Jan. 15(1):210-9.
198. Abu-Elmagd K. The concept of gut rehabilitation and the future of visceral transplantation. Gastroenterol. Nat Rev Gastroenterol Hepatol. 2015 Feb;12 (2):108-20.
199. Nyaganga C, Kochhar G, Shen B, Abu-Elmagd K. Update on Intestinal and Multivisceral Transplantation for the Treatment of Crohn’s Disease. Journal of Inflammatory Bowel Disease (in press).
200. Abu-Elmagd K, Doellman D, Drews B., Durack JC, Journeycake JM., Kocoshis SA., McLennan G, Rupp SM, Towbin RB, Wasse HM.. Proceedings from the Research Consensus Panel on Critical Issues in Chronic Central Venous Access and Pathways for Investigation. Journal of Vascular and Interventional Radiology, In Press.
201. Koval CE, Khanna A, Pallotta A, Spinner M, Taege AJ, Eghtesad B, Fujiki M, Hashimoto K, Rodriguez B, Morse G, Bennett A, Abu-Elmagd K. En Bloc Multivisceral and Kidney Transplantation in an HIV Patient: First Case Report. Am J Transplant. 2015 Oct 5.
Kareem Abu-Elmagd, M.D., PhD. 17
202. Abu-Elmagd KM, Costa G, McMichael D, Khanna A, Cruz RJ, Parekh N, Fujiki M, Hashimoto K, Quintini C, Koritsky AD, Kroh MD, Sogawa H, Kandeel A, da Cunha-Melo JR, Steiger E, Kirby D, Matarese L, Shatnawei A, Humar A, Walsh RM, Schauer PR, Simmons R, Billiar T, Fung J. Autologous Reconstruction and Visceral Transplantation for Management of Patients with Gut Failure after Bariatric Surgery: 20 Years of Experience. Ann Surg. 2015 Oct; 262 (4):586-601.
203. Q, Nassar A, Farias K, Buccini L, Mangino MJ, Baldwin W, Bennett A, O'Rourke C, Iuppa G, Soliman BG, Urcuyo-Llanes D, Okamoto T, Uso TD, Fung J, Abu-Elmagd K, Miller C, Quintini C. Comparing Normothermic Machine Perfusion Preservation with Different Perfusates on Porcine Livers From Donors After Circulatory Death. Am J Transplant. Accepted
204. Kandeel A, Abu-Elmagd K, Spinner M, Khanna A, Hashimoto K, Fujiki M, Parsi M, Bennett A, El-Gazzaz G, Abd-Elaal A. Atypical Clinical Presentation of a Newer Generation Anti-Fungal Drug-Resistant Fusarium Infection after a Modified Multi-Visceral Transplant. Ann Transplant. 2015 Sep 3;20:512-8.
205. Hashimoto K, Costa G, Khanna A, Fujiki M, Quintini C, Abu-Elmagd K. Recent Advances in Intestinal and Multivisceral Transplantation. Adv Surg. 2015;49:31-63.
206. Ascha M, Zein NN, Alkhouri N, Eghtesad B, Abu-Elmagd K, Diago T, Hanouneh IA. Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir. Int J Organ Transplant Med. 2015;6(2):86-90.
207. Nazzal MD, Kawamura N, El-Gazzaz G, Spaggiari M, Abu-Elmagd K. Peritoneal decortication: an innovative technique for treatment of obstructive sclerosing encapsulating peritonitis. Am Surg. 2015 Apr;81(4):E143-5 Erratum in: Am Surg. 2015 Jul;81(7):753.
208. Borhani AA, Dasyam AK, Papachristou G, Furlan A, Almusa O, Abu-Elmagd K, Costa G, Slivka A, Bae KT. Radiologic features of pancreatic and biliary complications following composite visceral transplantation. Abdom Imaging. 2015 Aug; 40 (6):1961-70.
209. Grant D, Abu-Elmagd K, Mazariegos G, Vianna R, Langnas A, Mangus R, Farmer DG, Lacaille F, Iyer K, Fishbein T; Intestinal Transplant Association. Intestinal transplant registry report: global activity and trends.Am J Transplant. 2015 Jan; 15 (1):210-9.
210. Liu Q, Nassar A, Farias K, Buccini L, Mangino MJ, Baldwin W, Bennett A, O'Rourke C, Iuppa G, Soliman BG, Urcuyo-Llanes D, Okamoto T, Uso TD, Fung J, Abu-Elmagd K, Miller C, Quintini C. Comparing Normothermic Machine Perfusion Preservation with Different Perfusates on Porcine Livers from Donors after Circulatory Death. Am J Transplant. 2015 Dec 10.
211. Von Websky MW, Kitamura K, Ludwig-Portugall I, Kurts C, von Laffert M, LeMaoult J, Carosella ED, Abu-Elmagd K, Kalff JC, Schäfer N. Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation. PLoS One 2016 Jul 12:11(7): e0158907
212. Nyabanga C, Kochhar G, Costa G, Soliman B, Shen B Abu-Elmagd K. Management of Crohn's Disease in the New Era of Gut Rehabilitation and Intestinal Transplantation. Inflamm Bowel Dis 2016 Jul; 22(7):1763-76
213. Liu Q, Nassar A, Farias K, Buccini L, Mangino MJ, Baldwin W, Bennett A, O'Rourke C, Iuppa G, Soliman BG, Urcuyo-Llanes D, Okamoto T, Uso TD, Fung J, Abu-Elmagd K, Miller C, Quintini C. Comparing Normothermic Machine Perfusion Preservation With Different Perfusates on Porcine Livers From Donors After Circulatory Death. Am J Transplant. 2016 Mar; 16(3):794-807
214. Koval CE, Khanna A, Pallotta A, Spinner M, Taege AJ, Eghtesad B, Fujiki M, Hashimoto K, Rodriguez, B
Morse G, Bennett A, Abu-Elmagd K. En Bloc Multivisceral and Kidney Transplantation in an HIV Patient:
First Case Report. Am J Transplant. 2016 Jan; 16(1):358-63
215. Aminian A, Brethauer S, Parekh N, Abu-Elmagd K, Schauer P. Metabolic Consequences of Restorative Surgery After Gastric Bypass. Diabetes Care Apr 2017 (Diabetes Care 2017 Apr 7; 40(4):e42-e43. Epub 2017 Feb 7)
Kareem Abu-Elmagd, M.D., PhD. 18
216. Bharadwaj S, Tandon P, Gohel T, Brown J, Steiger E, Kirby D, Khanna A, Abu-Elmagd K. Current Status of Intestinal and Multivisceral Transplantation. Oxford University Press Gastroenterol Rep (Oxf) (Jan 2017) 5(1):20-28. (Gastroenterol Rep (Oxf) 2017 Jan 26. Epub 2017 Jan 26)
217. Okano S, Abu-Elmagd K, Kish DD, Keslar K, Baldwin WM 3rd, Fairchild RL, Fujiki M, Khanna A, Osman M, Costa G, Fung J, Miller C, Kayashima H, Hashimoto K. Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients. Am J Transplant. 2018 Oct;18(10):2544-2558.
218. Nassar A, Quintini C, Costa G, Lennon E, Bottino R, Hatipoglu B, Hashimoto K, Fujiki M, Kandeel F, Walsh RM, Abu-Elmagd K. Total pancreaticoduodenectomy with autologous islet transplantation 14 years after liver-contained composite visceral transplantation. Am J Transplant. 2018 Aug;18(8):2068-2074.
219. Costa G, Parekh N, Osman M, Armanyous S, Fujiki M, Abu-Elmagd K. Composite and Multivisceral Transplantation: Nomenclature, Surgical Techniques, Current Practice, and Long-term Outcome. Gastroenterol Clin North Am. 2018 Jun;47(2):393-415.
220. Baskin KM, Durack JC, Abu-Elmagd K, Doellman D, Drews BB, Journeycake JM, Kocoshis SA, McLennan G, Rupp SM, Towbin RB, Wasse H, Mermel LA, Toomay SM, Camillus JC, Ahrar K, White SB. Chronic Central Venous Access: From Research Consensus Panel to National Multistakeholder Initiative. J Vasc Interv Radiol. 2018 Apr;29(4):461-469.
221. Rees MA, Amesur NB, Cruz RJ, Borhani AA, Abu-Elmagd KM, Costa G, Dasyam AK. Imaging of Intestinal and Multivisceral Transplantation. Radiographics. 2018 Mar-Apr;38(2):413-432.
222. Liu Q, Nassar A, Buccini L, Iuppa G, Soliman B, Pezzati D, Hassan A, Blum M, Baldwin W, Bennett A, Chavin K, Okamoto T, Uso TD, Fung J, Abu-Elmagd K, Miller C, Quintini C. Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. Liver Transpl. 2018 Feb;24(2):233-245.
223. Hiroshi S, Costa G, Bond G, Ruy C, Soltys K, Aboutableb E, William S, Martin L, Koritsky D, McMichael D, Armanyous S, Sindhi R, Humar A, Mazariegos G, Abu-Elmagd K. Gut Transplantation and Chronic Intestinal Pseudo-Obstruction: Technical Innovation, Long-Term Outcome, Quality of Life, and Disease Recurrence. Am J Transplant. 2018.
224. Liu Q, Nassar A, Buccini L, Iuppa G, Soliman B, Pezzati D, Hassan A, Blum M, Baldwin W, Bennett A, Chavin K, Okamoto T, Uso TD, Fung J, Abu-Elmagd K, Miller C, Quintini C. Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. Liver Transplantation. 2018 Feb;24(2):233-45.
225. Okano S, Abu-Elmagd K, Kish DD, Keslar K, Baldwin III WM, Fairchild RL, Fujiki M, Khanna A, Osman M, Costa G, Fung J, Miller C, Kayashima H, Hashimoto K. Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients. American Journal of Transplantation. 2018 Oct 1;18(10):2544-58.
226. Nassar A, Quintini C, Costa G, Lennon E, Bottino R, Hatipoglu B, Hashimoto K, Fujiki M, Kandeel F, Walsh RM, Abu-Elmagd K. Total pancreaticoduodenectomy with autologous islet transplantation 14 years after liver-contained composite visceral transplantation. American Journal of Transplantation. 2018 Aug 1;18(8):2068-74.
227. Kandeel A, Abu-Elmagd K. Operative Treatment for Bariatric Complications: Case Series and Literature Review of Techniques. of. 2018;10:2.
228. Baskin KM, Mermel LA, Saad TF, Journeycake JM, Schaefer CM, Modi BP, Vrazas JI, Gore B, Drews BB, Doellman D, Kocoshis SA, Abu-Elmagd KM, Towbin RB. Evidence‐based strategies and recommendations for preservation of central venous access in children. Journal of Parenteral and Enteral Nutrition. 2019 Jul;43(5):591-614.
Kareem Abu-Elmagd, M.D., PhD. 19
229. Abu-Elmagd KM, Armanyous SR, Fujiki M, Parekh NR, Osman M, Scalish M, Newhouse E, Fouda Y, Lennon E, Shatnawei A, Kirby D. Management of five hundred patients with gut failure at a single center: surgical innovation versus transplantation with a novel predictive model. Annals of Surgery. 2019 Oct 1;270(4):656-74.
230. Kharrat N, Assidi M, Abu-Elmagd M, Pushparaj PN, Alkhaldy A, Arfaoui L, Naseer MI, El Omri A, Messaoudi S, Buhmeida A, Rebai A. Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset. Bioinformation. 2019 May 30;15(6):372-379.
231. Kitamura K, Buchholz BM, Abu-Elmagd K, Kalff JC, Schäfer N, von Websky MW. Chronic rejection after intestinal transplantation: a systematic review of experimental models. Transplantation Reviews. 2019 Jul 1;33(3):173-81.
232. Sogawa H, Costa G, Armanyous S, Bond GJ, Cruz RJ, Humar A, Mazariegos G, Abu-Elmagd KM. Twenty years of gut transplantation for chronic intestinal pseudo-obstruction: technical innovation, long-term outcome, quality of life, and disease recurrence. Annals of Surgery. 2021 Feb 1;273(2):325-33.
233. Abu-Elmagd K, Mazariegos G, Armanyous S, Parekh N, ElSherif A, Khanna A, Kosmach-Park B, D’Amico G, Fujiki M, Osman M, Scalish M. Five hundred patients with gut malrotation: thirty years of experience with the introduction of a new surgical procedure. Annals of Surgery. 2021 Oct;274(4):581.
234. Matsushima H, Morita‐Nakagawa M, Datta S, Pavicic Jr PG, Hamilton TA, Abu‐Elmagd K, Fujiki M, Osman M, D’Amico G, Eguchi S, Hashimoto K. Blockade or deficiency of PD‐L1 expression in intestinal allograft accelerates graft tissue injury in mice. American Journal of Transplantation. 2022 Mar;22(3):955-65.
II-Reviews and Invited Papers
1. Alessiani M, Jain A, Abu-Elmagd K, Todo S, Fung J, Starzl TE. An overview on clinical organ transplantation under FK 506. In: Transplantation and Clinical Immunology XXII (JL Touraine, J Traeger, H Betuel, JM Dubernard, JP Revillard, C Dupuy, eds) Elsevier Science, New York, New York, pp. 135-143, 1991.
2. Fung JJ, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Jordan M, Armitage J, Jain A, Martin M, Bronsther O, Stieber A, Kormos R, Selby R, Gordon R, Starzl TE. Current status on FK 506 in organ transplantation. In: Seminaires D’Uro-Nephrologie Publies Sous La Direction de (C Chatelain, C Jacobs, eds), pp. 196-201, 1991.
3. Starzl TE, Abu-Elmagd K, Fung JJ, Todo S, Tzakis AG, McCauley J, Demetris AJ. Experience clinique du FK506. La Presse Medicale 20 (40): 1967-1973, 1991.
4. Abu-Elmagd K, Todo S, Tzakis A, Nakamura K, Wright H, Fung J, Reyes J, Gordon R, Van Thiel DH, Starzl TE. An isolated complete intestinal transplantation in an adult: a complicated postoperative course. Transplant Sci 2(1):23-27, 1992.
5. Thomson AW, Carroll PB, McCauley J, Woo J, Abu-Elmagd K, Starzl TE, Van Thiel DH. FK 506: A novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Spring Semin Immunopathol 14:323-344, 1993.
6. Reynolds JA, Trellis DR, Abu-Elmagd K, Fung J. The rationale for FK506 in inflammatory bowel disease. Can J Gastroenterol 7(No.2):208-210, 1993.
7. Nour B, Tzakis AG, Abu-Elmagd K, Furukawa H, Todo S, Reyes J, Starzl TE. Small bowel transplantation. Curr Prac Surg 14:2-15, 1993.
8. Todo S, Tzakis A, Abu-Elmagd K, Reyes J, Starzl TE. Current Status of intestinal Transplantation. In: Advances in Surgery (YB Cameron, ed) 27:295-316, 1994.
9. El-Babary M, El-Hak NG, Abdel Wahab M, Fathy O, El-Ebiedy G, Abu-Elmagd K, Ezzat F. Four surgical procedures in treatment for Cicatricial Pyloric obstruction: seventeen years experience. Int. Gastro-Surgical Club, 1994.
Kareem Abu-Elmagd, M.D., PhD. 20
10. Campbell WL, Abu-Elmagd K, Furukawa H, Todo S. Intestinal and multivisceral transplantation. In: Radiologic Clinics of North America. (MP Federle, ed) WB Saunders Company, Philadelphia, Pennsylvania, 33(3):595-614, 1995.
11. DiMartini A, Fitzgerald MG, Magill J, Funovits M, Abu-Elmagd K, Furukawa H, Todo S. Psychiatric evaluation of Small Intestine Transplantation Patients. General Hospital Psychiatry 18(6Suppl):25S-29S, 1996.
12. Abu-Elmagd K, Reyes J, Fung JJ. Transplantation of the human intestine: The forbidden organ. Current Opinion in Organ Transplantation, 3:286-292, 1998.
13. Furukawa H, Todo S, Reyes J, Abu-Elmagd K, Starzl TE. Technical aspects of small bowel transplantation. Current Opinion in Organ Transplantation, 3:279-285, 1998.
14. Vargas HE, Gerber D, Abu-Elmagd K. Management of portal hypertension-related bleeding. In: Surgical Clinics of North America: Liver Transplantation - Current Management. (eds. J Fung, J Rakela) W.B. Saunders Company, Philadelphia, PA 79:1-22, 1999.
15. Balan V, Abu-Elmagd K, Demetris A. Autoimmune liver disease: Recurrence after liver transplantation. In: Surgical Clinics of North America: Liver Transplantation - Current Management. 79:1-22, 1999.
16. Abu-Elmagd K, Reyes J, Fung JJ, Mazariegos G, Bueno J, Martin D, Colangelo J, Rao A, Demetris A, Starzl TE. Clinical Intestinal Transplantation in 1998: Pittsburgh experience. Acta Gastro-Enterologica Belgica, 62:244-247, 1999.
17. Green M, Bueno J, Sigurdsson L, Mazariegos G, Abu-Elmagd KM, Reyes J. Unique aspects of the infectious complications of intestinal transplantation. Current Opinion Organ Transplantation. 4:361-367, 1999.
18. Regueiro M, Abu-Elmagd KM. Small Bowel Transplantation for Crohn’s Disease. CCFA Magazine “Focus”. Spring/Summer 2001.
19. Abu-Elmagd KM, The UPMC Intestinal Rehabilitation and Transplant Center – Helping promote total recovery for patients with gastrointestinal failure. Physicians Practice Digest, 11(5): September/October 2001.
20. Abu-Elmagd KM, Bond G, Reyes J, Fung J. Intestinal transplantation: A coming of age. Advances in Surgery, 36:65-101, 2002.
21. Abu-Elmagd KM, Bond G. The current status and future outlook of intestinal transplantation. Minerva Chirurgia (Italy) 57(5):543-560, 2002.
22. Abu-Elmagd K, Bond G. Gut failure and abdominal visceral transplantation. Proceedings of the Nutrition Society 62(3):727-737, 2003.
23. Abu-Elmagd K, Balan V. Recurrent primary sclerosing cholangitis: from an academic illusion to a clinic reality. Liver Transplantation 11(11): 1326-1328, 2005.
24. Abu-Elmagd K. Intestinal transplantation for short gut syndrome and gut failure: Rewarding outcomes and current consensus. Gastroenterology, 130(2):132-137, 2006.
25. Matarese LE, Abu-Elmagd K. Intestinal Rehabilitation and Short Bowel Syndrome – Current and future treatment options. US Gastroenterology Review, March 2006.
26. Abu-Elmagd KM, Costa G, Bond GJ, Wu T, Murase N, Zeevi A, Simmons R, Soltys K, Sindhi R, Stein W, Demetris A, Mazariegos G. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transplant International, 1(22):96-101, 2009.
27. Kumar G, Ekser B, Abu-Elmagd KM, Cooper DKC. Multivisceral xenotransplantation – does it have a future? Xenotransplanation, 17:418-422, 2010.
Kareem Abu-Elmagd, M.D., PhD. 21
28. Nassar A, Liu Q, Farias K, D'Amico G, Tom C, Grady P, Bennett A, Diago Uso T, Eghtesad B, Kelly D, Fung J, Abu-Elmagd K, Miller C, Quintini C. Ex vivo normothermic machine perfusion is safe, simple, and reliable: results from a large animal model. Surg Innov. 2015 Feb; 22 (1):61-9.
29. Liu Q, Nassar A, Farias K, Buccini L, Baldwin W, Mangino M, Bennett A, O'Rourke C, Okamoto T, Uso TD, Fung J, Abu-Elmagd K, Miller C, Quintini C. Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers. Liver Transpl. 2014 Aug; 20(8):987-99.
30. Costa G, Parekh N, Osman M, Armanyous S, Fujiki M, Abu-Elmagd K. Composite and multivisceral transplantation: nomenclature, surgical techniques, current practice, and long-term outcome. Gastroenterology Clinics. 2018 Jun 1;47(2):393-415
31. Rees MA, Amesur NB, Cruz RJ, Borhani AA, Abu-Elmagd KM, Costa G, Dasyam AK. Imaging of intestinal and multivisceral transplantation. Radiographics. 2018 Mar;38(2):413-32.
32. Baskin KM, Durack JC, Abu-Elmagd K, Doellman D, Drews BB, Journeycake JM, Kocoshis SA, McLennan G, Rupp SM, Towbin RB, Wasse H. Chronic central venous access: from research consensus panel to national multistakeholder initiative. J Vasc Interv Radiol. 2018 Apr 1;29(4):461-9.
33. Fahad H, Abu-Elmagd K, Lashner B, Fiocchi C. Recurrence of Crohn’s disease after small bowel transplantation: fact or fiction. Inflammatory Bowel Diseases. 2020 Jan 1;26(1):21-3.
34. Osman M, Parekh N, Fujiki M, D’Amico G, Abu-Elmagd K. Disease recurrence after gut transplantation. Current Opinion in Organ Transplantation. 2021 Apr 1;26(2):207-19.
35. Farmer DG, Abu-Elmagd K. The liver and intestinal allocation policy: Decades of disparity calling for action. American Journal of Transplantation. 2022 Feb 1;22(2):341-3.
36. Abu-Elmagd K, Mazariegos G. Professionalism, Legitimacy and Collegiality. Journal of Pediatric Surgery. 2022 Jul 1;57(7):1448-9.
37.
III-Proceedings and Symposia
1. Alessiani M, Ricordi C, Fung JJ, Abu-Elmagd KM, Jain A, Scotti C, Pinna A, Cillo U, Carrieri G, Zetti G, Starzl TE. USO Clinico Dell' FK 506 Nel Trapianto Di' Fegato. In: "Il Trapianto Oggi - Proceedings of the 21st Congress of the Italian Society of Organ Transplantation (Monduzzi, ed), 611-615, 1991.
2. Venkataramanan R, Jain A, Warty VW, Abu-Elmagd K, Furakawa H, Imventarza O, Fung J, Todo S, Starzl TE: Pharmacokinetics of FK 506 following oral administration: A comparison of FK506 and cyclosporine. Transplant Proc 23(1):931-933, 1991.
3. Starzl TE, Abu-Elmagd K, Tzakis A, Fung JJ, Porter KA, Todo S. Selected topics on FK506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs", side effects, mechanisms, and practical pharmacokinetics. Transplant Proc 23(1): 914-919, 1991.
4. Alessiani M, Kusne S, Martin M, Jain A, Abu-Elmagd K, Moser J, Fung J, Starzl T. Infections in adult liver transplant patients under FK506 immunosuppression. Transplant Proc 23(1): 1501-1503, 1991.
5. Fung JJ, Todo S, Tzakis A, Demetris A, Jain A, Abu-Elmagd K, Alessiani M, Starzl TE. Conversion of liver allograft recipients from cyclosporine to FK506 based immunosuppression: benefits and pitfalls. Transplant Proc 23:14-21, 1991.
6. Jain AB, Fung JJ, Todo S, Alessiani M, Takaya S, Abu-Elmagd K, Tzakis A, Starzl TE. Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK506. Transplant Proc 23(1):928-930, 1991.
Kareem Abu-Elmagd, M.D., PhD. 22
7. Zeevi A, Eiras G, Kaufman C, Alessiani M, Demetris AJ, Abu-Elmagd K, Jain A, Warty V, Venkataramanan R, Burckart G, Starzl T, Todo S, Fung J, Duquesnoy R. Correlation between bioassayed plasma levels of FK506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. Transplant Proc 23(1):1406-1408, 1991.
8. McCauley J, Takaya S, Fung J, Tzakis A, Abu-Elmagd K, Jain A, Todo S, Starzl TE. The question of FK506 nephrotoxicity after liver transplantation. Transplant Proc 23(1):1444-1447, 1991.
9. Fung JJ, Todo S, Tzakis A, Alessiani M, Abu-Elmagd K, Jain A, Bronsther O, Martin M, Gordon R, Starzl TE. Current status of FK506 in liver transplantation. Transplant Proc 23(6):1902-1905, 1991.
10. Jain AB, Venkataramanan R, Fung J, Burckart G, Emeigh J, Diven W, Warty V, Abu-Elmagd K, Todo S, Alessiani M, Starzl TE. Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK506. Transplant Proc 23(6):2777-2779, 1991.
11. Abu-Elmagd K, Van Thiel D, Jegasothy BV, Ackerman CD, Todo S, Fung JJ, Thomson AW, Starzl TE. FK506: A new therapeutic agent for severe recalcitrant psoriasis. Transplant Proc 23:3322-3324, 1991.
12. Abu-Elmagd KM, Bronsther O, Kobayashi M, Yagihashi A, Iwaki Y, Fung J, Alessiani M, Bontempo F, Starzl T. Acute hemolytic anemia in liver and bone marrow transplant patients under FK506 therapy. Transplant Proc 23(6):3190-3191, 1991.
13. Abu-Elmagd KM, Fung J, Draviam R, Shannon W, Jain A, Alessiani M, Takaya S, Venkataramanan R, Warty VS, Tzakis A, Todo S, Starzl TE. Four-hour versus 24-hour intravenous infusion of FK506 in liver transplantation. Transplant Proc 23(6):2767-2770, 1991.
14. Abu-Elmagd KM, Fung JJ, Alessiani M, Jain A, Takaya S, Venkataramanan R, Warty VS, Shannon W, Todo S, Tzakis A, Van Thiel D, Starzl TE. Strategy of FK 506 therapy in liver transplant patients: effect of graft function. Transplant Proc 23(6):2771-2774, 1991.
15. Abu-Elmagd K, Jegasothy BV, Ackerman CD, Thomson AW, Rilo H, Nikolaidis N, Van Thiel D, Fung JJ, Todo S, Starzl TE. Efficacy of FK506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 23(6):3328-3329, 1991.
16. Alessiani M, Kusne S, Fung JJ, Torre-Cisneros J, Jain A, Abu-Elmagd K, Takaya S, Cillo U, Martin M, Todo S, Starzl TE. CMV infection in liver transplantation under Cyclosporine or FK506 immunosuppression. Transplant Proc 23(6):3035-3037, 1991.
17. Carroll PB, Tzakis AG, Ricordi C, Rilo HR, Abu-Elmagd K, Murase N, Zeng Y-J, Alejandro R, Mintz D, Starzl TE. The use of FK506 in new-onset type I diabetes in man. Transplant Proc 23(6):3351-3353, 1991.
18. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, Alessiani M, Abu-Elmagd K, Van Thiel DH, Starzl TE. FK506 used as rescue therapy for human liver allograft recipients. Transplant Proc 23(6):3005-3006, 1991.
19. Eidelman BH, Abu-Elmagd K, Wilson J, Fung JJ, Alessiani M, Jain A, Takaya S, Todo S, Tzakis A, Van Thiel D, Shannon W, Starzl TE. Neurological complications of FK506. Transplant Proc 23(6):3175-3178, 1991.
20. Fung JJ, Alessiani M, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Van Thiel D, Armitage J, Jain A, McCauley J, Selby R, Starzl TE. Adverse effects associated with the use of FK506. Transplant Proc 23(6):3105-3108, 1991.
21. Fung J, Abu-Elmagd K, Jain A, Gordon R, Tzakis A, Todo S, Takaya S, Alessiani M, Demetris A, Bronsther O, Martin M, Mieles L, Selby R, Reyes J, Doyle H, Stieber A, Casavilla A, Starzl TE. A randomized trial of primary liver transplantation under immunosuppression with FK506 versus cyclosporine. Transplant Proc 23:2977-2983, 1991.
Kareem Abu-Elmagd, M.D., PhD. 23
22. Jain AB, Fung JJ, Tzakis AG, Venkataramanan R, Abu-Elmagd K, Alessiani M, Reyes J, Irish W, Warty V, Mehta S, Todo S, Starzl TE. Comparative study of cyclosporine and FK506 dosage requirements in adult and pediatric orthotopic liver transplant. Transplant Proc 23(6):2763-2766, 1991.
23. Jain AB, Todo S, Fung JJ, Venkataramanan R, Day R, Bryant J, Abu-Elmagd KM, Alessiani M, Takaya S, Tzakis A, Starzl TE. Correlation of rejection episodes with FK 506 dosage, FK506 level, and steroid following primary orthotopic liver transplant. Transplant Proc 23(6):3023-3025, 1991.
24. Nikolaidis NL, Abu-Elmagd K, Thomson AW, Rilo HR, Irish WD, Van Thiel DH, Fung JJ, Starzl TE. Metabolic effects of FK506 in patients with severe psoriasis: short-term follow-up of seven cases. Transplant Proc 23(6):3325-3327, 1991.
25. Todo S, Tzakis A, Reyes J, Abu-Elmagd K, Casavilla A, Nour BM, Selby R, Fung JJ, Van Thiel D, Starzl TE. Clinical small bowel or small bowel plus liver transplantation under FK506. Transplant Proc 23(6):3093-3095, 1991.
26. Tzakis AG, Abu-Elmagd K, Fung JJ, Bloom EJ, Nour B, Greif F, Starzl TE. FK506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc 23(6):3225-3227, 1991.
27. Tzakis AG, Reyes J, Todo S, Green M, Ohya T, Jain A, Abu-Elmagd K, Alessiani M, Fung JJ, Starzl TE. FK506 versus cyclosporine in pediatric liver transplantation. Transplant Proc 23(6):3010-3015, 1991.
28. Uknis ME, Abu-Elmagd K, Suwan S, Block G, Van Thiel D, Reyes J, Tzakis A, Demetris AJ, Todo S, Starzl TE, Duquesnoy R, Zeevi A. Functional analysis of graft lamina propria associated lymphocytes from a recipient of a human cadaveric small bowel allograft primarily immunosuppressed by FK506. Transplant Proc 23(6):2943-2944, 1991.
29. Venkataramanan R, Jain A, Warty VS, Abu-Elmagd K, Alessiani M, Lever J, Krajak A, Flowers J, Mehta S, Zuckerman S, Fung J, Todo S, Starzl TE. Pharmacokinetics of FK506 in transplant patients. Transplant Proc 23(6):2736-2740, 1991.
30. Whiteside TL, Wilson J, Bryant J, Zeevi A, Abu-Elmagd K, Jain A, Alessiani M, Fung J, Herberman RB, Starzl TE. Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK506. Transplant Proc 23(6):3047-3051, 1991.
31. Zeevi A, Venkataramanan R, Warty V, Eiras G, Woan M, Abu-Elmagd K, Alessiani M, Jain A, Demetris AJ, Zerbe T, Fung J, Todo S, Starzl T, Duquesne RJ. In vitro assessment of FK506 immunosuppressive activity in transplant patients. Transplant Proc 23(6):2897-2899, 1991.
32. Takaya S, Bronsther O, Todo S, Abu-Elmagd KM, Jain A, Alessiani M, Madariaga J, Marino IR, Selby R, Fung JJ, Gordon RD, Starzl TE. Retransplantation of liver: a comparison of FK506-and cyclosporine-treated patients. Transplant Proc 23(6):3026-3028, 1991.
33. Thomson AW, Nalesnik M, Abu-Elmagd K, Starzl TE. Influence of FK506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study. Transplant Proc 23(6):3330-3331, 1991.
34. Kusne S, Fung J, Alessiani M, Martin M, Torre-Cisneros J, Irish W, Ondick L, Jain A, Abu-Elmagd K, Takaya S, Todo S, Starzl TE. Infections during a randomized trial comparing cyclosporine to FK506 immunosuppression in liver transplantation. Transplant Proc 24(1):429-430, 1992.
35. Reyes J, Abu-Elmagd K, Tzakis A, Nour B, Casavilla A, Kusne S, Green M, Alessiani M, Jain A, Fung JJ, Todo S, Starzl TE. Infectious complications after human small bowel transplantation. Transplant Proc 24(3):1249-1250, 1992.
36. Uknis ME, Abu-Elmagd K, Suwan S, Block G, Van Thiel D, Reyes J, Tzakis A, Demetris AJ, Todo S, Starzl TE, Duquesnoy R, Zeevi A. Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. Transplant Proc 24(3):1137, 1992.
Kareem Abu-Elmagd, M.D., PhD. 24
37. Nakamura K, Nalesnik M, Todo S, Takenaka T, Yagihashi A, Iwaki Y, Abu-Elmagd K, Reyes J, Tzakis A, Warty V, Fung JJ, Starzl TE, Demetris AJ. Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc 24:1197-1198, 1992.
38. Nakamura K, Todo S, Abu-Elmagd K, Reyes J, Tzakis A, Fung JJ, Starzl TE, Demetris AJ. Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc 24(3): 1199-1200, 1992.
39. Yagihasi A, Takenaka T, Noguchi K, Kobayashi M, Konno A, Hayashi S, Yoshida Y, Terasawa K, Nakamura K, Selby R, Demetris AJ, Abu-Elmagd K, Reyes J, Tzakis A, Todo S, Iwaki Y, Starzl TE. Changes in cell surface markers in human small bowel transplantation with FK506. Transplant Proc 24:1203, 1992.
40. Noguchi K, Yoshida Y, Yagihashi A, Kita Y, Takenaka T, Terasawa K, Hayashi S, Konno A, Kobayashi M, Nakamura K, Reyes J, Abu-Elmagd K, Demetris AJ, Tzakis AG, Todo S, Iwaki Y, Starzl TE. Serum levels of Interleukin-6, tumor necrosis factor-, and Interleukin-2 in rejecting human small bowel allografts. Transplant Proc 24(3):1152, 1992.
41. Jain A, Venkataramanan R, Todo S, Abu-Elmagd K, Fung J, Warty V, Tzakis A, Reyes J, Alessiani M, Starzl TE. Intravenous, oral pharmacokinetics and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 24:1181-1182, 1992.
42. Abu-Elmagd K, Fung JJ, Reyes J, Casavilla A, Van Thiel DH, Iwaki Y, Warty V, Nikolaidis N, Block J, Nakamura K, Goldbach B, Demetris A, Tzakis AG, Todo S, Starzl TE. Management of intestinal transplantation in humans. Transplant Proc 24(3):1243-1244, 1992.
43. Tzakis AG, Todo S, Reyes J, Abu-Elmagd K, Casavilla A, Ohya T, Fung JJ, Yunis E, Demetris AJ, Kocoshis S, Van Thiel DH, Starzl TE. Clinical intestinal transplantation: focus on complications. Transplant Proc 24:1238-1240, 1992.
44. Alessiani M, Cillo U, Fung JF, Irish W, Abu-Elmagd K, Jain A, Takaya S, Van Thiel DH, Starzl TE. Adverse effects of FK505 overdosage after liver transplantation. Transplant Proc 25(1):628-634, 1993.
45. Abu-Elmagd KM, Tzakis A, Todo S, Reyes J, Fung J, Nakamura K, Wright H, Furukawa H, Demetris J, Van Thiel, Starzl TE. Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc 25:1202-1203, 1993.
46. Todo S, Tzakis A, Reyes J, Abu-Elmagd K, Casavilla A, Fung J, Starzl TE. Intestinal transplant in humans under FK 506. Transplant Proc 25(1):1198-1199, 1993.
47. Abu-Elmagd KM, Selby R, Iwatsuki S, Fung J, Tzakis A, Todo S, Demetris AJ, Baddour N, Irish W, Van Thiel DH, Starzl TE. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 25(1):1124, 1125, 1993.
48. Fung J, Todo S, Abu-Elmagd K, Jain A, Tzakis A, Martin M, Selby R, Bronsther O, Doyle H, Gayowski T, Ramos H, Kishida A, Starzl T. A randomized trial in primary liver transplantation under immunosuppression with FK 506 or Cyclosporine. Transplant Proc 25: (1)1130, 1993.
49. Reyes J, Tzakis AG, Todo S, Nour B, Casavilla A, Abu-Elmagd K, Fung JF, Starzl TE. Nutritional management of intestinal transplant recipients. Transplant Proc 25(1):1200-1201, 1993.
50. Todo S, Tzakis A, Abu-Elmagd K, Reyes J, Furukawa H, Nour B, Fung JJ, Starzl TE. Clinical intestinal transplantation. Transplant Proc 25(3):2195-2197, 1993.
51. Takaya S, Bronsther O, Abu-Elmagd K, Ramos H, Fung JJ, Todo S, Starzl T. Use of Prostaglandin E1 in cross match negative liver transplant patients treated with FK506. Transplant Proc 25(3):2381-2385, 1993.
52. Casavilla A, Selby R, Abu-Elmagd K, Tzakis A, Todo S, Starzl TE. Donor selection and surgical technique for en bloc liver-small bowel graft procurement. Transplant Proc 25(4):2622-2623, 1993.
Kareem Abu-Elmagd, M.D., PhD. 25
53. Reyes J, Zeevi Z, Ramos H, Tzakis A, Todo S, Demetris AJ, Nour B, Nalesnik M, Trucco M, Abu-Elmagd K, Fung JJ, Starzl TE. Frequent achievement of a drug free state after orthotopic liver transplantation. Transplant Proc 25(6):3315-3319, 1993.
54. Nakamura K, Nalesnik M, Jaffe R, Todo S, Tzakis A, Abu-Elmagd K, Reyes J, Wright H, Murase N, Van Thiel DH, Fung JJ, Starzl TE, Demetris AJ. Morphological monitoring of human small bowel allografts. Transplant Proc 25:1212, 1993.
55. Tzakis A, Todo S, Reyes J, Nour B, Abu-Elmagd K, Furukawa H, Kadry Z, Bron K, Starzl TE. Evolution of surgical techniques in clinical intestinal transplantation. Transplant Proc 26(3):1407-1408, 1994.
56. Todo S, Tzakis A, Reyes J, Abu-Elmagd K, Furukawa H, Nour B, Kadry Z, Fung JJ, Starzl TE. Intestinal transplantation at the University of Pittsburgh. Transplant Proc 26(3):1409-1410, 1994.
57. Hassanein T, Schade R, Soldevilla-Pico C, Tabasco-Minguillan J, Abu-Elmagd K, Furukawa H, Kadry Z, Demetris A, Tzakis A, Todo S. Clinical and endoscopic features of rejection in small bowel transplant recipients. Transplant Proc 26(3):1413, 1994.
58. Hassanein T, Schade RR, Soldevilla-Pico C, Tabasco-Minguillan J, Abu-Elmagd K, Furukawa H, Kadry Z, Demetris A, Tzakis A, Todo S. Endoscopy is essential for early detection of rejection in small bowel transplant recipients. Transplant Proc 26(3):1414-1415, 1994.
59. Funovits M, Miller SA, Kovalak JA, Altieri K, Staschak-Chicko S, Abu-Elmagd K, Todo S, Starzl TE. Hospitalization and readmission of intestinal transplantation recipients. Transplant Proc 26(3):1419, 1994.
60. Manez R, Kusne S, Abu-Elmagd K, Reyes J, Irish W, Green M, Furukawa H, Kadry Z, Tzakis A, Todo S, Starzl TE. Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. Transplant Proc 26(3):1422-1423, 1994.
61. Reyes J, Tzakis AG, Bonet H, Green M, Yunis E, Nalesnik M, Nour B, Kocoshis S, Abu-Elmagd K, Todo S, Starzl TE. Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc 26(3):1426-1427, 1994.
62. Abu-Elmagd K, Todo S, Tzakis A, Furukawa H, Nour B, Reyes J, Nakamura K, Scotti-Foglieni C, El-Hammadi H, Kadry Z, Fung J, Demetris J, Starzl TE. Rejection of human intestinal allografts: Alone or in combination with the liver. Transplant Proc 26(3):1430-1431, 1994.
63. Nour B, Reyes J, Tzakis A, Todo S, Kocoshis S, Abu-Elmagd K, Furukawa H, Kadry Z, Fung J. Intestinal transplantation with or without abdominal organs: Nutritional and dietary management of 50 patients. Transplant Proc 26(3):1432-1433, 1994.
64. Reyes J, Tzakis A, Nour B, Todo S, Abu-Elmagd K, Green M, Kochosis S. Candidates for intestinal transplantation and possible indicators of outcome. Transplant Proc 26(3):1447-1448, 1994.
65. Furukawa H, Casavilla A, Nour B, Reyes J, Abu-Elmagd K, Kadry Z, Tzakis A, Todo S, Fung J, Starzl TE. Basic considerations for the procurement of intestinal grafts. Transplant Proc. 26(3):1470, 1994.
66. Spada M, Arbustini E, Alessiani M, Morbini P, Genovese C, Vischi S, Maestri M, Merli M, Dionigi P, Todo S, Abu-Elmagd K, Zonta A. Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. Transplant Proc 26(3):1543-1545, 1994.
67. Jain A, Venkataramanan R, Lever J, Warty V, Abu-Elmagd K, Furukawa H, Reyes J, Nour B, Asrian A, Tzakis A, Todo S, Fung J, Starzl T. FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. Transplant Proc 26(3):1609-1610, 1994.
68. Furukawa H, Brown M, Abu-Elmagd K, Hutson W, Campbell W, Reyes J, Tzakis A, Todo S, Starzl TE. Abnormal gastric emptying after intestinal transplantation. Transplant Proc 26(3):1634, 1994.
Kareem Abu-Elmagd, M.D., PhD. 26
69. Kadry Z, Furukawa H, Abu-Elmagd K, Manez R, Venkataramanan R, Tzakis A, Reyes J, Nour B, Fung J, Todo S, Starzl TE. Use of D-xylose absorption test in the monitoring of intestinal allografts. Transplant Proc 26(3):1645, 1994.
70. Kusne S, Manez R, Bonet H, Abu-Elmagd K, Furukawa H, Irish W, Tzakis A, Todo S, Starzl TE. Infectious complications after small bowel transplantation in adults. Transplant Proc 26(3):1682-1683, 1994.
71. Abu-Elmagd K, Todo S, Tzakis A, Furukawa H, Bonet H, Mohamed H, Nour B, Reyes J, Green M, Manez R, Pasculle W, Fung J, Starzl TE. Intestinal transplantation and bacterial overgrowth in humans. Transplant Proc 26(3):1684-1685, 1994.
72. Jain A, Fung JJ, Todo S, Reyes J, Selby R, Irish W, Doyle H, Abu-Elmagd K, Casavilla A, Nour B, Bronsther O, Jabbour N, Pinna A, Dodson F, Ramos H, McMichael JJ, McCauley J, Tzakis AG, Marino I, Marsh W, Venkataramanan R, Iwatsuki S, Starzl TE. One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc 27(1):1099-1104, 1995.
73. Todo S, Tzakis A, Reyes J, Abu-Elmagd K, Furukawa H, Fung J, Starzl TE. Intestinal transplantation: 4-year experience. Transplant Proc 27 (1):1355-1356, 1995.
74. Furukawa H, Manez R, Kusne S, Abu-Elmagd K, Green M, Reyes J, Todo S, Starzl TE. Cytomegalovirus disease in intestinal transplantation. Transplant Proc 27(1):1357-1358, 1995.
75. Furukawa H, Abu-Elmagd K, Reyes W, Hutson J, Tabasco-Minguillan, Lee R, Kusne S, Starzl TE, Todo S. Intestinal transplantation in 31 adults. Transplant Proc 28(5):2731-2732, 1996.
76. Tsamandas AC, Furukawa H, Abu-Elmagd K, Todo S, Demetris AJ, Lee RG. Liver allograft pathology in liver/small bowel or multivisceral recipients. Transplant Proc 28(5):2772, 1996.
77. Fontes P, Rao AS, Reyes J, Furukawa H, Abu-Elmagd K, Jabbour N, Zeevi A, Iyengar A, Todo S, Fung JJ, Starzl TE. Concomitant Infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc 28(5):2757-2758, 1996.
78. Tabasco-Minguillan J, Weber K, Nelson F, Hutson W, Furukawa H, Abu-Elmagd K, Todo S, Rakela J. Variability in the interpretations of endoscopic findings in patients with intestinal transplantation. Transplant Proc 28(5):2775-2776, 1996.
79. Tabasco-Minguillan J, Hutson W, Weber K, Lee RG, Demetris AJ, Furukawa H, Abu-Elmagd K, Todo S, Rakela J. Prospective evaluation of endoscopy in acute cellular rejection and cytomegalovirus infection. Transplant Proc 28(5):2778-2779, 1996.
80. Tabasco-Minguillan J, Hutson W, Weber K, Lee RG, Furukawa H, Abu-Elmagd K, Todo S, Rakela J. Endoscopic features of acute cellular rejection. Transplant Proc 28(5):2765-2766, 1996.
81. Furukawa H, Kusne S, Abu-Elmagd K, Green M, Reyes J, Starzl TE, Todo S. Effect of CMV serology on outcome after clinical intestinal transplantation. Transplant Proc 28(5):2780-2781, 1996.
82. Lee RG, Tsamandas AC, Abu-Elmagd K, Furukawa H, Hutson WR, Reyes J, Tabasco-Minguillan J, Todo S, Demetris AJ. Histological spectrum of acute cellular rejection in human intestinal allografts. Transplant Proc 28(5):2767, 1996.
83. Reyes J, Todo S, Bueno J, Furukawa H, Abu-Elmagd K, Green M, Kocoshis S, Kasper S, Yunis E, Starzl TE. Intestinal transplantation in children: Five-year experience. Transplant Proc 28(5):2755-2758, 1996.
84. Rao AS, Fontes P, Dodson F, Zeevi A, Rugeles MT, Abu-Elmagd K, Aitouche A, Rosner G, Truco M, Demetris AJ, Rybka W, Todo S, Fung JJ, Starl TE. Augmentation of Natural ChimerismWith Donor Bone Marrow in Orthotoic Liver Recipients. Transplant Proc 29(5):2959-2956, 1996.
85. Kusne S, Furukawa H, Abu-Elmagd K, Irish W, Rakela J, Fung J, Starzl TE, Todo S. Infectious complications after small bowel transplantation in adults: An update. Transplant Proc 28(5):2761-2762, 1996.
Kareem Abu-Elmagd, M.D., PhD. 27
86. Furukawa H, Smith C, Lee R, Knisely AS, Irish W, Reyes J, Abu-Elmagd K, Starzl TE, Todo S. Influence of donor criteria on early outcome after intestinal transplantation. Transplant Proc 29:690, 1997.
87. Furukawa H, Reyes J, Abu-Elmagd K, Mieles L, Hutson W, Kocoshis S, Tabasco-Manguillan J, Lee RG, Knisley A, Starzl TE, Todo S. Intestinal transplantation at the University of Pittsburgh - six year experience. Transplant Proc 29:688-689, 1997.
88. Rao AS, Phil D, Shapiro R, Corry R, Dodson F, Abu-Elmagd K, Pham S, Jordan M, Gupta K, Zeevi A, Rastellini C, Keenan R, Reyes J, Griffith B, Fung JJ, Starzl TE. Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc, 30:1367-1368, 1998.
89. Rovera GM, DeMartini A, Graham TO, Hutson WR, Furukawa H, Todo S, Rakela J, Fung JJ, Abu-Elmagd KM. Quality of life after intestinal transplantation and on total parenteral nutrition. Transplant Proc. Transplant Proc, 30:2513-2514, 1998.
90. Rovera GM, Abu-Elmagd KM, Hutson WR, Furukawa H, Goldbach B, Todo S, Rakela J, Fung JJ, Graham T.O. Long term nutritional monitoring after clinical intestinal transplantation. Transplant Proc. Transplant Proc, 30:2515-2516, 1998.
91. Rovera GM, Graham TO, Hutson WR, Furukawa H, Goldbach B, Todo S, Fung JJ, Rakela J, Abu-Elmagd KM. Nutritional management of intestinal allograft recipients. Transplant Proc. 30:2517-2518, 1998.
92. Rovera GM, Strohm S, Bueno J, Kocoshis SA, Abu-Elmagd K, Todo S, Reyes J. Nutritional monitoring of pediatric intestinal transplant recipients. Transplant Proc, 30:2519-2520, 1998.
93. Cicalese L, Abu-Elmagd K, Bueno J, Todo S, Reyes J. Intestinal transplantation in children after primary liver transplantation. Transplant Proc, 30:2680-2681, 1998.
94. Abu-Elmagd KM, Reyes J, Fung JJ, Mazariegos G, Bueno J, Janov C, Colangelo J, Rao A, Demetris A, Starzl TE. Evolution of clinical intestinal transplantation: Improved outcome and cost effectiveness. Transplant Proc 31:582-584, 1999.
95. Rao AS, Shapiro R, Corry R, Dodson F, Abu-Elmagd K, Pham S, Jordan M, Salgar S, Zeevi A, Rastellini C, Ostrowski L, Aitouche A, Keenan R, Reyes J, Griffith B, Starzl TE, Fung JJ. Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc 31:700-701, 1999.
96. Murase N, Ye Q, Lee RG, Demetris AJ, Abu-Elmagd K, Reyes J, Starzl TE: Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. Transplant Proc 31:565-566, 1999.
97. Bond G, Reyes J, Mazariegos G, Wu T, Schaefer N, Demetris J, Fung JJ, Starzl TE, Abu-Elmagd K. The impact of positive T-cell lymphocytotoxic cross-match on intestinal allograft rejection and survival. Transplant Proc 32(6):1197-1198, 2000.
98. Abu-Elmagd K, Fung J, McGhee W, Martin D, Mazariegos G, Schaefer N, Demetris J, Starzl TE, Reyes J. The efficacy of daclizumab for intestinal transplantation: Preliminary report. Transplant Proc 32(6):1195-1196, 2000.
99. De Vera ME, Reyes J, Demetris J, Mazariegos G, Schaefer N, Vargas H, Bond G, Wu T, Fung J, Starzl TE, Abu-Elmagd K. Isolated intestinal versus composite visceral allografts: causes of graft failure. Transplant Proc 32(6):1221-1222, 2000.
100. Nalesnik M, Jaffe R, Reyes J, Mazariegos G, Fung JJ, Starzl TE, Abu-Elmagd K. Posttransplantation lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc 32(6):1213, 2000.
101. Madariaga JR, Reyes J, Mazariegos G, Fung JJ, Starzl TE, Abu-Elmagd K. The long term efficacy of multivisceral transplantation. Transplant Proc 32(6):1219-1220, 2000.
Kareem Abu-Elmagd, M.D., PhD. 28
102. Giraldo M, Martin D, Colangelo J, Bueno J, Reyes J, Fung JJ, Starzl TE, Abu-Elmagd K. Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc 32(6):1223-1224, 2000.
103. Cicalese L, Sileri P, Green M, Abu-Elmagd K, Fung JJ, Starzl TE, Reyes J. Bacterial translocation in clinical intestinal transplantation. Transplant Proc 32(6):1210, 2000.
104. Kashyap A, Jain A, Reyes J, Demetris AJ, Abu-Elmagd K, Dodson SF, Marsh W, Madariaga V, Mazariegos G, Geller D, Bonham CA, Cacciarelli T, Fontes P, Starzl TE, Fung JJ. Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc 33; 1486-1487, 2001.
105. Rao AS, Dvorchik I, Dodson F, Abu-Elmagd K, Schaefer AT, Ostrowski L, Valenti M, Zeevi A, Kuddus R, Starzl TE, Fung JJ. Donor bone marrow infusion in liver recipients: Effect on the occurrence of acute cellular rejection. Transplant Proc 33:1352, 2001.
106. Garrido V, Bond GJ, Mazariegos G, Wu T, Martin D, Colangelo J, Ezzelarb M, Fung J, Reyes J, Abu-Elmagd K. Late severe rejection of intestinal allografts: Risks and survival outcome. Transplant Proc 33:1556-1557, 2001.
107. Wu T, Abu-Elmagd KM, Bond G, Murase N, Demetris AJ. A clinicopathologic study of isolated intestinal allografts with performed IgG lymphocytotoxic antibodies. Transplant Proc 34:878-880, 2002.
108. Jain A, Pokharna R, Abu-Elmagd K, Shapiro R, Scantlebury V, Eghtesad B, Fontes P, Gadomski M, Fung J. Use of rituximab (chimeric anti-CD20 antibody) in post transplant lymphoproliferative disorder (PTLD) after liver, kidney and pancreas transplantation. Transplant Proc 2002.
109. Martin D, Ezzelarb M, Bond G, Reyes J, Mazariegos G, Abu-Elmagd KM. Patient profile and candidacy for intestinal transplantation at the University of Pittsburgh. Transplant Proc 34:1897-1898, 2002.
110. Nakao A, Nalesnik MA, Azhipa O, Ishikawa T, Abu-Elmagd K, Starzl TE, Murase N. Immunodulation of intestinal transplantation: antilymphocyte serum donor pretreatment vs. ex vivo graft irradiation. Transplantation Proc 34(3): 986-987, 2002.
111. McGhee W, Mazariegos GV, Sindhi R, Abu-Elmagd K, Reyes J. Rituximab in the treatment of pediatric small bowel transplant patients with post-transplant lymphoproliferative disorder unresponsive to standard treatment. Transplantation Proc 34(3):921, 2002.
112. Iwanami K, Ishikawa T, Okuda T, Zhu Y, Tuerler A, Moore BA, Zhang S, Bauer AJ, Venkataramanan R, Abu-Elmagd K, Starzl TE, Nalesnik MA, Murase N. Long-term function and morphology of intestinal allografts in outbred canine transplantation model. Transplantation Proc 34 (3):994-995, 2002.
IV-Book Chapters
1. Fung JJ, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Jordan M, Armitage J, Jain A, Alessiani M, Martin M, Bronsther O, Stieber A, Kormos R, Selby R, Gordon R, Przepiorka D, Bloom E, Starzl TE. Overview of FK 506 in transplantation. In: Clinical Transplants 1990 (PI Terasaki, ed) UCLA Tissue Typing Laboratory, Los Angeles, California, pp 115-121, 1991.
2. Reyes J, Tzakis AG, Todo S, Abu-Elmagd K, Starzl TE. Post-operative care of small bowel transplant recipients. In: Care of the Critically Ill, Mosby Year Book, Europe, 9(5) 193-198, 1993.
3. Furukawa H, Abu-Elmagd K, Reyes J, Nour B, Tzakis A, Todo S, Starzl TE. Technical aspects of intestinal transplantation. In: Surgical Technology International II (MH Braverman, RL Tawes, eds) Surgical Technology International, pp 165-170, 1994.
4. Abu-Elmagd K, Bronsther O, Jain A, Irish W, Ramos H, Marino I, Dodson F, Selby R, Doyle H, Furukawa H, Gayowski T, Nour B, Reyes J, Mazariegos G, Pinna A, Rao A, Fontes P, Casavilla A, Jabbour N, Marsh W, Madariage J, Demetris AJ, Tzakis A, Todo S, Iwatsuki S, Fung JJ, Starzl TE. Recent advances in hepatic
Kareem Abu-Elmagd, M.D., PhD. 29
transplantation at the University of Pittsburgh. In: Clinical Transplants 1993 (PL Terasaki, ed) UCLA Tissue Typing Laboratory, Los Angeles, California, pp 137-152. 1994.
5. Scotti-Foglieni C, Marino IR, Cillo U, Furukawa H, Abu-Elmagd K, Todo S, Tzakis AG, Fung JJ, Starzl TE. Human intestinal-multivisceral transplantation. In: Liver Transplantation: Procedures and Management (DF D'Amico, N Bassi, U Tedeschi, U Cillo, eds) Masson Publishing Company, Milan, Italy, pp 235-254, 1994.
6. Marino IR, Doyle HR, Abu-Elmagd K, Scotti-Foglieni CL, Manez R, Tzakis AG, Todo S, Fung JJ, Starzl TE. The latest advances in liver transplantation at the Pittsburgh Transplantation Institute: Evolution of FK506, liver-intestinal transplantation, clinical xenotransplantation, and the induction of graft acceptance. In: Surgical Technology International III (Z Szabo, MD Kerstein, JE Lewis, eds) University Medical Press, Inc, San Francisco, California, pp 375-389, 1994.
7. Reyes J, Todo S, Tzakis A, Abu-Elmagd K, Nour B, Furukawa H, Starzl TE. Transplantation of the small bowel and other abdominal organs in humans. In: Intra-Abdominal Organ Transplantation 2000 (LS Sher, L Makowka, eds) RG Landes Company, Austin, Texas, 11:165-181, 1994.
8. Abu-Elmagd K, Todo S, Fung JJ, Demetris AH, Rakela J, Iwatsuki S, Starzl TE. Hepatic transplantation at the University of Pittsburgh: New horizons and paradigms after 30 years of experience. In: Clinical Transplants 1994 (PL Terasaki, ed) UCLA Tissue Typing Laboratory, Los Angeles, California, pp 133-156, 1995.
9. Reyes J, Selby R, Abu-Elmagd K, Tzakis AG, Todo S, Casavilla A, Starzl TE. Intestinal and multiple organ transplantation. In: Textbook of Critical Care, Third Edition (WC Shoemaker, SM Ayers, NA Grenvik, PR Holbrook, eds) WB Saunders Company, Florida, Section XIV, pp 1678-1687, 1995.
10. Abu-Elmagd K, Fung J, Todo S, Rao A, Reyes J, Demetris J, Mazariegos G, Fontes P, McMichaels J, Furukawa H, Dodson F, Jain A, Pinna A, Marsh W, Marino I, Gayowski T, Doyle H, Madariaga J, Casavilla A, Corry R, Rakela J, Iwatsuki S, Starzl TE. The current status of hepatic transplantation at the University of Pittsburgh. In: Clinical Transplants 1995 (PL Terasaki ed) UCLA Tissue Typing Laboratory, Los Angeles, California, pp 145-170, 1996.
11. Carroll PB, Thomson AW, McCauley J, Abu-Elmagd K, Rilo HR, Irish W, McMichael J, Van Thiel DH, Starzl TE. Tacrolimus and therapy of human autoimmune disorders. In: Principles of Drug Development In Transplantation and Autoimmunity (R Lieberman, A Mukherjee, eds) RG Landes Company, Austin, Texas, pp 211-220, 1996.
12. Fung JJ, Abu-Elmagd K, Todo S. Intestinal and multivisceral transplantation. In: Digestive Tract Surgery: A Text and Atlas (RH Bell Jr, ed) JB Lippincott Company, pp 1229-1261, 1996.
13. Demetris AJ, Tsamandas AC, Delaney CP, Abu-Elmagd K, Fung JJ, Starzl TE. Pathology of liver transplantation. In: Transplantation of the Liver (RW Busuttil, GB Klintmalm, eds) Orlando, Florida, WB Saunders Company, Philadelphia, Pennsylvania, pp 681-723, 1996.
14. Furukawa H, Reyes J, Abu-Elmagd K, Todo S, Fung JJ, Starzl TE. Donor procurement for intestinal transplantation. In: Multiorgan Selection Management (RSD Higgins, JA Sanchez, MI Lorber, JC Baldwin, eds) Blackwell Science Inc., Boston, MA, pp 221-240, 1997.
15. Scotti-Foglieni CL, Tinozzi SD, Abu-Elmagd K, Starzl TE. Enteroscopy of the transplanted small bowel. In: Atlas of Enteroscopy (FP Rossini, G Gay, eds) Springer Verlag, Berlin, pp 151-169, 1998.
16. Abu-Elmagd K, Fung J, Reyes J, Rao A, Jain A, Mazariegos G, Marsh W, Madariaga J, Dvorchik I, Bueno J, Rogers J, McMichael J, Dodson F, Vargus H, Martin J, Slivka A, Balan V, Corry R, Rakela J, Murase N, Demetris J, Iwatsuki S, Starzl T. Hepatic and intestinal transplantation at The University of Pittsburgh. In: Clinical Transplants 1998 (PL Terasaki, JM Cecka eds) UCLA Tissue Typing Laboratory, Los Angeles, CA, pp 263-286, 1999.
17. Reyes J, Abu-Elmagd K. Small bowel and liver transplantation in children. In: Pediatric Liver Disease (D.A. Kelly ed) Blackwell Science Ltd., Oxford, United Kingdom, pp 313-331, 1999.
Kareem Abu-Elmagd, M.D., PhD. 30
18. Reyes J, Selby R, Abu-Elmagd K, Todo S, Mazariegos G, Bueno J, Starzl TE. Intestinal and multiple organ transplantation. In: Textbook of Critical Care, Fourth Edition (WC Shoemaker, SM Ayers, NA Grenvik, PR Holbrook, eds) WB Saunders Company, Florida, pp 1986-1997, 1999.
19. Doria C, Giraldo M, Bueno JR, Mazariegos G, Vargas H, Kocoshis S, Marino I, Demetris A, Fung JJ, Starzl TE, Abu-Elmagd K. Intestinal transplantation: current and latest developments. In: Surgical Technology International VIII (Zoltan Szabo, James E. Lewis, Gary A. Fantini, Raghu S. Savalgi, eds) Universal Medical Press, Inc., San Francisco, CA, pp 309-317, 1999.
20. Lee KKW, Abu-Elmagd K. Intestinal transplantation. In: Advanced Therapy in Inflammatory Bowel Disease (S Hanauer, T Bayless, eds) B.C. Decker Publishing, Hamilton, Ontario, Canada, pp 485-489, 2000.
21. Abu-Elmagd K, Iwatsuki S. Portal hypertension: The role of liver transplantation. In: Current Surgical Therapy, 2001.
22. Abu-Elmagd K, Reyes J, Fung J. Clinical intestinal transplantation: recent advances and future consideration. AST Primer on Transplantation, 2001.
23. Abu-Elmagd K. Long-Term Survivors…In Their Own Words, pp 299-334. Clinical Transplants, J.M Cecka & PI Terasaki, 2002.
24. Abu-Elmagd K. The history of intestinal transplantation. In: The History of Organ and Cell Transplantation, Imperial College Press, March 2003.
25. Reyes J, Abu-Elmagd K. Small bowel transplantation in children. In: Diseases of the Liver and Biliary System in Children, Blackwell Publishing 2003.
26. Bond G, Costa G, Mazariegos G, Reyes J, Abu-Elmagd K. Intestinal Failure and Visceral Transplantation: A New Era of Colossal Achievement. In: Intestinal Failure and Rehabilitation: A Clinical Guide (Laura Matarese, Ezra Steiger, Douglas L. Seidner, eds) CRC Press, Boca Raton, London, New York, Washington, D.C., pp 295-319, 2004.
27. Starzl T, Murase N, Demetris AJ, Trucco M, Eghtesad B, Fontes P, Abu-Elmagd K, Marcos A, Fung JJ. Cell Migration, Chimerism, and Graft Acceptance: with Particular Reference to the Liver. In: Transplantation of the Liver 2nd Edition (RW Busuttil, GB Klintamlm, eds) Elsevier Science, Philadelphia, PA, pp 1183-1198, 2005.
28. Thai N, Abu-Elmagd K, Khan A, Bond G, Basu A, Tom K, Mazariegas G, Shapiro R, Starzl T E. Pancreatic Transplantation under a Regimen of Campath-1H, In: Clinical Transplants 2004 (PL Terasaki, JM Cecka eds) UCLA Tissue Typing Laboratory, Los Angeles, CA, pp 205-214, 2005.
29. Mazariegos G, Reyes J, Abu-Elmagd K, Starzl T E. Intestinal and Multiple Organ Transplantation. In: Textbook of Critical Care 5th Edition (MP Fink, E Abraham, J Vincent, PM Kochanek, eds) Elsevier Saunders, Philadelphia, PA, pp 2001-2012, 2005.
30. Bond GJ, Felmet KA, Jaffe R, Soltys KA, Squires RH, Martin D, Sindhi R, Abu-Elmagd K, Mazariegos GV. Intestinal and Multivisceral Transplantation. In: Rogers’ Textbook of Pediatric Intensive Care 4th Edition (DG Nichols, ed) Lippincott Williams & Wilkins, Philadelphia, PA, pp 1550-1561, 2008.
31. Abu-Elmagd K. Intestinal Transplantation: Indications and Patient Selection. In: Intestinal Failure: Diagnosis, Management and Transplantation (A Langnas, O Goulet, E Quigley, K Tappenden, eds) Blackwell Publishing, Oxford, UK, pp 245-253, 2008.
32. Costa G, Cruz R, Abu-Elmagd KM. Surgical Shunt Versus TIPS for Treatment of Variceal Hemorrhage in the Current Era of Liver and Multivisceral Transplantation. In: Surgical Clinics of North America (D Geller, ed) Elesevier Saunders, Philadelphia, PA, pp 891-905, 2010.
33. Abu-Elmagd KM, Costa G, Bond G, Soltys K, Martin L, Koritsky D, Cunha-Mela J, Sogawa, Irish W, Tzakis T, Mazariegos. A Decade of Experience with a Single-Dose of rATG or Alemtuzumab Pretreatment for
Kareem Abu-Elmagd, M.D., PhD. 31
Intestinal and Multivisceral Transplantation. Clinical Transplants, J.M Cecka & PI Terasaki, Pp 155-166, 2012.
34. Abu-Elmagd K, Costa G, Waiting List Management for Intestinal and Multivisceral Transplantation in Textbook of Organ Transplantation 1st ed. (eds Kirk A, Knechtle S, Larsen C, Madsen J and Pearson T. Wiley-Blackwell, John Wiley and Sons 2014:489-494. Editors: Allan D. Kirk, Stuart J. Knechtle, Christian P. Larsen, Joren C. Madsen, Thomas C. Pearson and Steven A. Webber.
35. Khanna A, Masato F, Hashimoto K, Quintini C, Radhakrishnan K, Costa G, Abu-Elmagd K. Intestinal and Multivisceral Transplantation: An Update in the Milieu of Gut Rehabilitiation”, in Pediatric Gastrointestional and Liver Dieases, 5th Edition. Elsevier Publishing Co. Elsevier Philadelphia 2015, Editors: WyllieHyams, Kay.
36. Nassar A, Fujiki M, Costa G, Khanna A, Hashimoto K, Quintini C, Anesthesia and Perioperative Care for Organ Transplantation, Springer Science+Busiiness Medica, Inc, NY, Editors: Sakai and Subramanian. 2015.
37. Starzl TE, Murase N, Eghtesad B, Abu-Elmagd K, Demetris AJ, Fung J. “Leukocyte Chimerism: Meaning and Consequences” in Transplantation of the Liver, Saunders+Elsevier Inc. Philadelphia, Editors: Busuttil and Klintmalm. 2015.
38. Abu-Elmagd K, Soliman B, Khanna A, Fujiki M, Eghtesad B, Costa, G. “Surgery in Patients with Hepatic Cirrhosis: Management of Portal Hypertension” in Surgical Procedures on the Cirrhotic Patient, Springer Nature Inc. Editors: Eghtesad B, and Fung J. Jan 2017
39. Recent Advances in Intestinal and MultivisceralTransplantation: Koji Hashimoto, MD, PhD, Guilherme
Costa, MD, Ajai Khanna, MD, PhD, Masato Fujiki, MD., PhD,Cristiano Quintini, MD, Kareem Abu-Elmagd, MD, PhD. Advances in Surgery, 2016
40. Surgery for Gut Failure: Auto-Reconstruction and Allo-Transplantation. Abu-Elmagd K, Khanna A, Fujiki M,
Hashimoto H, El-Gazzaz G, Shatnawei A, Guilherme C., Current Therapy in Colon and Rectal Surgery, 3rd
Edition Elsevier Philadelphia 2017 Editors: Victor Fazio MD., James Church MD., Conor P Delaney MD.,
Ravi Kiran MD., 2017.
41. Technical Innovation and Visceral Transplantation. Masato Fujiki, MD, PhD, Koji Hashimoto, MD, PhD,
Ajai Khanna, MD, PhD, Guilherme Costa, MD, Cristiano Quintini, MD, Kareem Abu-Elmagd MD, PhD.
Anesthesia and Perioperative Care for Organ Transplantation (Springer Science+Business Media, Inc, NY)
Editors: Sakai T and Subramanian K. Nov 2017.
42. The Historic Evolution of Intestinal and Multivisceral Transplantation: Ahmed Nassar, Masato Fujiki, MD., PhD,,Guilherme Costa, MD, Ajai Khanna, MD., PhD, Koji Hashimoto, MD, PhD, Cristiano Quintini, MD, Kareem Abu-Elmagd, MD, PhD Anesthesia and Perioperative Care for Organ Transplantation (SpringerScience+Business Media,Inc, NY) Editors: Sakai T and Subramanian K. Nov 2017.
43. Intestinal Lengthening and Transplantation Candidacy, Logistics and Techniques: Kareem Abu-Elmagd, MD
Guilherme Costa, MD, PhD. Springer Surgery Atlas Series: Transplantation Surgery (Springer-Verlag Berlin
Heidelberg) Editor: Oniscu G and Forsythe J, 2017.
44. Surgery in Patients with Hepatic Cirrhosis: Management of Portal Hypertension. Kareem Abu-Elmagd, MD, PhD,Basem Soliman, MD, PhD, Ajai Khanna, MD, PhD, MasatoFujiki, MD, PhD, Bijan Eghtesad, MD, PhD, Guilherme Costa, MD, PhD. Surgical Procedures on the Cirrhotic Patient (Springer International), Editors: Eghtesad B and Fung J. 2017
45. The Enigma of Gut Failure after Bariatric Surgery: Clinical Types and Surgical Ingenuity”. Kareem Abu-
Elmagd, G Costa, Masato Fujiki, Ajai Khanna, Koji Hashimoto. Complications of Bariatric surgery. Editors: Thomas Rogula, Phil Schauer, 2017
46. Intestinal lengthening and transplantation surgery: candidacy, logistics, and techniques. Abu-Elmagd K, Costa G. In: Springer Surgery Atlas Series: Transplantation Surgery. Edited by Oniscu G et al. Milan, Italy: Springer; 2018.
Kareem Abu-Elmagd, M.D., PhD. 32
47. Recent evolution of gut rehabilitation. In: Shah A, Doria C. (eds) Contemporary Small Bowel Transplantation. Parekh N., Abu-Elmagd K. (2018) Organ and Tissue Transplantation. Springer Nature, Switzerland.
48. Visceral transplantation: Current trends and long-term outcome. In: Shah A, Doria C. (eds) Contemporary Small Bowel Transplantation. Parekh N., Abu-Elmagd K. (2018). Organ and Tissue Transplantation.
49. Gut Failure After Bariatric Surgery. Abu-Elmagd KM, Khanna A, Fujiki M, Hashimoto K, Rogula TG, Costa G. Prevention and Management of Complications in Bariatric Surgery. 2018 Apr 25:195.
50. History of Visceral Transplantation. Armanyous S, Osman M, Parekh N, Fujiki M, Girlanda R, Costa G, Abu-Elmagd KM. Psychosocial Care of End-Stage Organ Disease and Transplant Patients. 2019:307-19.
51. Intestinal and Multivisceral Transplantation: Recent Advances. Girlanda R, Fujiki M, Osman M, Costa G, Radhakrishnan K, Abu-Elmagd K. (2020). In R. Wyllie, J.S. Hyams, M. Kay (Ed) Pediatric Gastrointestinal and Liver Disease. Elsevier, Philadelphia, PA. pp 376-387.
52. Gut Dysmotility and Transplantation: Long-Term Outcomes with New Insights into Surgical Integration and Allograft Motility Disorders. Osman M, ElSherif A, Chen CB, Fujiki M, D’Amico G, Radhakrishnan K, Abu-Elmagd K. InPediatric Neurogastroenterology: Gastrointestinal Motility Disorders and Disorders of Gut Brain Interaction in Children 2023 Jan 1 (pp. 661-678). Cham: Springer International Publishing.
V- Published Abstracts (Selected)
1. Vinayek R, Balan V, Oshakil O, Abu-Elmagd K, Irish W, McMichael J, Fung JJ, Rakela J. Optimal timing and outcome of liver transplantation in primary biliary cirrhosis using Mayo risk score: an experience from the second decade. Hepatology 26(4):164A, 1997.
2. Abu-Elmagd K, Demetris J, Rakela J, Balan V, Vinayek R, Irish W, Martin D, Lee R, Mazariegos J, Starzl T, Fung J. Transplantation for primary biliary cirrhosis: disease recurrence and outcome in 421 patients. Hepatology 26(4):176A, 1997.
3. Vinayek R, Balan V, Demetris A, Abu-Elmagd K, Irish W, Fung JJ, Rakela J. Autoimmune cholangitis: clinical presentation and recurrent disease after liver transplantation (LT). Hepatology 26(4):403A, 1997.
4. Abu-Elmagd K, Reyes J, Mazariegos G, Lee R, Furukawa H, Bueno, Geraldo M, Murase N, Demetris A, Todo S, Fung J, Starzl TE. Clinical intestinal transplantation: risk factors and new strategies. The Transplantation Society XVII World Congress, Transplantation Book of Abstracts, p 147, 1998.
5. Kelly D, Abu-Elmagd K, Reyes J, Mazariegos G, Bueno J, Geraldo M, Lee R, Murase N, Demetris A, Starzl TE, Fung J. Portal versus systemic venous drainage of intestinal allografts in humans. The Transplantation Society XVII World Congress, Transplantation Book of Abstracts, p 148, 1998.
6. Murase N, Ye Q, Lee RG, Demetris AJ, Abu-Elmagd K, Reyes J, Starzl TE. Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. The Transplantation Society XVII World Congress, Transplantation Book of Abstracts, p 148, 1998.
7. Rao AS, Shapiro R, Corry R, Dodson F, Abu-Elmagd K, Pham S, Jordan M, Zeevi A, Rastellini C, Seskey T, Braun M, Aitouche A, Keenan R, Reyes J, Griffith B, Ostrowski I, Fung JJ, Starzl TE. Single vs multiple donor bone marrow infusion in organ allograft recipients. The Transplantation Society XVII World Congress, Transplantation Book of Abstracts, p 273, 1998.
8. Rao AS, Shapiro R, Corry R, Dodson F, Abu-Elmagd K, Jordan M, Pham S, Zeevi A, Rastelini C, Aitouche A, Keenan R, Reyes J, Griffith B, Ostrowski L, Fung JJ, Starzl TE. Immune modulation in organ recipients by single or multiple donor bone marrow infusions. Transplantation, 65(12):126, 1998.
9. Molmenti E, Balan V, Marsh JW, Ishii T, Dvorchik I, Abu-Elmagd K, Minervini M, Demetris AJ, Fung JJ, Rakela J. Liver transplantation and autoimmune hepatitis recurrence. Hepatology 28(4):191A, 1998.
Kareem Abu-Elmagd, M.D., PhD. 33
10. Khanna A, Abu-Elmagd K, Virji MA, Carr BI. Retrospective analysis of 20 hepatocellular carcinoma patients with adrenal metastases: the influence of liver transplantation and adrenalectomy. Hepatology 28(4):246A, 1998.
11. Bueno J, Ohwada S, Mazariegos G, Abu-Elmagd K, Kocoshis S, Reyes J. Elevated alpha fetoprotein predicts poor outcome in children with total parenteral nutrition associated cholestasis and intestinal failure. Hepatology 28(4):434A, 1998.
12. Abu-Elmagd K, Demetris J, Rakela J, Kang Y, Martin D, Dvorchik I, McMichael J, Balan V, Starzl TE, Fung J. Recurrence of primary sclerosing cholangitis (PSC) after hepatic transplantation (HTx): single center experience with 380 Grafts. Hepatology 28(4):739A, 1998.
13. Abu-Elmagd K, Demetris AJ, Rakela J, Martin D, Dvorchik I, Iwatsuki S, Starzl TE, Fung J. Long term efficacy of hepatic transplantation (HTx) for primary sclerosing cholangitis (PSC) complicated with hepatobiliary carcinoma. Hepatology 28(4):759A, 1998.
14. Salgar S, Shapiro R, Corry R, Dodson F, Abu-Elmagd K, McCurry K, Jordan M, Zeevi A, Keenan R, Reyes J, Griffith B, Ostrowski L, Fung JJ, Starzl TE, Rao AS. Adjuvant donor bone marrow infusion in organ transplant recipients is associated with reduced incidence of acute and chronic rejection. Transplantation 67(7):S14, 1999.
15. Mazariegos G, Abu-Elmagd K, Bueno J, Kocoshis S, Reyes J. Expanding indications for intestinal transplantation. Transplantation 67(7):S195, 1999.
16. Abu-Elmagd K, Demetris J, Rakela J, Kang Y, Martin D, Dvorchik I, McMichael J, Balan V, Starzl TE, Fung JJ. Recurrence of primary sclerosing cholangitis (PSC) after hepatic transplantation: single center experience with 380 grafts. Transplantation 67(7):S236, 1999.
17. Abu-Elmagd K, Reyes J, Mazariegos G, Demetris J, Murase N, Rakela J, Rao A, Starzl TE, Fung J. Intestinal transplantation and end stage gastrointestinal disease: improved outcome and cost effectiveness. Transplantation 67(7):S236, 1999.
18. Madariaga J, Reyes J, Sindhi R, Abu-Elmagd K, Mazariegos GV, Fung JJ, Starzl TE. Monosegmental bile duct occlusion after split liver transplantation. Transplantation 67(9):S577, 1999.
19. Abu-Elmagd K, McGhee W, Martin D, Mazariegos G, Fung JJ, Starzl TE, Reyes J. The efficacy of daclizumab for intestinal transplantation: preliminary report. Transplantation 67(9):S588, 1999.
20. Jain AB, Rohal S, Madariaga J, Abu-Elmagd K, Dodson F, Rakela J, Fung JJ. Reasons for long-term steroid use following primary adult liver transplantation under tacrolumus. Transplantation 67(9):S601, 1999.
21. Rogers J, Martin D, Bueno J, Madariaga J, Vargas H, Reyes J, Fung JJ, Starzl TE, Abu-Elmagd K. Intestinal transplantation for end stage Crohn’s disease. Transplantation 67(9):S639, 1999.
22. Giraldo M, Colangelo J, Rogers J, Madariaga J, Vargas H, Reyes J, Fung JJ, Starzl TE, Abu-Elmagd K. Intestinal transplantation for patients with visceral vascular occlusive disease. Transplantation 67(9):S639, 1999.
23. Murase N, Ye Q, Lee RG, Demetris AJ, Abu-Elmagd K, Reyes J, Starzl TE. Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. Transplant Proc 31:565-566, 1999.
24. Sigurdsson L, Reyes J, Kocoshis SA, Mazariegos G, Bueno J, Abu-Elmagd KM, DiLorenzo C. Do we need to refer children with chronic intestinal pseudo-obstruction for small bowel transplantation? Gastroentrology 116(4):G2403 Part 2, 1999.
25. Abu-Elmagd KM, Reyes JD, Mazariegos GV, Bond GJ, Demetris AJ, Murase N, Rao AK, Starzl TE, Fung JJ. Intestinal transplantation. Transplantation 69(8):S137, 2000.
Kareem Abu-Elmagd, M.D., PhD. 34
26. Abu-Elmagd KM, Demetris AJ, Mazariegos GV, Bond GJ, Starzl TE, Fung JJ, Reyes JD. Chronic rejection of the intestinal allograft. Transplantation 69(8):S166, 2000.
27. Bond GJ, Reyes JD, Rao AK, Mazariegos GV, Murase N, Demetris AJ, Starzl TE, Fung JJ, Abu-Elmagd KM. Intestinal transplantation and bone marrow augmentation. Transplantation 69(8):S308, 2000.
28. Abu-Elmagd KM, Reyes J, Mazariegos G, Demetris J, Murase N, Rao A, Starzl TE, Fung JJ. Long term efficacy of intestinal transplantation. Am J Gastroenterol 95(9):271, 2000.
29. Abu-Elmagd KM, Reyes JD, Mazareigos GV, Bond GI, Demetris AJ, Ruppert K, Wu T, Murase N, Rao AS, Starzl TE, Fung JJ. Hepatology, 32(4):268 Part 2, 2000.
30. Lopez-Plaza I, Fonzi F, Abu-Elmagd K, Triulzi D. Blood utilization in small bowel transplantation. Transfusion 41(90):565-56S Supplement, 2001.
31. Bentlejewski C, Abu-Elmagd K, Harris C, Zak M, Bond G, Post D, Kowalski R, Britz J, Zeevi. Sequential analysis of cell mediated immunity in small bowel transplant recipients. Human Immunology, 63(10): Supplement 1:S74, 2002.
32. Reyes J, Mazariegos GV, Bond GJ, Sindhi R, Smith A, McGhee W, Fung JJ, Abu-Elmagd KM. Rabbit anti-thymocyte globulin (rATG) preconditioning and induction for pediatric intestine transplantation. Liver Transplantation 9(6):123, 2003.
33. Nalesnik M, Wu T, Martin D, Bond G, Mazariegos G, Demetris A, Reyes J, Abu-Elmagd K. Post transplant lymphoproliferative disorders (PTLD) in intestinal transplant recipients. Transplantation, 78(2): Supplement: O85, 2004.
34. Kwak E J, Bond G, Laughlin K, McHenry B, Costa G, Hussein S, Patterson D, Kusne S, Abu-Elmagd K. Invasive Fungal infections after adult small bowel transplantation: risk factors and efficacy of prophylactic therapy: Transplantation, 78(2): Supplement: P831, 2004.
35. Sinclair S, Folk P, Martin L, Jones D, Stamos J, Laughlin K, Bond G, Abu-Elmagd K. Acute peripartum intestinal ischemia and intestinal transplantation. Transplantation, 78(2): Supplement: P620, 2004.
36. Bond G, Mazariegos G, Sindhi R, Reyes J, Abu-Elmagd K. Is histadine-tryptophan-ketoglutarate (HTK) better than University of Wisconsin (UW) solution for the cold preservation of intestinal and multivisceral allografts. Transplantation, 78(2): Supplement: P49, 2004.
37. Schuster B, Bond G, Martin L, Costa G, Soltys, Mazariegos G, Kandil H, Abu-Elmagd K. Acute irreversible intestinal failure and early intestinal transplantation: indications and survival outcomes. Transplantation, 78(2): Supplement: O61, 2004.
38. Martin L, Wu T, Koritsky D, Colangelo J, Laughlin K, Stamos J, Schuster B, Costa G, Bond G, Abu-Elmagd K. Does isolated intestinal transplantation reverse TPN induced hepatic injury. Transplantation, 78(2): Supplement: P617, 2004.
39. Harris C, Bond G, Ezzelarab M, Costa G, Soltys K, Sindhi R, Mazariegos G, Abu-Elmagd K. Intestinal and multivisceral transplantation for portomesenteric venous thrombosis: technical considerations and therapeutic efficacy. Transplantation, 78(2): Supplement: P607, 2004.
40. Laughlin K, Harris C, Martin D, Stamos J, Costa G, Bond G, Abu-Elmagd K. The efficacy of intravenous immune globulin (IVIG) in small bowel and multivisceral allografts transplanted across a positive lymphocytotoxic crossmatch. Transplantation, 78(2): Supplement: P13, 2004.
41. Stamos J, Martin L, Colangelo J, Koritsky D, Soltys K, Costa G, Harris C, Ezzelarab M, Kandil H, Bond G, Abu-Elmagd K. Intestinal and multivisceral transplantation in patients with abdominal malignancy: disease recurrent and survival outcomes. Transplantation, 78(2): Supplement: O57, 2004.
Kareem Abu-Elmagd, M.D., PhD. 35
42. Kandil H, Bond G, Harris C, Martin L, Koritsky D, Graham T, O’Keefe S, Mazariegos G, Abu-Elmagd K. Small bowel and multivisceral transplantation: indications and outcome analysis. Transplantation, 78(2): Supplement: P616, 2004.
43. Abu-Elmagd K, Bond G, Mazariegos G, Murase N, Martin D, Koritsky D, Sindhi R, Laughlin K, Wu T, Demetris A, Marcos A, Fung J, Starzl T E, Reyes J. A new tolergenic immunosuppressive strategy for human intestinal transplantation. Transplantation, 78(2): Supplement: O58, 2004.
44. Abu-Elmagd K, Bond G, Mazariegos G, Costa G, Martin D, Sindhi R, Wu T, Soltys, Demetris A, Murase N, Marcos A, Fung J, Starzl T E, Reyes J. Pancreatic transplantation in abdominal visceral recipients: indications, immunogenicity and functional outcomes. Transplantation, 78(2): Supplement: O380, 2004.
45. Wu T, Bond G, Martin D, Demetris A, Abu-Elmagd K. Histopathologic characteristics of human intestine allograft acute rejection in patients with tolergenic immunosuppression. Transplantation, 78(2): Supplement: O59, 2004
46. Aggarwal S, Planinsic R M, Ezzelarab M B, Harris C, Bond G, Abu-Elmagd K. Histadine-tryptophan-ketoglutarate (HTK) versus university of wisconsin (UW) solution for intestinal and multivisceral grafts: intra-operative observation. Transplantation, 78(2): Supplement: P47, 2004.
47. Reidy M, Schuster B, Emerling M, Stamos J, Laughlin K, Colangelo J, Costa G, Bond G, Abu-Elmagd K. Physical and occupational rehabilitation before and after intestinal Transplantation. Transplantation, 78(2): Supplement: P619, 2004.
48. Emerling M, Koritsky D, Martin L, Costa G, Bond G, Abu-Elmagd K. Psychosocial rehabilitation after intestinal transplantation. Transplantation, 78(2): Supplement: P873, 2004.
49. Bond G, Costa G, Soltys K, Abu-Elmagd K, Starzl TE. The role of intestinal reconstruction and rehabilitation in an intestinal transplant center. Am J Transplant, 6(S2):852 and Transplantation, 82(1) S3:852, 2006.
50. Stamos J, Martin L, Koritsky D, Walsh G, Laughlin K, Schuster B, Costa G, Bond G, Abu-Elmagd K. Intestinal and multivisceral transplantation for patients with abdominal malignancy: disease recurrence and survival outcome. Am J Transplant, 6(S2):851 and Transplantation, 82(1) S3:851, 2006.
51. Laughlin K, Martin L, Stamos J, Koritsky D, Dvorchik I, Wu T, Murase N, Costa G, Bond G, Abu-Elmagd K. The efficacy of intravenous immune globulin (IVIG) in small bowel and multivisceral allografts transplanted across a positive lymphocytotoxic crossmatch. Am J Transplant, 6(S2):775 and Transplantation, 82(1) S3:775, 2006.
52. Reidy M, Zafonte R, Schuster B, Emerling M, Koritsky D, Costa G, Bond G, Abu-Elmagd K. Physical and occupational rehabilitation before and after intestinal transplantation. Am J Transplant, 6(S2):596 and Transplanation, 82(1) S3:596, 2006.
53. Seward L, Mazariegos G, Abu-Elmagd K, Haberman K, Blice J, Gargarella N, Harris P, Stamos J, Walsh G, Wagner K, Roberts M, Rose J. Abdominal transplant acuity scoring system. Am J Transplant, 6(S2):596 and Transplantation, 82(1) S3:596, 2006.
54. Emerling M, Ayyash M, Koritsky D, Martin L, Schuster B, Stamos J, Matarese L, Bond G, Costa G, Abu-Elmagd K. Psychosocial rehabilitation after intestinal and multivisceral transplantation. Am J Transplant, 6(S2):466-467 and Transplantation, 82(1) S3:466-467, 2006.
55. Sindhi R, Khera N, Nucci A, Kowalski L, Perez G, Soltys K, Bond G, Abu-Elmagd K, Fazzolare T, Remaley L, Kosmach B, Seward L, Haberman K, Mazariegos G. Susstained survival and growth advantages of steroid-free intestinal transplantation at 2-year follow-up. Am J Transplant, 6(S2):282 and Transplantation, 82(1) S3:282. 2006.
56. Sindhi R, Khera N, Nucci A, Kowalski L, Perez G, Soltys K, Bond G, Abu-Elmagd K, Mazariegos G. Steroid-free pediatric intestinal transplantation four-year experience in 75 children. Am J Transplant, 6(S2):280 and Transplantation, 82(1) S3:280, 2006.
Kareem Abu-Elmagd, M.D., PhD. 36
57. Schuster B, Bond G, Koritsky D, Emerling M, Martin L, Stamos J, Laughlin K, Costa G, Abu-Elmagd K. Early intestinal transplantation for patients with acute irreversible intestinal failure. Am J Transplant, 6(S2):279 and Transplantation, 82(1) S3:279, 2006.
58. Bond G, Aggarwal S, Schuster B, Soltys K, Sindhi R, Costa G, Reyes J, Mazariegos G, Abu-Elmagd K. Is histadine-trypophan-ketoglutarate (HTK) a better cold preservative solution for intestinal and multivisceral allografts. Am J Transplant, 6(S2):279 and Transplantation, 82(1) S3:279, 2006.
59. Matarese L, Martin L, Koritsky D, Costa G, Bond G, Abu-Elmagd K. Weight gain and obesity after intestinal transplantation. Am J Transplant 6(S2):279 and Transplantation, 82(1) S3:279, 2006.
60. Bond G, Soltys K, Costa G, Slivka A, Sindhi R, Mazariegos G, Abu-Elmagd K. Biliary complications after composite visceral transplantation with preservation of the donor duodenum. Am J Transplant, 6(S2):279 and Transplantation, 82(1) S3:279, 2006.
61. Schaefer N, Tahara K, Websky MV, Wehner S, Koscielny A, Abu-Elmagd K, Kalff J, Hirner A, Turler A. Resident macrophages within the intestinal muscularis play a key role in the initiation and manifestation of acute rejection in allogeneic rodent small bowel transplantation (SBTx). Am J Transplant, 6(S2):982-983 and Transplantation, 82(1) S3:982-983, 2006.
62. Ahmad J, Dvorchik I, Chadalavada R, Abu-Elmagd K, Fontes P, Marcos A, Demetris J. Acute rejection is associated with recurrent primary sclerosing cholangitis after liver transplantation. Am J Transplant, 6(S2):210-211 and Transplantation, 82(1) S3:210-211, 2006.
63. Popescu I, Macedo C, Hua y, Abu-Elmagd K, Shapiro R, Engelstad B, Fung J, Metes D. Ex vivo generation of EBV-specific CTLs using peptide pulsed DC1 from solid organ transplant recipients results in expansion of CD8+ type-1 like-regulatory (IFN-[gamma] and IL-10) FOXP3+T cells. Am J Transplant, 6(S2):204 and Transplantation, 82(1) S3:204, 2006.
64. Boyer TD, Henderson JM, Heerey A, Abu-Elmagd KM, Galloway J, Rikkers L, Jeffers L. Cost-effectiveness of distal splenorenal shunt (DSRS) vs. transjugular intrahepatic portosystemic shunt (TIPS). Hepatology, 44(4) S1:440A, 2006.
65. Abu-Elmagd K, Wu T, Bond G, Costa G, Kandil H, Soltys K, O’Keefe S, Demetris A. Intestinal transplantation for end stage Crohn’s disease: therapeutic efficacy and risk of recurrence. Am J Gastro, 101(S2):S468, 2006.
66. Abu-Elmagd K, Mazariegos G, Bond G, Costa G, Sindhi R, Soltys K, Kandil H, Squires R, O’Keefe S. Intestinal transplantation: current status and future considerations. Am J Gastro, 101(S2):S145-S146, 2006.
67. Abu-Elmagd KM, Mazariegos G, Bond GJ, Murase N, Wu T, Costa G, Soltys K, Sindhi R, Demetris AJ, Marcos A, Starzl TE. The immunoprotective effect of the liver as part of a composite visceral graft: the impact on survival and long-term outcome. Jour of Hepatology, 46(S1):S15, 2007.
68. Abu-Elmagd K, Costa G, Haider H, Bond G, Wu T, Fontes P, Marsh W, Marcos A, Starzl T. Evolution of the surgical management of portomesenteric venous thrombosis (PMVT): 25 years of experience at a single center. Am J Transplant, 7(S2):297-298, 2007.
69. Machaidze A, Bond G, Soltys K, Squires R, Martin D, Perez G, Abu-Elmagd K, Sindhi R, Mazariegos G. Long term outcomes of intestinal transplantation from donors under age 1. Am J Transplant, 7(S2):300, 2007.
70. Sindhi R, Talukdar A, Abu-Elmagd K, Soltys K, Bond G, Mazariegos. Chronic rejection and renal failure cause major morbidity after steroid-free pediatric small bowel transplantation (SBTx). Am J Transplant, 7(S2):300, 2007.
71. Haider H, Costa G, Bond G, Koritsky D, Martin L, Kadry Z, Soltys K, Sindhi, Wu T, Mazariegos G, Abu-Elmagd K. Recipient age and survival after intestinal transplantation: Outcome analysis. Am J Transplant, 7(S2):407, 2007.
Kareem Abu-Elmagd, M.D., PhD. 37
72. Talukdar AJ, Ashokkumar C, Wilson P, Sun Q, Boig L, Abu-Elmagd K, Mazariegos G, Sindhi, R. Lymphocyte subset reconstitution patterns after steroid-free induction in 70 children with small bowel/multi-visceral transplantation (SB/MVTx). Am J Transplant, 8(S2):387, 2008.
73. Ayyash M, Steele J, Stone B, Costa G, Bond G, Abu-Elmagd K. Psychiatric disorders among candidates for intestinal and multivisceral transplantation: prevalence and risk factors. Am J Transplant, 8(S2):397, 2008.
74. Abu-Elmagd KM, Nalesnik M, Costa G, Bond GJ, Soltys K, Sindhi R, Green M, Jaffe R, Wu T, Patel S, Mazariegos G. Lymphoproliferative disorder, de novo malignancy, and tumor recurrence after intestinal and multivisceral transplantation: Innovative strategies with new outlook. Am J Transplant, 8(S2): 477, 2008.
75. Patel S, Costa G, Bond G, El-Wahidi A, von Websky M, Martin L, Wu T, Matarese L, Soltys K, Mazariegos G, Abu-Elmagd K. The fate of TPN-associated liver injury after intestinal transplantation. Am J Transplant, 8(S2): 558, 2008.
76. Cunha-Melo J, Costa G, Bond GJ, Slivka A, Kandil H, O’Keefe SJ, Soltys K, Mazariegos G, Abu-Elmagd KM. Intestinal transplantation and autologous reconstruction for gastrointestinal failure following bariatric surgery. Am J Transplant, 8(S2): 559, 2008.
77. Patel S, Costa G, Bond G, El-Wahid A, von Websky M, Martin L, Macara W, Wu T, Matarese L, Soltys K, Mazariegos G, Abu-Elmagd K. Reversibility of TPN-associated liver injury with successful intestinal transplantation. Liver Transplantation 14(7) S1: S82, 2008 P-53.
78. Bond GJ, Soltys K, Sindhi R, Abu-Elmagd K, Mazariegos G. Pediatric intestinal transplantation: An evolution still in progress. Liver Transplantation 14(7)S1: S215, 2008.
79. Abu-Elmagd K, Nalesnik M, Costa G, Bond G, Soltys K, Sindhi R, Green M, Jaffe R, Wu T, Patel S, Mazariegos G. Lymphoproliferative disorder, de novo malignancy and tumor recurrence after intestinal, liver-intestine, and multivisceral transplantation: Innovative strategies with new outlook. Liver Transplantation 14(7)S1: S215, 2008.
80. Abu-Elmagd K, Haider H, Costa G, Bond G, Mazariegos G, Marsh W, Fontes P, Amesur N, Marcos A, Starzl T. Portomesenteric venous thrombosis: A new classification in the era of intestinal and multivisceral transplantation. Liver Transplantation 14(7) S1: S222, 2008.
81. Linden P, Posey K, Johnson H, Marcos A, Abu-Elmagd K, Paterson D, DeVera M. Stratified voriconazole prophylaxis for the prevention of aspergillosis in liver and multivisceral transplant recipients: Comparison with a control cohort. Am J Transplant, 8(S2): 564, 2008.
82. Abu-Elmagd KM, Costa G, Bond GJ, Soltys K, Sindhi R, Wu T, Murase N, Cruz R, Zeevi A, Mazariegos G. Evolution and minimization of immunosuppression in five hundred intestinal and multivisceral transplantations at a single center. Am J Transplant 9(S2):239, 2009.
83. Matarese LE, Martin D, Costa G, Bond G, Wu G, Cruz R, Kandil H, Koritsky D, Schuster B, Abu-Elmagd K. Intestinal rehabilitation as an alternative to transplantation for restoration of nutritional autonomy: survival and outcomes. JPEN 34(2): 185, 2010 ST35-4.
84. Cruz R, Costa G, Bond G, Martin D, Matarese LE, Soltys K, Sindhi R, Mazariegos G, Abu-Elmagd K. JPEN 34(2):226, 2010 SP51.
85. Cruz R, Costa G, Bond G, Martin D, Matarese LE, Soltys K, Sindhi R, Mazariegos G, Abu-Elmagd K. Intestinal and multivisceral transplantation for the restoration of nutritional autonomy in patients with intestinal pseudoobstruction. JPEN 34(2):227, 2010 SP52.
86. Wu G, Lunz J, Costa G, Bond G, Cruz R, Soltys K, Mazariegos G, Sindhi R, Zeevi A, Abu-Elmagd K. Donor specific human leukocyte antigen (HLA) antibodies and allograft survival after intestinal transplantation. Am J Transplant 10(S4):162, 2010.
87. Kosmach-Park B, Sindhi R, Sun Q, Abu-Elmagd K, Mazariegos G. Long term outcomes at 25 years following pediatric intestine transplantation (ITx). Am J Transplant 10(S4):162, 2010.
Kareem Abu-Elmagd, M.D., PhD. 38
88. Costa G, Cruz R, bond G, Soltys K, Sindhi R, Mazariegos G, Abu-Elmagd K. rATG versus alemtuzumab single dose pretreatment for visceral allograft recipients. Am J Transplant 11(S2):133, 2011.
89. Arterial grafts created in intestinal and multivisceral transplantation: CT and angiographic evaluation of the normal appearance and common complications. Electronic exhibit 113th ARRS meeting, April, 2013.
90. Soliman B.G, Okamoto T, Quintini C, Liu Q , Iuppa G, Khanna A, Fujiki M, Hashimoto K, Fung J, Abu-Elmagd K. Establishing an Ex-Vivo Intestine Perfusion Model Utilizing Pig Grafts, 35th Cleveland Clinic Annual Research Day. Cleveland Clinic Foundation, Cleveland, OH, United States. 2015.
91. Basem G. Soliman, MD1, Ramy A. Hassan MD PhD1, Cristiano Quintini MD, Federico Aucejo MD PhD1, Qiang Liu MD PhD1, John Fung MD PhD1, Bijan Eghtesad MD1, Kareem Abu-Elmagd MD PhD. Impact of alpha fetoprotein level on the outcome of liver transplantation for hepatocellular carcinoma (submitted).
92. Okamoto T, Mitsuhashi M. Soliman B, Abu-Elmagd K. Detection of lung-specific exosome in perfusates of ex-vivo lung perfusion system. Submitted ISHLT.
93. Soliman B, Karagkounis G, Abu-Elmagd K, Church J. Kalady M. Mucinous histology signifies poor oncologic outcomes in young colorectal cancer patients (Submitted).
94. Soliman S, Okamoto T, Quintini C, Liu Q, Luppa G, Khanna A, Hashsimoto K, Fujiki M, Fung J, Abu-Elmagd K. Normothermic Ex-Vivo perfusion of the intestine: The introduction of an innovative physiologic model with novel biomarkers ATC 2016.
95. Soliman BG, Ramy A, Quintini C, Federico A, Liu Q, Fung J, Eghtesad B, Abu-Elmagd K. Impact of alpha fetaprotein level on the outcome of liver transplantation for hepatocellular carcinoma. ATC 2016
96. Abu-Elmagd K. Intestinal Transplant: Concept to Reality. CIRTA 2017
97. Abu-Elmagd K. Gut Failure and Surgical Ingenuity: Over Five Hundred Open Restorative Procedures at a Single Center. CIRTA 2017
98. Costa, G., Abu-Elmagd K. Visceral Transplantation for End Stage Crohn’s Disease: 25 years of Experience at a Single Center. CIRTA 2017
99. Fujiki, M., Abu-Elmagd K. Donor Specific Antibodies in Primary Liver-Free Visceral Allograft Recipients; Anti-B Cell Therapy, Immunologic Monitoring, and Outcome Measures. CIRTA 2017
100. Fujiki, M., Abu-Elmagd K. Normothermic Ex-Vivo Perfusion of the Intestine: The introduction of an Innovative Physiologic Model with Novel Biomarkers. CIRTA 2017
101. Fujiki, M., Abu-Elmagd K. Serial Transverse Enteroplasty Procedure in the New Era of Gut Rehabilitation. CIRTA 2017
102. Khanna, AJ. Abu-Elmagd K. Innovative Sphincter Preserving Pull-Through Technique with En Bloc Colon and Small Bowel Transplantation. CIRTA 2017
103. Khanna, AJ. Abu-Elmagd K. Successful Liver, Pancreas and Intestinal Transplantation for RFX6 Mutation Associated Syndrome: Insights into Disease Pathophysiology. CIRTA 2017
104. Khanna, AJ., Abu-Elmagd K. Preoperative vascular interventions in complex visceral transplantation CIRTA 2017
105. Okano, S., Abu-Elmagd K. Myeloid-Derived Suppressor Cells Accumulate in Intestinal Transplant Patients and Suppress Anti-Donor T-Cell Responses to Donor Epithelial Stem Cells. CIRTA 2017
106. Recurrent Celiac Disease after Intestinal Transplantation Digestive Disease Week 2018 June 2018
Kareem Abu-Elmagd, M.D., PhD. 39
107. Vu L, Mohammad A, Khazaaleh S, Olayan M, Shatnawei A, Abu-Elmagd K. Celiac Strikes Back: Recurrent Celiac Disease After Intestinal Transplantation: 2577. Official journal of the American College of Gastroenterology| ACG. 2018 Oct 1;113:S1432.
108. Harris K, Hoscheit M, Armanyous S, Costa G, AbuElmagd K, Gabbard S. “Intestinal Malrotation is Associated with Visceral Hypersensitivity in Adult Patients”, Gastroenterol. 156(6S1):S1443, May 2019.
109. Fouda Y, Fujiki M, Parekh N, Pogatschnik C, Moccia L, Perdue S, Costa G, Pahari H, Hashimoto K, Osman M, Abu-Elmagd K. 200.4: Serial Transverse Enteroplasty (STEP) for the Short Gut Syndrome (SGS) Patients with Gut Failure (GF). Transplantation. 2019 Jul 1;103(7S2):S2.
110. Goel M, Pruchnicki A, Lennon E, Robinson J, Pahari H, Fouda Y, Osman M, Girlanda R, Fujiki M, Costa G, Abu-Elmagd K. 230.7: Disease Recurrence After Intestinal and Multivisceral Transplantation. Transplantation. 2019 Jul 1;103(7S2):S7.
111. Fujiki M, Osman M, Matsushima H, Pahari H, Fouda Y, Girlanda R, Zhang A, Abu-Elmagd K. 350.6: The impact of circulating DSA in visceral transplant recipients without histological evidence of rejection: How should we treat or not treat?. Transplantation. 2019 Jul 1;103(7S2):S22.
112. Osman M, Fujiki M, Girlanda R, Barnoski A, Goel M, Parekh N, Jarancik S, Armanyous S, Petrey J, Fouda Y, Pahari H, Cline M, Costa G, Abu-Elmagd KM. P3. 47: Multimodality Surgical Management of Patients with Global Gut Dysmotility: Techniques and Long-Term Outcome. Transplantation. 2019 Jul 1;103(7S2):S131.
113. Parekh N, Scalish M, Armanyous S, Shovary C, Moccia L, Pogatschnick C, Osman M, Fujiki M, Abu-Elmagd K. P3. 49: GLP-2 therapy for patients with short gut syndrome and intestinal insufficiency: A single center experience with future considerations. Transplantation. 2019 Jul 1;103(7S2):S132.
114. Pahari H, Fujiki M, Moore C, Fouda Y, Osman M, Girlanda R, Costa G, Abu-Elmagd K. P3. 50: Portal hypertensive surgery for management of diffuse portomesenteric venous thrombosis-Surgical technique and long-term outcome. Transplantation. 2019 Jul 1;103(7S2):S132.
115. Parekh N, Barnoski A, Girlanda R, Abu-Elmagd K. P1. 54: Global gut dysmotility: Patient characteristics and unique clinical features. Transplantation. 2019 Jul 1;103(7S2):S88.
116. Native Jejunal Conduit for Urinary Diversion in enbloc Liver-intestine-kidney Transplantation for a Patient with Irradiation Enteritis and Cystitis. 17th Congress of the Intestinal Rehabilitation & Transplant Association. June 30th-July 2nd, Auckland, New Zealand. Video Presentation
117. Improved Graft Survival in Liver-free Visceral Transplantation with Strong Preformed Donor Specific Antibody. 17th Congress of the Intestinal Rehabilitation & Transplant Association. June 30th-July 2nd, Auckland, New Zealand. Distinguished Poster
118. The Primary and Adjunctive Benefit of Serial Transverse Enteroplasty on Short Gut Patients with Gut Failure. 17th Congress of the Intestinal Rehabilitation & Transplant Association. June 30th-July 2nd, Auckland, New Zealand. Oral Presentation
119. Comprehensive Gut Rehabilitation and Transplantation for Gut Failure in Crohn’s Disease: Evolving Role of Serial Transverse Enteroplasty 17th Congress of the Intestinal Rehabilitation & Transplant Association. June 30th-July 2nd, Auckland, New Zealand. Oral Presentation
120. Management of One Thousand Patients With Portomesenteric Venous Thrombosis: A New Classification with Thirty Years of Innovative Portal Hypertensive & Transplant Surgery, American Surgical Association In Review
PROFESSIONAL SERVICES
Kareem Abu-Elmagd, M.D., PhD. 40
I- Journal Referee
Transplantation Proceedings
1992 - Present
Digestive Diseases and Sciences
1992 - Present
Clinical Transplantation
1993 - Present
Gastroenterology
1994 - Present
Liver Transplantation and Surgery
1997 - Present
Journal of the American College of Surgeons
1998 - Present
Transplantation
1998 - Present
American Journal of Transplantation
2003 - Present
Lancet
2003 - Present
Journal of Infectious Disease
2009 - Present
Journal of Cellular and Molecular Medicine
2009- Present
II-Advisory Board
a- ALX-0600 Use in Patients with Short Bowel Syndrome (NPS Pharmaceuticals)
b- FDA approval of growth hormone treatment for patients with short gut syndrome (Serono Pharmaceuticals).
c- Use of Rituxan in pediatric solid organ recipients with post-transplant lymphorproliferative diseases: An open label phase II multicenter non-randomized study.
d- Normothermic ex-vivo perfusion of the liver in humans. Multicenter pivotal trial (TransMedics).
III- Service and Society Committee
1. Staff member at Children’s Hospital of Pittsburgh, UPMC Presbyterian / Montefiore, and the VA Pittsburgh Health Care System, Oakland Division, Pittsburgh, PA (1991-2012).
2. Surgical consultant at UPMC St Margaret, Passavant, and Shadyside Hospitals, Pittsburgh, PA (1997-2012).
3. Member of the Organ Donation Committee (1999-2002) organized by the American Society of Transplantation (AST).
4. Public education about intestinal and multivisceral transplantation through local media, newspapers and web sites (1990-present).
5. Lecturing the community physicians through scheduled seminars and Grand Rounds at the community hospitals (1991-present).
6. Member of the Pittsburgh Medical and Surgical Society (1993-2000).
7. Active member of the Crohn’s & Colitis Foundation of America (CCFA) (2001-present).
8. President of the Intestinal Transplant Association (ITA) (2009-2011).
9. Chair of the Advocacy and Policy Committee of the Intestinal Transplant Association (ITA) (2012-2015).
10. Co-chair of the Reimbursement Committee of the American Society of Transplant Surgeons (ASTS) (2010- 2013).
Kareem Abu-Elmagd, M.D., PhD. 41
11. At Large Member of the OPTN/UNOS Liver and Intestinal Transplantation Committee (2010-2012).
12. President of the Intestinal Transplant Association (ITA) (2011-2013).
13. Chair of the Educational Committee of the Intestinal Transplant Association (ITA) (2013-2015).
14. Chair of the Reimbursement and Regulatory Committee, ASTS (2014-2018).
15. Co-chair of the clinical research at Thomas E. Starzl Transplantation Institute (1998-2001).
16. Member of the Committee for Optimizing Organ Procurement (COOP) (1999-2000).
17. Member of the Executive Committee at Thomas E. Starzl Transplantation Institute (2001-2012).
18. Member of the local scientific committee that organizes different national and international meetings in the field of abdominal organ transplantation (1993-present).
19. Initiation and conduction of an international collaboration between the University of Pittsburgh, Clevand Clinic and various Egyptian Universities including Mansoura, Alexandria, Ain Shams, and Cairo Universities including clinical services and fellowship-training programs (1990-present).
20. Member of the Standing Committee for Non-Tenured Faculty Promotions and Appointments (NTFPA) at UPMC (2006-2009).
21. Member of the Xth International Small Bowel Transplant Symposium Scientific Planning Committee, Santa Monica, CA, (2006-2007).
22. Member of the XXII International Congress of The Transplantation Society (TTS) Scientific Planning Committee, Sydney, Australia, (2006-2007).
23. Member of the XIth International Small Bowel Transplant Symposium Scientific Planning Committee, Bologna, Italy, (2009).
24. Member of the XIIth International Small Bowel Transplant Symposium Scientific Planning Committee, Washington, DC, (2011).
25. Member of the XIIIth International Small Bowel Transplant Symposium Scientific Planning Committee,
Oxford, UK, (2013).
26. Member of the XIVth International Small Bowel Transplant Symposium Scientific Planning Committee,
Buenos Aires, Argentina, (2015).
IV - Education Committee
1. Ph.D. Committee selected for Huessein Osman Mohamed, Ain Shams University, Egypt, 1996.
2. Ph.D. Committee selectef for Amgad Hassan, Mansoura University, Egypt, 1997.
3. Ph.D. Committee selected for Laura Matarese, University of Medicine and Dentistry of New Jersey, Newark, NJ, 2005.
4. Ph.D. Committee selected for Dr. Mohamad A. Rabei Abdelaziz Abdelfattah, University of Alexandria, Egypt, 2006.
5. Ph.D. Committee selected for Jennifer Bonner, “University of Pittsburgh School of Pharmacy, Pittsburgh, PA, 2006.
6. Ph.D. Committee selected for Guilherme Costa, “University of Pittsbrugh Medical Center, Pittsburgh, PA, 2014.
TEACHING ACTIVITIES
Kareem Abu-Elmagd, M.D., PhD. 42
I - Curriculum/Course Development
1. Teaching clinical courses and lecturing medical students (40 per year) at Mansoura University School of Medicine, Mansoura, Egypt in the capacity of Clinical Instructor and Assistant Professor of Surgery (1986-1989).
2. Transplantation Mini-Course and General Surgery Grand Rounds (70-100 attendants), Department of Surgery, School of Medicine, UPMC Health System, Pittsburgh, PA, (1997-2012).
3. Transplantation and General Surgery Clinical Services with Mini-Course and Grand Rounds, Department of General Surgery, Cleveland Clinic, Cleaveland, OH, (2012-2017).
II – National and International Invited Lectures, Seminars and Workshops
1. “Small bowel transplantation,” Egyptian Medical Association, Ain Shams University, Cairo, Egypt, 1992.
2. “Primary hepatic carcinoma: clinical and histopathological evaluation,” Proceedings of the Annual Scientific Meeting of Hepatitis & Related Disorders, Mansoura & Port Said, Mansoura, Egypt, 1992.
3. “Efficacy of liver transplantation in patients with primary sclerosing cholangitis,” 15emes Journees de Chirurgie Digestive Meeting, Rennes, France, 1993.
4. “Small bowel transplantation,” Fifth Liver Symposium - Clinical Exchange Program at the University of Pittsburgh School of Medicine, Pittsburgh, PA, 1993.
5. “Current status of small bowel transplantation,” The Oley Foundation, 8th Annual Consumer/Clinician Conference, Saratoga Springs, NY, 1993.
6. “Small bowel transplantation,” Sixth Liver Symposium - Clinical Exchange Program at the University of Pittsburgh School of Medicine, Pittsburgh, PA, 1993.
7. “Small bowel transplantation,” Loma Linda University Medical Center Grand Rounds, Loma Linda, CA, 1994.
8. “Surgical management of portal hypertension; current status of hepatic transplantation,” 11th Arab Conference on Liver Disease, Cairo, Egypt, 1995.
9. “Disease recurrence after liver transplantation,” Hepatology and Liver Transplantation Annual Conference at the University of Pittsburgh Medical Center, Pittsburgh, PA, 1995.
10. “Small bowel and multivisceral transplantation,” Hepatology and Liver Transplantation Annual Conference at the University of Pittsburgh Medical Center, Pittsburgh, PA, 1995.
11. “Current status of small bowel transplantation,” The Cleveland Clinic Foundation Grand Rounds, Cleveland, OH, 1995.
12. “Evaluation of function in small bowel transplantation,” Challenges in Immunosuppression, Roundtable Meetings Series, Birmingham, London, 1995.
13. “Surgical Aspects of Liver Transplantation,” Medical College of Georgia Lecture Series, Augusta, GA, 1998.
14. “The Evolution of Small Bowel Transplantation,” Medical College of Georgia Surgical Grand Round, Augusta, GA, 1998.
15. “Overview of bowel transplantation,” The First GCC Organ Transplantation Congress, Abu Dhabi, United Arab Emirates, 1998.
16. “Current status of intestinal transplantation,” Military Medical Academy, Belgrade, Yugoslavia, 1998.
17. “Clinical experience with intestinal transplantation,” Surgical Grand Rounds, University of Tennessee Medical Group Inc., Memphis, TN, 1998.
Kareem Abu-Elmagd, M.D., PhD. 43
18. “Small bowel transplantation,” Surgical Grand Rounds, Guthrie Clinic, Robert Packer Hospital, Sayre, PA, 1999.
19. “Hepatic and abdominal visceral transplantation: new perspectives and paradigms,” The Sixth Saudi Gastroenterology Association Meeting, Jeddah, Saudi Arabia, 1999.
20. “Current status of organ transplantation,” The Second Annual Meeting of the Liver Institute, Cairo, Egypt, 1999.
21. “Current concepts – intestinal transplantation in the new millennium,” 16th Annual Controversies, Problems and Techniques in Surgery, New York, NY, 1999.
22. “Hepatic and intestinal transplantation at the UPMC Health System,” General Surgery Grand Rounds, Pittsburgh, PA, 1999.
23. “Surgical shunt or liver transplant for variceal bleeding,” Post-Graduate Course (70 attendants), American College of Surgeons 85th Annual Clinical Congress, San Francisco, CA, 1999.
24. Israel Penn M.D. Transplant Fellows Symposium of the University of Pittsburgh (40 fellows), Scottsdale, AZ, 1999.
25. “Healing of the biliary tree following injury,” Advanced Laparoscopic Biliary Surgery Featuring Laparoscopic Common Bile Duct Exploration Workshop (30 attendants), Pittsburgh, PA, 2000.
26. “Current status of small bowel transplantation,” 1000th Transplants Symposium, University of Gent, Gent, Belgium, 2000.
27. “Gastrointestinal failure & intestinal transplantation,” 13th Annual Meeting of the Japanese Society of Small Bowel Transplantation, Sendai, Japan, 2000.
28. “Current Status of Intestinal Transplantation” Grand Rounds, University of Southern California, Los Angeles, CA, 2000.
29. Human Body Course: Problem Based Learning (PBL) Session consisting of two paired two-hour sessions on 1) Abdomen and 2) Pelvis; class of six (6) first-year medical students, University of Pittsburgh, September, 2000.
30. “Portal systemic shunts in the era of liver transplantation” Society of Gastroenterology, San Diego, CA, 2000.
31. “Current status of intestinal transplantation,” Medical Grand Rounds, University of California, San Diego, CA, 2000.
32. “Should patients with metastatic neuroendocrine tumor undergo liver transplantation?” Meet Professors at Luncheon, AASLD 51st Annual Meeting, Dallas, TX, 2000.
33. “Management of portal hypertension and variceal bleeding,” Medical Grand Rounds, Frick Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, 2001.
34. “Advances in intestinal transplantation,” Medical Grand Rounds Tulane University, New Orleans, LA, 2001.
35. “Small Bowel Transplantation,” UPMC Shadyside Medical Grand Rounds, Pittsburgh, PA, 2001.
36. “Small Bowel Transplantation is a Reality,” Central Surgical Association Meeting, Pittsburgh, PA, 2002.
37. “Intestinal Transplantation,” Transplantation Grand Rounds Lecture Series, UPMC, Pittsburgh, PA, 2002.
38. “Intestinal Transplantation: A Coming of Age,” Surgical Grand Rounds, Stanford University, San Francisco, CA, 2002.
Kareem Abu-Elmagd, M.D., PhD. 44
39. “Intestinal Transplant and Crohn’s Disease,” Western PA/WV Crohn’s & Colitis Foundation of America’s Annual Meeting, Pittsburgh, PA, 2002.
40. Liver Transplantation, Resident Case Conference/Journal Club. University of Pittsburgh, Pittsburgh, PA, November, 2002.
41. “Intestinal Transplantation,” Surgical Grand Rounds, Wayne State University, Detroit, MI, 2002.
42. “A New Face for Immunosuppression: A Pre-Conditioning and Acquired Tolerance,” Transplant Academia, Duke University, 2003.
43. “A New Era for Intestinal and Multivisceral Transplantation,” Surgical Grand Rounds, Duke University, 2003.
44. “Latest Treatments and Trends in Short Gut Surgery and Intestinal Failure,” UPMC Passavant/UPMC Passavant Cranberry, Continuing Medical Education Conference, 2003.
45. “New Developments in Minimization of Immunosuppression” (Overview), UNOS Region II Forum, Coraopolis, PA, 2003.
46. “Intestinal Failure: Artificial Feeding versus Innovative Surgery,” Surgical Grand Rounds, Allegheny General Hospital, Pittsburgh, PA, 2003.
47. “Intestinal Transplantation: Outcomes” (Moderator), Intestinal Failure: Current and Emerging Therapies Including Transplantation, Joint NIDDK and A.S.P.E.N. Intestinal Failure Workshop, Las Vegas, 2004.
48. “Surgical Aspects of Short Bowel Syndrome”, Serono Symposia International, Las Vegas, NV, 2004.
49. “Intestinal Transplantation”, Surgical Science (Combined Clinical Symposia), Digestive Disease Week, New Orleans, LA, 2004.
50. “Portal Hypertensive Variceal Bleeding,” Surgical Grand Rounds, Geisinger Medical Center, Danville, PA, 2004.
51. “Small Bowel Transplantation: State of Art,” University of Bonn Symposium on Gastrointestinal Surgery, Bonn, Germany, 2004.
52. “A New Tolerogenic Immunosuppressive Strategy for Human Intestinal Transplantation,” The 3rd International Congress on Immunosuppression, San Diego, CA, 2004.
53. Human Body Course: Problem Based Learning (PBL) Session consisting of two paired two-hour sessions on Vascular, class of seven (7) first-year medical students, University of Pittsburgh, October, 2004.
54. “Small Bowel Transplantation: Coming of Age,” GI Grand Rounds, University of California, San Diego, CA 2005.
55. “One Hundred Multivisceral Transplants (MVTx) At A Single Center,” Discussant at the 125th
Annual Meeting of the American Surgical Association, West Palm Beach, Florida, 2005.
56. “Current Status of Intestinal Transplantation at the University of Pittsburgh,” The Society of Black
Academic Surgeons, Pittsburgh, PA, 2005.
57. “Intestinal Rehabilitation: A Multidisciplinary Team Approach,” Serono Speakers Bureau, Digestive Disease Week, Chicago, Illinois, 2005.
58. “Intestinal Failure and Transplantation: New Perspectives and Future Considerations,” Intestinal Failure Symposium, Royal Children’s Hospital, Melbourne, Australia, 2005.
59. “Intestinal Transplantation,” State of the Art Lecture, Australian Gastroenterology Week, Brisbane, Australia, 2005.
Kareem Abu-Elmagd, M.D., PhD. 45
60. “Approach to the Management of Intestinal Failure,” Australian Gastroenterology Week, Brisbane, Australia, 2005.
61. “Challenging Cases in Adjuvant Colorectal Cancer,” Miami, Florida, 2005.
62. “Small Bowel Transplantation: Coming of Age,” Early Morning Workshop, American Transplant Congress, Seattle, Washington, 2005.
63. “Management of Intestinal Failure,” Kuwait, 2006.
64. “Medical and Surgical Rehabilitation for Short Gut Syndrome,” Kuwait, 2006.
65. “Management of GI Variceal Bleeding: From Medical Therapy to Multivisceral Transplantation,” Kuwait, 2006.
66. “Disease Recurrence after Liver Transplantation,” Kuwait, 2006.
67. “The Current Status of Intestinal and Multivisceral Transplantation,” Emory University, Atlanta, GA, 2006.
68. “Small Bowel Transplantation as a Cure for Crohn’s Disease,” American Gastroenterology Association, Digestive Disease Week, Los Angeles, CA, 2006.
69. “Chronic Intestinal Allograft Rejection: Diagnosis, Risk Factors and Outcomes,” World Transplant Congress, Boston, Massachusetts, 2006.
70. “Multivisceral Transplantation: Progress and Problems,” International Hepatobiliary Surgery Symposium of P.R. China, Beijing, China, 2006.
71. “Immunosuppressive Therapy Following Multivisceral Transplantation,” International Hepatobiliary Surgery Symposium of P.R. China, Beijing, China, 2006.
72. “Liver Transplantation as Part of a Composite Graft,” International Association for the Study of the Liver (IASL), Cairo, Egypt, 2006.
73. “Portal Hypertensive Gastropathy: From Hassab’s Operation to Multivisceral Transplantation,” International Association for the Study of the Liver (IASL), Cairo, Egypt, 2006.
74. “Intestinal and Multivisceral Transplantation: New Practical Guidelines,” Kaiser Permanente’s Annual Educational Meeting, Portland, Oregon, 2006.
75. “Intestinal Failure: Management Strategies,” (Moderator) General Session, 92nd Annual Clinical Congress of the American College of Surgeons, Chicago, Illinois, 2006.
76. “Intestinal Transplantation: Current Consensus and Practical Guidelines,” 92nd Annual Clinical Congress of the American College of Surgeons, Chicago, Illinois, 2006.
77. “Intestinal Transplantation: Current Status and Future Considerations,” The American College of Gastroenterology, Las Vegas, Nevada, 2006.
78. “Small Bowel Transplantation,” 7th Congress of the Czech and Slovak Transplantation Society, Brno, Czech Republic, 2006.
79. “Intestinal Transplantation for End Stage Crohn’s Disease: Therapeutic Efficacy and Risk of Recurrence,” Fifth Annual Advances in Inflammatory Bowel Disease, Miami, Florida, 2006.
80. “Intestinal Transplantation: New Practical Guidelines,” Post-Graduate Course, Society for Surgery of the Alimentary Tract, Digestive Disease Week, Los Angeles, CA, 2006.
Kareem Abu-Elmagd, M.D., PhD. 46
81. Human Body Course: Problem Based Learning (PBL) Session consisting of two paired two-hour sessions on Abdomen, class of first-year medical students, University of Pittsburgh, September 2007.
82. “Short Bowel Syndrome and Intestinal Failure: From Surgical Reconstruction to Multivisceral Transplantation,” The 3rd Abu Dhabi Annual International Surgical Conference, Abu Dhabi, United Arab Emirates, 2007.
83. “Disease Recurrence after Liver Transplantation: Management and Outcome,” The 3rd Abu Dhabi Annual International Surgical Conference, Abu Dhabi, United Arab Emirates, 2007.
84. “Intestinal and Multivisceral Transplantation for Gut Failure after Abdominal Trauma,” Grand Rounds, John C. Lincoln North Mountain Hospital, Phoenix, AZ, 2007.
85. “Thrombosis of the Portomesenteric Venous System: Shunt Surgery or Transplantation,” Sixth Annual Symposium, Golden Triangle Chapter, International Transplant Nurses Society, Pittsburgh, PA, 2007.
86. “Malignancy after Intestinal and Multivisceral Transplantation,” Workshop on Cancer Risk after Solid Organ Transplantation Coordination, Italian National Transplant Center, Rome, Italy, 2007.
87. “Nomenclature of a Visceral Graft,” Xth International Small Bowel Symposium, Los Angeles, CA, 2007.
88. “Surgical Management of Short Bowel Syndrome,” Surgical Grand Rounds, Strong Memorial Hospital, Rochester, NY, 2007.
89. “Intestinal and Multivisceral Transplantation: Current Indications, Patient Selection, and Outcome Analysis,” Transplant Clinical Conference Cigna Lifesource, Pittsburgh, PA, 2008.
90. “Lymphoproliferative Disorder, De Novo Malignancy, and Tumor Recurrence after Intestinal, Liver-Intestine, and Multivisceral Transplantation: Innovative Strategies with New Outlook,” Joint International Congress of ILTS, ELITA & LICAGE, Paris, France, 2008
91. “Portomesenteric Venous Thrombosis: A New Classification in the Era of Intestinal and Multivisceral Transplantation,” Joint International Congress of ILTS, ELITA & LICAGE, Paris, France, 2008.
92. “Where Do We Need To Focus In Intestinal Transplantation?” Fifth International Pediatric Intestinal Failure and Rehabilitation Symposium, Pittsburgh, PA, 2008.
93. “Intestinal and Multivisceral Transplantation: Indications, Patient Selection and Postoperative Care,” Society of Gastroenterology Nurses and Associates, Philadelphia, PA, 2008.
94. “Intestinal and Multivisceral Transplantation,” Young European Scientist Meeting, Lisbon, Portugal, September 27, 2008.
95. “Intestinal and Multivisceral Transplantation: The Art of Medicine and Love of Humanity,” American Medical Student Association, University of Pittsburgh, October 24, 2008.
96. “Evolution of the Immunosuppressive Strategy for Intestinal and Multivisceral Recipients,” (Plenary Session) Middle Eastern Society of Organ Transplantation (MESOT) 2008, Shiraz, Iran, November 20, 2008.
97. “Liver Transplantation En Bloc with other Abdominal Solid and Visceral Organs,” Egyptian Forum of Liver Disease, Cairo, Egypt, November 26, 2008.
“Recent Advances in Hepatocellular Carcinoma,” Egyptian Forum of Liver Disease, Cairo, Egypt, November 27, 2008.
98. “Portal Hypertension,” Senior and Chief Resident Conference. University of Pittsburgh, Pittsburgh, PA, October 8, 2008.
99. “Surgical Management of Short Gut Syndrome and Transplantation,” Senior and Chief Resident Conference. University of Pittsburgh, PA, October 22, 2008.
Kareem Abu-Elmagd, M.D., PhD. 47
100. “Evolution of Intestinal and Multivisceral Transplantation,” First International Surgical Conference, Jeddah, Saudi Arabia, March 27, 2009.
101. “Small Bowel Transplantation and Organ Donation,” The Center for Organ Donation and Transplant Annual Education Day, Albany, New York, April 1, 2009.
102. “Five Hundred Intestinal and Multivisceral Transplantations at a Single Center,” American Surgical Association (ASA), Indian Wells, California, April 23-25, 2009.
103. “Immunosuppression in Intestinal Transplantation,” IXth Congress of the Polish Transplantation Society, Krakow, Poland, May 14, 2009.
104. “Evolution of Intestinal and Multivisceral Transplantation,” Zurich, Switzerland, May 19, 2009.
105. “Evolution and Minimization of Immunosuppression in Five Hundred Intestinal and Multivisceral Transplantations at a Single Center,” American Transplant Congress, Boston, Massachusetts, May 31, 2009.
106. “Current Outcomes of Intestinal Transplants,” American Transplant Congress, Boston, Massachusetts, June 1, 2009.
107. “How Much Do You Know About Gut Rehabilitation and Intestinal Transplantation,” UPMC Passavant Grand Rounds, Pittsburgh, PA, July 21, 2009.
108. “Long-term Impact of Tolerogenic Immunosuppression,” Pre-Symposium Workshop, XIth International Small Bowel Transplant Symposium, Bologna, Italy, September 9, 2009.
109. “Early and Long-Term Immunosuppression in Intestinal Transplant,” Plenary Session, XIth International Small Bowel Transplant Symposium, Bologna, Italy, September 11, 2009.
110. “Small Bowel and Multivisceral Transplantation,” Prague, Republic of Czech, September 15, 2009.
111. “Living Related Bowel Transplantation: From Experimental to Standardized,” 11th Congress of the Asia Society of Transplantation (CAST 2009), Beirut, Lebanon, October 3, 2009.
112. “Evolution of Immunosuppression Strategies in the Multivisceral Organ Transplantation,” 11th Congress of the Asia Society of Transplantation (CAST 2009), Beirut, Lebanon, October 3, 2009.
113. “Minimizing Immunosuppression to Monotherapy,” 11th Congress of the Asia Society of Transplantation (CAST 2009), Beirut, Lebanon, October 3, 2009.
114. “How Much Do You Know About Gut Rehabilitation and Intestinal Transplantation,” Medical Grand Rounds, UPMC McKeesport, McKeesport, PA, October 20, 2009.
115. “Innovations in the Management of Short Bowel Syndrome Patients,” Medical Grand Rounds, UPMC Mercy, Pittsburgh, PA, January 28, 2010.
116. “The Current Status of Intestinal and Multivisceral Transplantation: Major Advances and New Challenges,” The First Egyptian Organ Transplant Congress, Cairo, Egypt, March 23, 2010.
117. “Management of Portomesenteric Venous Thrombosis,” Pan-Arab Liver Transplantation Society (PALTS), Tunis, Tunisia, April 2, 2010.
118. “Current Status of Multivisceral Transplantation,” Pan-Arab Liver Transplantation Society (PALTS), Tunis, Tunisia, April 2, 2010.
119. “Recent Advances in Hepatocellular Carcinoma,” The International Annual Surgical Conference, Jeddah, Saudi Arabia, April 7, 2010.
Kareem Abu-Elmagd, M.D., PhD. 48
120. “Liver Transplantation En Bloc with other Abdominal Solid and Visceral Organs,” The International Annual Surgical Conference, Jeddah, Saudi Arabia, April 7, 2010.
121. “Short Gut Syndrome and Intestinal Transplantation,” Surgical Grand Rounds, UPMC Mercy, Pittsburgh, PA, September 29, 2010.
122. “Tumors after Intestinal Transplantation,” The Sixth International Pediatric Intestinal Failure and Rehabilitation Symposium, Chicago, IL, September 11, 2010.
123. “Multivisceral Transplantation,” (Plenary Session) The 12th Congress of the Middle East Society of Organ Transplantation (MESOT), Tunis, Tunisia, October 19, 2010.
124. “The Many Faces of Chimerism: A Double-Edged Sword,” Transplantation Innovations: 30 Years of Transforming Lives, May 20, 2011.
125. “Ischemia in Small Bowel Transplantaton,” KFO Farewell Symposium, Bonn, Germany, June 16, 2011.
126. “Management of Adult Gut Failure,” XII International Small Bowel Symposium, Washington, DC, September 15, 2011.
127. “rATG Versus Alemtuzumab Single Dose Pretreatment for Visceral Allograft Recipients,” XII International Small Bowel Symposium, Washington, DC, September 16, 2011.
128. “Portomesenteric Venous Thrombosis: A New Classification in the Era of Visceral Transplantation,”
XII International Small Bowel Symposium, Washington, DC, September 18, 2011.
129. “Intestinal Rehabilitation and Transplantation,” Cigna LifeSource Transplant Webinar, Pittsburgh, PA, April 21, 2011.
130. “Long-Term Survival, Nutritional Autonomy, and Quality of Life after Intestinal and Multivisceral Transplantation,” American Surgical Association, San Francisco, CA, April 27, 2012.
131. “Organ Transplantation: The Many Faces of Chimerism,” The First Congress of Kasr Al-Ainy Liver Transplantation Unit, Cairo, Egypt, May 10, 2012.
132. “Immunologic Challenges in Intestinal Failure and Transplant - Chronic Rejection.” The 7th International Pediatric Intestinal Failure and Rehabiliatation Symposium, Children’s Hospital of Pittsburgh of UPMC, September 7, 2012
133. “Gut Elongation Surgeries.” UMPC Recent Advances in Digestive Diseases. Pittsburgh, PA, September 28, 2012
134. “Gut Rehabilitation and Intestinal Transplantation.” Cleveland Clinic, Digestive Diease Institute Grand Rounds, Cleveland, OH, October 3, 2012.
135. “Surgical Management of Intestinal Failure.” Egyptian Society of Surgeons 30th Annual Meeting 2012, October 5, 2012.
136. “Management of Short Gut Patients.” The 2nd Kuwait Conference on Hepato-Pancreato-Biliary Surgery and Transplantation, Kuwait, November 4-6, 2012.
137. “Update in Intestinal and MVT treatment.” The 2nd Kuwait Conference on Hepato-Pancreato-Biliary Surgery and Transplantation, Kuwait, November 4-6, 2012.
138. “Surgical Management of Portal Hypertension.” The 2nd Kuwait Conference on Hepato-Pancreato-Biliary Surgery and Transplantation, Kuwait, November 4-6, 2012.
139. “The Many Faces of Organ Transplantation”. DDI Liver Transplant Education Didactic Series, Cleveland Clinic, Cleveland, Ohio, April 4, 2013.
Kareem Abu-Elmagd, M.D., PhD. 49
140. “Current Trends in Management of Gut Rehabilitation and and Transplantation.” Metro Hospital, Surgical Grand Rounds, Cleveland, OH, August 1, 2013.
141. “Challenges of the Pediactric Liver Transplant Candidate”. Dayton OPO, Dayton, Ohio, April 18, 2013.
142. “Sharing Regional Experiences in Intestinal Failure & Intestinal Tansplantation.” XXII Transplant Congress Latin America & Carribean, Buenos Aires, Argentina December 1-4, 2013.
143. “Past, Present & Future of Immunosuppressive Thearpy for Intestinal Transplanation.” XXII Transplant Congress Latin America & Carribean, Buenos Aires, Argentina December 1-4, 2013.
144. “Disclosing Risks: Challenges and Solutions for Living Organ Donation.” Cleveland Clinic. Cleveland, OH., Bioethics Grand Rounds, May 12, 2014.
145. “Minimization of Immunosuppression and Type of Visceral Allograft”. World Transplant Congress, San Francisco, CA, July 28, 2014.
146. “Nutritional Support of Patients with Intestinal Failure”. Dar Al Fouad Hospital, Cairo, Egypt, August 31, 2014.
147. “Isolated Liver Transplant”, Dar Al Fouad Hospital, Cairo, Egypt, August 31, 2014.
148. “What needs to be done to Increase Again the Applicability of Intestinal Transplantation in the World?” Dar Al Fouad Hospital, Cairo, Egypt, August 31, 2014
149. “Nutritional Support after Intestinal Transplantation”. Dar Al Fouad Hospital, Cairo, Egypt, August 31, 2014.
150. “Role of Pathology in Intestinal Transplantation”. Dar Al Fouad Hospital, Cairo, Egypt, August 31, 2014.
151. “Immunosuppression in Intestinal Transplantation”. Dar Al Fouad Hospital, Cairo, Egypt, August 31, 2014.
152. “Vascular Anastomoses and its Complications”. Dar Al Fouad Hospital, Cairo, Egypt, September 1, 2014.
153. “Biliary Complications”. Dar Al Fouad Hospital, Cairo, Egypt, September 1, 2014.
154. “Grafts for Accessory Veins”. Dar Al Fouad Hospital, Cairo, Egypt, September 1, 2014.
155. “Combined Liver and Kidney Transplantation”. Dar Al Fouad Hospital, Cairo, Egypt, September 1, 2014.
156. “Recent Trends in the Management of Intestinal Failure.” Winfield L. Butch Memorial Lecturer, Buffalo, NY, September 12, 2014.
157. “Concept of Gut Rehabilitiation and Visceral Transplantation.” Winfield L. Butch Memorial Lecturer, Buffalo, NY, September 12, 2014.
158. “Managing Intestional Disasters and Intestinal Transplanation after Bariatric Surgery.” Cleveland Clinic Prevention and Management of Bariatric Complications. Cleveland Clinic, Cleveland, OH. October 17, 2014.
159. “Transplant Center Overview”. 1st Cleveland Clinic Global Solutions Summit. Cleveland Clinic, Cleveland, OH October 28, 2014.
160. Course Director: Beta Cell Symposium – Management of DM. Cleveland Clinic, Cleveland, OH, November 14, 2014
161. Moderator: Recent Advances in Isolation and Preservation of Beta Cells. Beta Cell Symposium – Management of DM. Clevealnd Clinic, Cleveland, OH, November 14, 2014.
162. “The New Paradigms in the Managament of Intestinal Failure”. Cigna Insurance Company- Webinar, Cleveland, Ohio, March 26, 2014.
Kareem Abu-Elmagd, M.D., PhD. 50
163. “State of the Art Issues in Intestinal Failure”.American Transplant Congress, Philadelphia, PA, May 4, 2015.
164. “Autologous Reconstruction and Visceral Transplantation for Gut Failure Following Bariatric Surgery: 20 years of Experience”. American Surgical Association, San Diego, CA, April 23, 2015.
165. “Current Status of Liver Transplantation”, The Third Arab-European Conference, Hurghada, Red Sea, Egypt, May 28, 2015.
166. “Surgical Management of life threatening complications after bariatric surgery”, Round Table, The Third Arab-European Conference, Hurghada, Red Sea, Egypt, May 29, 2015.
167. “Intestinal Failure: Rehabilitation and Tx. Are they really non-cost effective? (an economical vision of a comprehensive intestinal failure program”. The Third Arab European Conference, Hurghada, Red Sea, Egypt, May 27, 2015.
168. “Diffuse Port-Mesenteric Vein Thrombosis – Isolated Liver Transplant”. XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, June 11, 2015.
169. “What needs to be done to Increase the applicability of Intestinal transplantation in the World. XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, June 12, 2015.
170. “Visceral Transplantation for End Stage Crohn’s disease: 25 years of Experience at a single Center”. ACG Annual Scientific Session, Honolulu, Hawaii, October 20, 2015.
171. “Surgical Management of Gut Failure.” Grand Rounds, Cleveland Clinic Weston Hospital, Weston, Florida, November 17, 2015.
172. “The Evolving Field of Gut Rehabilitation and Visceral Transplantation.” II Annual Pediatric Liver Symposium. Cleveland Clinic, Cleveland, Ohio, November 19, 2015.
173. Moderate the weekly Mortality/ Morbidity Conference for the Small Bowel and Multivisceral Transplantation Service.
174. “Indication, techniques and outcomes of Small Bowel Transplantation.” Bariatric Surgery Day Special Lecture Cleveland Clinic, Cleveland, Ohio, February 6, 2016.
175. “Multivisceral Organ Transplant Therapeutics.” Transplant Institute at Baylor University Dallas, Texas, April 8, 2016
176. “Multivisceral Transplantations.” Cleveland Clinic Weston Grand Rounds. Weston, Florida. April 20, 2016
177. “Visceral Transplant Current Outcome, Future Perspectives.” American Transplant Congress Boston, Massachusetts. June 12, 2016.
178. “Small Bowel and Multivisceral Transplantation.” Lake Como School of Advanced Studies of Organ Transplantation. Como, Italy June 29, 2016
179. “The Evolving Field of Gut Rehabilitation.” 2016 Henry Ford Transplant Institute Lecture Series. Detroit, Michigan October 3, 2016.
180. “Managing Antibody Mediated Rejection in Intestine Transplant.” and “Teaching the next generation of Leaders in the Field of Intestine Transplantation.” IX International Pediatric Intestinal Failure and Rehabilitation Symposium. Los Angeles, CA October 29, 2016
181. “Surgical Management of Gut Failure with Special Reference to Bariatric Surgery.” Transplant Institute at Baylor University Dallas, Texas November 9, 2016
Kareem Abu-Elmagd, M.D., PhD. 51
182. “Evolution of intestinal, multivisceral transplant.” and “Surgical Management of Gut Failure after Bariatric Surgery.” II International Surgical Conference Surgical Vision 2020 King Fahad Armed Forces Hospital lectures Jeddah, Saudi Arabia January 18, 2017
183. “Farouk the Surgeon, Mentor, Father and Legend” 35th Annual Meeting of the Egyptian Society of Surgeons Fairmont Heliopolis Hotel Giza, Egypt March 22nd 2017
184. “What is the future of visceral transplantion in Egypt and Middle East?” 35th Annual Meeting of the Egyptian Society of Surgeons Fairmont Heliopolis Hotel Giza, Egypt March 23rd 2017
185. “What could go seriously wrong with bariatric surgery?” 35th Annual Meeting of the Egyptian Society of Surgeons Fairmont Heliopolis Hotel Giza, Egypt March 24th 2017
186. MBC Interview 12:00-2:00pm Dubai, March 28th 2017
187. “Gut Failure and Surgical Ingenuity” Cleveland Clinic Abu Dhabi Grand Rounds March 29th 2017.
188. Keynote speaker at the Intestinal and Multivisceral Transplantation Seminar, Sheikh Zaid Hospital May 14, 2017
189. “Surgical Management of Complications of Bariatric Surgery” Alsafwa Hospital, Egypt May 15, 2017
190. Cairo University Surgical Grand Rounds Cairo, Egypt May 16, 2017
191. Air Force Specialized Hospital, Cairo, Egypt May 16, 2017
192. Moderator, IBD and PSC: Pre-and Post-Transplant Issues. 2017 PSC Partners Annual Conference. Cleveland Clinic Intercontinental Hotel. June 23, 2017
193. “Intestinal Transplant: Concept to Reality” CIRTA 2017 Pre symposium Roosevelt Hotel New York, NY. Pre-Meeting on Surgical and Medical Management: How Did We Get Here? June 28, 2017
194. “Surgical Management of Gut Failure due to Bariatric Surgery” Cairo University Organ Transplant Seminar, Cairo Universtity Surgical Grand Rounds Cairo, Egypt September 7, 2017
195. “The Future of Gut Rehabilitation in Egypt and the Middle East” Cairo University Organ Transplant Seminar, Cairo Universtity Surgical Grand Rounds Cairo, Egypt September 7, 2017
196. “Management of Short Bowel Syndrome” Cairo University Surgery Department in Faculty of of Medicine Cairo, Egypt Saturday December 16, 2017
197. Cairo University Surgical Grand Rounds Cairo, Egypt Monday December 18, 2017
198. “Surgical Management of Gut Failure” Cairo University, Surgery Department in Faculty of of Medicine Cairo, Egypt December 23, 2017
199. “Intestinal Donor Graft Perfusion” Pittsburgh, Pensilvania, September 22, 2018
III - Thesis Supervision
1. Five theses submitted for Master (M.S.) and 2 Doctorate (Ph.D.) degrees in general and hepatobiliary surgery was successfully completed under my supervision at Mansoura University School of Medicine (Egypt) during the period from 1986 to 1989.
2. Two Ph.D. theses were successfully conducted under my supervision for two Egyptian clinical research fellows; Dr. Huessein Osman Mohamed and Dr. Amgad Hassan at the University of Pittsburgh Medical Center between 1993 and 1997. Both candidates were sponsored by the Egyptian government in collaboration with the University of Pittsburgh, Pittsburgh, PA.
Kareem Abu-Elmagd, M.D., PhD. 52
3. Ph.D. thesis of Laura Matarese, RD “Vitamin B6 Status during Restoration of Nutritional Autonomy with Intestinal Transplant Patients in Adults”, University of Medicine and Dentistry of New Jersey, Newark, NJ, 2005 - 2007.
4. Ph.D. thesis of Dr. Mohamad A. Rabei Abdelaziz Abdelfattah, “Live Donor Liver Transplantation: Surgical Techniques and Survival Outcomes”, University of Alexandria, Egypt, 2006.
5. Ph.D. thesis of Jennifer Bonner, PharmD “Short-and Long-term Effects of Small Bowel Transplantation on Intestinal First-Pass Metabolism and Bioavailability of Drugs”, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, 2006.
6. Ph.D. thesis of Dr. Kareem Riad Mostafa Eid, MD “Management of Post Liver Transplantation Biliary Strictures”, Faculty of Medicine, Ain Shams University, Cairo, Egypt, 2007.
7. Ph.D. thesis of Dr. Guilherme Costa, MD “Evolution of Intestinal and Multivisceral Transplantation: Surgical Innovations, Technical Complications, and Survival Outcomes”, Medical School of the Federal University of Minas Gerais, Belo Horizonte, MG Brazil, 2007.
8. Master thesis for MD degree of Ana Sequeira “Intestinal and Multivisceral Transplantation”, Porto, Portugal, 2009.
9. Master thesis for MD degree of Ahmed Hussein Ahmed Ibrahim Khalil “Principles of Management of Vascular Complications in Both Donors and Recipients in Living Related Donor Liver Transplantation”, Cairo University, Cairo, Egypt, 2009.
10. Ph.D. thesis for Dr. Ramy Abdelrahim Hassan “Liver Transplantation for Hepatocellular Carcinoma”, Assiut University, Assiut, Egypt, 2011.
11. Ph.D. thesis for Dr. Khaled Mohammed Mahmoud Shaalan “Technical Complications after Cadaveric and Live Donor Liver Transplantation”, Benha University, Egypt 2011.
12. Ph.D. thesis for Dr. Basem Gamal Abdelghany Soliman “Hepatic resection versus transplantation in hepatocellular carcinoma”, Assiut, Egypt, 2014.
IV - Supervision of Medical Students, House Staff Physicians, Residents and Fellows
1. 1986-1989: Mansoura University School of Medicine, Egypt
a) Teaching undergraduate medical students through weekly lecturing and biweekly clinical rounds.
b) Clinical teaching of the house staff at Mansoura University Hospital (50), and Gastroenterology Unit (10) and surgical training of the senior and chief residents (12) particularly in the field of gastrointestinal, hepatobiliary, and portal hypertensive surgery.
c) Designed protocols and directed clinical research for post-doctoral students in the field of portal hypertension and gastrointestinal diseases including esophageal sclerotherapy, shunt and non-shunt surgery, surgery for peptic ulcer disease, gastroesophageal reflux (GERD), and gastroesophageal reconstructive surgery.
d) Establishment of the Monefia Hepatobiliary Institute as a teaching and academic national center in the Delta region which is currently affiliated with Monefia University (Egypt).
2. 1991-2012: University of Pittsburgh School of Medicine and UPMC Health System
a) Clinical teaching during daily (2-3 hours) clinical rounds and surgical training of 40 clinical fellows and more than 50 surgical residents in the field of multiorgan retrieval (20 per year), abdominal organ transplantation (25 per year), hepatic resection (30 per year), hepatobiliary surgery (35 per year), and portal hypertensive surgery (15 per year) in the capacity of Assistant (1991-1995), Associate (1997-2000), and Full (2001– 2012) Professor, Department of Surgery and Division of Transplant Surgery
b) List of Transplant Surgery Fellows at UPMC 1990-2012
Kareem Abu-Elmagd, M.D., PhD. 53
Last Name
First Name
Start Date
Term Date
SURYAVANSHI
DILIP
10/1/2010
9/30/2012
ABOUTALEB
ESAM
11/11/2011
6/30/2012
MEJIA
JUAN
7/1/2010
6/30/2012
RAMOS DIAZ
EDGAR
7/1/2010
6/30/2012
KOSTARAS
VASILEIOS
7/1/2011
6/30/2012
GANOZA
ARMANDO
8/15/2011
6/30/2012
FINK
SUNNY
7/1/2011
4/30/2012
ABRAMS
PETER
6/29/2009
8/31/2011
SEBASTIAN
ELY
5/19/2008
6/30/2011
AKHAVANHEIDARI
MOHAMMAD
6/29/2009
6/30/2011
CHAUDHARY
ABHIDEEP
6/29/2009
6/30/2011
HUSSEIN
SHAKIR
7/1/2010
6/30/2011
NACHMANY
IDO
7/1/2008
12/31/2010
KOLAR RAMACHANDRA
SUMANA
8/12/2008
8/11/2010
WU
GUOSHENG
7/20/2009
7/12/2010
PINEDA
JAIME
9/11/2008
6/30/2010
GOPASETTY
MAHESH
6/29/2009
6/30/2010
OPALIC
VESNA
7/28/2008
7/27/2009
CAMPOS
STALIN
7/1/2007
6/30/2009
LAYMAN
RALPH
7/1/2007
6/30/2009
SIPARSKY
NICOLE
7/1/2007
6/30/2009
TRIVEDI
HEMALI
7/1/2008
6/30/2009
YIN
QIANG (MICHAEL)
10/1/2007
6/14/2009
TAO
RAN
5/1/2007
6/10/2009
RAMANATHAN
RAJAN
10/8/2007
10/10/2008
BAGIA
JAI SEEMA
9/10/2007
9/9/2008
ODOCHA
OKAY HAROLD
9/1/2007
8/31/2008
CRUZ
RUY
8/21/2006
8/20/2008
MOHANKA
RAVI
6/1/2006
6/30/2008
PATEL
SUNIL
7/1/2006
6/30/2008
DAILY
MICHAEL
7/1/2005
6/30/2007
MARTIN
ABIGAIL
7/1/2005
6/30/2007
PADMA
SRIKANTH
7/1/2005
6/30/2007
RAZA
KASHIF
7/1/2005
6/30/2007
XIAO
GARY (SHENG-GUANG)
7/1/2005
6/30/2007
MORGAN
CLAIRE
7/1/2006
5/31/2007
SHIM
INBO
8/1/2006
10/13/2007
RIJHWANI
ASHOK
2/1/2007
7/20/2007
MAHMOUD
KARIM
7/9/2007
11/30/2007
KUMARAN
VINAY
2/1/2004
1/31/2007
SHARMA
VIVEK
8/23/2004
8/22/2006
SILVEIRA
FERNANDA
7/1/2005
6/30/2006
RIJHWANI
ASHOK
2/12/2006
6/30/2006
HAKIM
JONATHAN
7/1/2004
6/30/2006
PIMENTEL
SILVANIA
3/13/2006
5/31/2006
KARUMAN
PHILIP
2/16/2004
2/15/2006
Kareem Abu-Elmagd, M.D., PhD. 54
SANDHU
RAJ
7/1/2005
1/31/2006
KHAKHAR
ANAND
8/23/2004
8/14/2005
LOPEZ-SOLIS
ROBERTO
7/1/2003
6/30/2005
ROHANINEJAD
MOHAMMAD
7/23/2003
6/30/2005
VUKCEVIC
ZORAN
11/1/2003
6/30/2005
KAYLER
LIISE
7/1/2004
6/30/2005
THAI
NGOC
7/1/2002
6/30/2004
SHARMA
SUNIL
8/5/2002
6/30/2004
LEE
YI-HORNG
7/1/2003
6/30/2004
SOLTYS
KYLE
7/1/2003
6/30/2004
THOMAS
PHILIP
8/1/2002
7/31/2003
KHAN
AKHTAR
7/1/2000
6/30/2003
KWAK
EUN
7/1/2001
6/30/2003
MALEK
SAYEED
7/1/2001
6/30/2003
PATEL-TOM
KUSUM
7/1/2001
6/30/2003
SMETANKA
CYNTHIA
7/1/2001
12/31/2002
BASU
AMIT
7/1/2000
7/31/2002
DALY
IVONNE
5/1/2000
6/30/2002
FRIDELL
JONATHAN
7/1/2000
6/30/2002
ASHAM
EMAD
10/1/2000
6/30/2002
CANADY
JEROME
7/16/2001
6/30/2002
DEVERA
MICHAEL
10/1/2001
6/30/2002
BOND
GEOFFREY
2/1/2000
11/30/2001
FREZZA
ERMENEGILDO
7/1/1999
6/30/2001
GAUTAM
AMITABH
7/1/1999
6/30/2001
POTDAR
SANTOSH
7/1/1999
6/30/2001
CHAKRABARTI
PRADIP
7/1/1997
7/31/2000
KHAN
ABRAR
7/1/1998
7/31/2000
GIRALDO
MAURICIO
8/1/1997
6/30/2000
KATZ
DANIEL
7/1/1998
6/30/2000
LUKE
PATRICK
7/1/1998
6/30/2000
MATEO
RODRIGO
7/1/1997
6/30/1999
BOZORGZADEH
ADEL
7/1/1997
6/30/1999
ROGERS
JEFFREY
7/1/1995
6/30/1999
DALLER
JOHN
7/1/1997
1/31/1999
MOLMENTI
ERNESTO
7/1/1996
9/30/1998
BLESSIOS
GEORGE
7/1/1996
6/30/1998
GELLER
DAVID
7/1/1996
6/30/1998
GERBER
DAVID
7/1/1996
6/30/1998
KAPUR
SANDIP
7/1/1996
6/30/1998
FONTES
PAULO
3/27/1997
6/30/1998
DORIA
CATALDO
12/1/1995
11/30/1997
SUGITANI
ATSUSHI
1/1/1994
6/30/1997
BONHAM
CLARK
7/1/1994
6/30/1997
HECKER
WILLIAM
7/1/1995
6/30/1997
ISSA
SAMIR
1/1/1994
6/30/1996
BATTY
DONALD
7/1/1994
6/30/1996
SMITH
CRAIG
7/1/1994
6/30/1996
Kareem Abu-Elmagd, M.D., PhD. 55
MCQUITTY
DWAYNE
7/1/1995
6/30/1996
VEERABAGU
MANJAKKOLLAI
7/1/1995
6/30/1996
LIM
JAMES W.
8/1/1994
4/30/1996
MAGNONE
MARIO
12/1/1993
9/30/1995
RAMIREZ
CARLO GERARDO B
7/1/1992
6/30/1995
KOSTECKE
RITA
7/1/1993
6/30/1995
THOMAS
PHILIP
7/1/1993
6/30/1995
KHAN
M. FARRUKH ALI
7/15/1993
6/30/1995
SINGHAL
AJAY
1/1/1995
6/30/1995
FELEKOURAS
EVANGELOS
7/1/1993
12/31/1994
ABOU EL-EZZ
ASHRAF Y.
7/1/1991
6/30/1994
WEBB
MARC GREGORY
7/1/1992
6/30/1994
HASEGAWA
TOSHIMICHI
7/1/1992
6/30/1994
GRITSCH
HANS ALBIN
7/1/1993
6/30/1994
JABBOUR
NICOLAS
7/1/1991
5/31/1994
MAZARIEGOS
GEORGE VINCENT
7/1/1991
1/1/1994
DIMARCO
LUCIANO
7/1/1993
12/31/1993
CHOI
SANG YONG
8/1/1993
11/30/1993
KADRY
ZAKIYAH
7/1/1991
6/30/1993
ERSOZ
SADIK SEYET MEH
7/1/1991
6/30/1993
WRIGHT
HARLAN I.
4/1/1991
6/30/1993
ODOCHA
OKAY HAROLD
7/1/1991
6/30/1993
SORENSEN
JOHN B.
7/1/1991
6/30/1993
ECHEVERRI
LUIS GUILLERMO
9/16/1991
6/30/1993
GURAKAR
AHMET
7/1/1991
4/15/1993
KISHIDA
AKIHIRO
7/1/1990
3/31/1993
DODSON
STANTON FORREST
7/1/1991
2/28/1993
SEBAYEL
MOHAMMED I.
9/1/1991
1/31/1993
MARINO
IGNAZIO ROBERTO
6/11/1990
12/31/1992
UKAH
FERDINAND OKECH
7/1/1990
12/31/1992
WEGENER
MICHAEL
9/1/1992
9/30/1992
JAIN
ASHOKKUMAR BABU
2/1/1989
9/30/1992
CHRISTIE
PETER
9/1/1990
8/31/1992
MERHAV
HADAR
7/14/1989
8/31/1992
DARRAS
FRANK SAM
7/1/1990
6/30/1992
GAYOWSKI
TIMOTHY
7/1/1989
6/30/1992
KLEOPOULOS
IRENE
11/1/1991
6/30/1992
GREIF
FRANKLIN
11/1/1990
10/31/1991
MARTIN
MAUREEN
7/12/1989
8/31/1991
RAMOS
HECTOR CIRILO
2/1/1990
7/31/1991
TOUSSAINT
ROSE MARIE
7/1/1988
6/30/1991
MADARIAGA
JUAN
8/24/1989
6/30/1991
YOKOYAMA
ITSUO
7/1/1987
6/30/1991
BURKHALTER
EDWARD LOUIS
7/1/1990
6/30/1991
FUNAKOSHI
YOICHI
2/1/1990
12/31/1990
SUZUKI
MASATOSHI
10/1/1989
9/30/1990
FABALAMELI
PARVIZ
6/13/1990
9/1/1990
CHARCO
RAMON
6/11/1990
7/10/1990
Kareem Abu-Elmagd, M.D., PhD. 56
MAZA
JORGE
6/11/1990
7/30/1990
NAKAO
AKIMASA
9/22/1989
6/30/1990
VIVAS
CARLOS
5/1/1989
3/31/1990
c) Teaching medical students (2 per each rotation), house staff, and surgical residents (2 per each rotation) of clinical science and surgical techniques during my formal surgical rotations in the capacity of Senior and Chief Surgical Resident (1995-1997) at the University of Pittsburgh Medical Center (see enclosed evaluation forms from both the faculty members and medical students).
3. 2012-present: Cleveland Clinic Foundation
a) Daily clinical teaching and surgical teaching of a secondary year surgical resident, transplant fellow and mid-level personnel in the field of surgical nutrition, gut rehabilitation, immunosuppression, transplant immunology, opportunisitic infections and visceral transplantation.
b) Intestinal Fellows and Residents 2012-present:
Fellows:
February 2014-October 2014: Ahmed Kandeel, M.D.
July 2015-June 2016: Galal Hussein Mohamed El-Gazzaz, M.D.
October 2016-present: Mohammed Osman, M.D.
Residents
Last Name
First Name
PGY 5 2013-2014
- General Surgery
Abdel Azim
Anas
- General Surgery
Babadjanov
Djurabek
- General Surgery
Chang
Julietta
- General Surgery
Davis
Matthew
- General Surgery
Fong
Kathryn
- General Surgery
Mace
Adam
- General Surgery
Nguyen
Trang
- General Surgery
Peng
June
- General Surgery
Petrosky
Jacob
- General Surgery
Reznick
David
PGY4 2014-2015
- General Surgery
Abbass
Mohammad Ali
- General Surgery
Dorsey
Amelia
- General Surgery
Fernando
Emil
- General Surgery
Ilie
Ramona
- General Surgery
Joyce
Daniel
- General Surgery
Keshava
Hari
- General Surgery
Liu
Yitian
- General Surgery
Lloyd
S. Julie Ann
- General Surgery
Takahashi
Hideo
- General Surgery
Yan
JingLiang
PGY3 2015-2016
- General Surgery
Ardila Gatas
Jessica
- General Surgery
Bruns
Nicholas
- General Surgery
Gause
Colin
- General Surgery
Horne
Charlotte
Kareem Abu-Elmagd, M.D., PhD. 57
- General Surgery
Karagkounis
Georgios
- General Surgery
Koprivanac
Marijan
- General Surgery
Moslim
Maitham Ammory Moslim
- General Surgery
Nassar
Ahmed
- General Surgery
Sideris
Antonios
- General Surgery
Vacharathit
Voranaddha
PGY2 2016-2017
- General Surgery
Adenuga
Paul
- General Surgery
Ahmed
Muhammad Fayyaz
- General Surgery
Burneikis
Dominykas
- General Surgery
Burneikis
Talia
- General Surgery
Burstein
Matthew
- General Surgery
Chung
Jin Woo
- General Surgery
Fagbongbe
Eniola
- General Surgery
Hallac
Alexander
- General Surgery
Isabella
Monica
- General Surgery
Landreneau
Joshua
- General Surgery
Muntean
Julia
- General Surgery
Park
Lisa
- General Surgery
Sohrabi
Maryna
- General Surgery
Tang
Andrew
PGY1 2017-2018
- General Surgery
Adams
Alicia
- General Surgery
Afzaal
Muhammad
- General Surgery
Aguilar Palacios
Diego
- General Surgery
Aram
Pedram
- General Surgery
Benlice
Cigdem
- General Surgery
Boules
Mena
- General Surgery
Bryk
Darren
- General Surgery
Bucak
Emre
- General Surgery
Connors
Bess
- General Surgery
Elshamy
Mohammed
- General Surgery
Fafaj
Aldo
- General Surgery
Fascelli
Michele
- General Surgery
Gibbons
Alexander
- General Surgery
Hemal
Kshitij
- General Surgery
Judeeba
Sami
- General Surgery
Lavryk
Olga
- General Surgery
Murthy
Prithvi
- General Surgery
Naples
Robert
- General Surgery
Navarrete
Salvador
- General Surgery
Orabi
Danny
- General Surgery
Philip
Justin
- General Surgery
Soliman
Basem
- General Surgery
Vilchez Parra
Valery
Kareem Abu-Elmagd, M.D., PhD. 58
- General Surgery
Zolin
Samuel
c) Basic medical and surgical teaching to medical students during a 4 week rotation.
RESEARCH SUPPORT AND ACTIVITIES
I - Grants
Grant No.
Grant Title
Role in Project &
Percent of Effort
Years Inclusive
Source &
$ Amount
1.
Teduglutide (ALX-0600) A Study of the Efficacy and Safety of Teduglutide in Subjects with Parenteral Nutrition-Dependent Short Bowel Syndrome
Principal Investigator
10%
5/1/04-12/31/07
NPS
$200,000
2.
Mechanisms of Adaptation in Human Short Bowel Syndrome
Co-Investigator
5%
3/1/04- 12/31/06
NIH
$200,000
3.
Clinical and Economic Outcome Associated with the Use of Thymoglobulin as a Preconditioning Agent in Intestinal Transplant Patients.
Co-Investigator
5%
8/22/03-8/22/06
Sangstat
$24,000
4.
Multicenter randomized control trial of TIPS versus DSRS / Pittsburgh Center of Participation
Principal Investigator
10%
3/01/98-12/31/05
NIH
$803,611
5.
Dendritic Cell-based Therapy of Post-Transplant Lymphoproliferative Disorders
Co-Investigator
5%
9/1/01-12/31/05
American Cancer Society
$358,750
6.
Modulation of Chimerism for Intestinal
Transplantation
Co-Investigator
10%
7/01/99-6/30/05
NIH
$485,108
7.
Pathogenesis and Treatment of Chronic Rejection
Co-Investigator
5%
1/01/98 -12/31/03
NIH
$144,039
8.
A Phase II, Open-Label, Randomized Study of Conventional Dose Tacrolimus Plus Corticosteroids Versus Reduced Dose Tacrolimus Plus Sirolimus and Corticosteroids in Recipients of Orthotopic Liver Grafts
Co-Investigator
5%
7/01/01- 6/30/03
Wyeth-Ayerst Pharmaceuticals
$209,256
9.
Ex Vivo CTL Generation-Based Immunotherapy for PTLD in Pediatric and Adult Small Bowel Recipients
Co-Investigator
5%
7/01/99 -6/30/01
CMRF
$25,000
10.
Combined Bone Marrow and Organ Transplantation in Humans
Co-Investigator
20%
4/01/96 - 3/31/01
NIH
$963,323
Kareem Abu-Elmagd, M.D., PhD. 59
11.
RPC #: 2014-1052
Title: Establishment of normothermic ex vivo perfusion of small intestine from deceased donors
Principal Investigator
2014-2015
Cleveland Clinic
$25,000
12.
RPC #: 2014-1052
Title: Establishment of normothermic ex vivo perfusion of small intestine from deceased donors
Principal Investigator
2015-2016
Cleveland Clinic
$25,000
13.
Establishment of normothermic ex vivo perfusion of small intestine from deceased donors
Principal
Investigator
2015-2016
TransMedics
$250,000
II - Research Related Presentations, Seminars, and Invited Lectureships
1. FK506: a new therapeutic agent for severe recalcitrant psoriasis,” The First International Congress on FK506, Pittsburgh, PA, 1991.
2. “Acute hemolytic anemia in liver and bone marrow transplant patients under FK506 therapy,” The First International Congress on FK506, Pittsburgh, PA, 1991.
3. “Four-hour versus 24-hour intravenous infusion of FK506 in liver transplantation,” The First International Congress on FK506, Pittsburgh, PA, 1991.
4. “The strategy of FK506 therapy in liver transplant patients: The effect of graft function,” The First International Congress on FK506, Pittsburgh, PA, 1991.
5. “Efficacy of FK506 in the treatment of recalcitrant pyoderma gangrenosum,” The First International Congress on FK506, Pittsburgh, PA, 1991.
6. “FK506 used as rescue therapy for human liver allograft recipients,” The First International Congress on FK506, Pittsburgh, PA, 1991.
7. “Metabolic effects of FK506 in patients with severe psoriasis: short-term follow up of seven cases,” The First International Congress on FK506, Pittsburgh, PA, 1991.
8. “Clinical small bowel or small bowel plus liver transplantation under FK506,” The First International Congress on FK506, Pittsburgh, PA, 1991.
9. “FK506 rescue in chronic graft-versus-host-disease after bone marrow transplantation,” The First International Congress on FK506, Pittsburgh, PA, 1991.
10. “Influence of FK506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study,” The First International Congress on FK506, Pittsburgh, PA, 1991.
11. “Strategy of FK therapy in liver transplant patients: effect of graft function,” The First International Congress on FK 506, Pittsburgh, PA, 1991.
Kareem Abu-Elmagd, M.D., PhD. 60
12. “Efficacy of FK506 in the treatment of recalcitrant pyoderma gangrenosum,” The First International Congress on FK 506, Pittsburgh, PA, 1991.
13. “FK506: a new therapeutic agent for severe recalcitrant psoriasis,” The First International Congress on FK 506, Pittsburgh, PA, 1991.
14. “Management of intestinal transplantation in humans,” International Symposium on Small-bowel Transplantation, London, Ontario, Canada, 1991.
15. “Does colorectal cancer in patients with primary sclerosing cholangitis prohibit liver transplantation?” Digestive Diseases Week, San Francisco, CA, 1992.
16. “Cholangiocarcinoma and sclerosing cholangitis: clinical characteristic and effect on survival after liver transplantation,” XIV International Congress of the Transplantation Society, Paris, France, 1992.
17. “Intestinal transplantation in humans with intestinal failure,” American College of Gastroenterology Meeting, Miami, FL, 1992.
18. “Combined liver-intestine transplantation versus intestine,” American Association for the Study of Liver Diseases, Chicago, IL, 1992.
19. “Intestinal transplantation in humans: with or without a liver,” American Association for the Study of Liver Diseases, Chicago, IL, 1992.
20. “The course of inflammatory bowel disease under FK506 immunosuppression after liver transplantation for primary sclerosing cholangitis,” American Association for the Study of Liver Diseases, Chicago, IL, 1992.
21. "Efficacy of liver transplantation in patients with primary sclerosing cholangitis,” American College of Surgeons Clinical Congress, New Orleans, LA, 1992.
22. “Small bowel transplantation,” Egyptian Medical Association, Ain Shams University, Cairo, Egypt, 1992.
23. “Use of FK 506 for graft-versus-host disease (GVHD) following bone marrow transplantation (BMT),” Keystone Symposium, Vail, CO, 1993.
24. “Small bowel transplantation for irreversible intestinal failure,” American Gastroenterological Association, Boston, MA, 1993.
25. “Combined liver-intestine transplantation versus intestine alone: three years experience,” American Association for the Study of Liver Diseases, Boston, MA, 1993.
26. “Intestinal transplantation in composite visceral grafts or alone,” American College of Surgeons, San Francisco, CA, 1993.
27. “Isolated intestinal transplantation,” American Society of Transplant Surgeons, Houston, TX, 1993.
28. “Intestinal transplantation and bacterial overgrowth,” III International Symposium on Small Bowel Transplantation, Paris, France, 1993.
29. “Management of intestinal allograft recipients,” III International Symposium on Small Bowel Transplantation, Paris, France, 1993.
30. “Monitoring and treatment of intestinal allograft rejection in humans,” XIV International Congress of the Transplantation Society, Paris, France, 1993.
31. “Cholangiocarcinoma and sclerosing cholangitis: clinical characteristic and effect on survival after liver transplantation,” XIV International Congress of the Transplantation Society, Paris, France, 1993.
32. “Clinical intestinal transplantation: three-year experience,” III International Symposium on Small Bowel Transplantation, Paris, France, 1993.
Kareem Abu-Elmagd, M.D., PhD. 61
33. “Nutritional and clinical outcome of patients following intestinal transplantation,” American Gastroenterological Association and American Association for the Study of Liver Disease, Washington, DC, 1997.
34. “The evolution of clinical intestinal transplantation: a single center experience,” The American Society of Transplant Surgeons, 1997.
35. “Disease recurrence and outcome in 421 patients,” American Association for the Study of Liver Diseases, Chicago, IL, 1997.
36. “Adjuvant donor bone marrow infusion to augment chimerism in intestinal allograft recipients,” V- International Symposium of Intestinal Transplantation, Cambridge, England, 1997.
37. “The current status of adult intestinal transplantation at the University of Pittsburgh,” V-International Symposium of Intestinal Transplantation, Cambridge, England, 1997.
38. “Hepatic transplantation in composite visceral grafts,” Fourth Congress International Liver Transplantation Society, Seattle, WA, 1997.
39. “Clinical intestinal transplantation: An update and new perspectives,” American College of Surgeons, Chicago, IL, 1997.
40. “Clinical intestinal transplantation at the Thomas E. Starzl Transplantation Institute,” The Fifth Congress of the Asian Society of Transplantation, Manila, Philippines, 1997.
41. “Clinical intestinal transplantation: reassessment and new perspectives,” The International Congress on Immunosuppression, Orlando, FL, 1997.
42. “Does colorectal cancer in patients with primary sclerosing cholangitis prohibit liver transplantation,” The American Society of Colon and Rectal Surgeons, San Antonio, TX, 1998.
43. “Portal versus systemic venous drainage of intestinal allografts in humans,” The American Society of Transplant Surgeons, Chicago, IL, 1998.
44. “Clinical intestinal transplantation: risk factors and new strategies,” The American Society of Transplant Surgeons, Chicago, IL, 1998.
45. “Long-term efficacy of intestinal transplantation in patients with end stage gastrointestinal failure,” American Gastroenterological Association and American Association for the Study of Liver Diseases at Digestive Disease Week, New Orleans, LA, 1998
46. “Clinical intestinal transplantation: risk factors and new strategies,” The Transplantation Society XVII World Congress, Montreal, Quebec, Canada, 1998.
47. “Portal versus systemic venous drainage of intestinal allografts in humans,” The Transplantation Society XVII World Congress, Montreal, Quebec, Canada, 1998.
48. “Evolution of clinical intestinal transplantation: Improved outcome and cost effectiveness,” 7th Meeting of the European Intestinal Transplantation Study Group (ESGIT), Brussels, Belgium, 1998.
49. “Recurrence of primary sclerosing cholangitis (PSC) after hepatic transplantation (HTx): single center experience with 380 graft,” American Association for the Study of Liver Diseases, Chicago, IL, 1998.
50. “Recurrence of primary sclerosing cholangitis (PSC) after hepatic transplantation: single center experience with 380 grafts,” American Society of Transplant Physicians, Chicago, IL, 1999.
51. “Intestinal transplantation and end stage gastrointestinal disease: improved outcome and cost effectiveness,” American Society of Transplant Physicians, Chicago, IL, 1999.
Kareem Abu-Elmagd, M.D., PhD. 62
52. “The efficacy of daclizumab for intestinal transplantation: preliminary report,” The American Society of Transplant Surgeons, Chicago, IL, 1999.
53. “Intestinal transplantation and end stage gastrointestinal disease: improved outcome and cost effectiveness,” 9th Congress of the European Society for Organ Transplantation, Oslo, Norway, 1999.
54. “Long-term efficacy of intestinal transplantation in patients with end stage gastrointestinal failure,” International College of Surgeons Meeting, Cancun, Mexico, 1999.
55. “Monosegmental bile duct occlusion after split liver transplantation,” Fifth International Liver Transplantation Society Meeting, Pittsburgh, PA, 1999.
56. “Recurrence of primary cholestatic liver diseases after hepatic transplantation (HTx),” Fifth International Liver Transplantation Society Meeting, Pittsburgh, PA, 1999.
57. “Inflammatory bowel disease (IBD) and risk of colorectal cancer (CRC) before and after hepatic transplantation (HTx) for primary sclerosing cholangitis (PSC),” Fifth International Liver Transplantation Society Meeting, Pittsburgh, PA, 1999.
58. “Long term efficacy of liver transplantation (LTX) for primary sclerosing cholangitis (PSC) complicated with hepatobiliary carcinoma,” Fifth International Liver Transplantation Society Meeting, Pittsburgh, PA, 1999.
59. “The efficacy of Daclizumab for intestinal transplantation: preliminary report,” VI International Small Bowel Transplantation Symposium, Omaha, NE, 1999.
60. “Intestinal transplantation,” Transplant 2000 AST, Chicago, IL, 2000.
61. “Intestinal transplantation,” AASLD Digestive Disease Week – 2000, San Diego, CA, 2000.
62. “Clinical intestinal transplantation: single center experience,” XVIII International Congress of the Transplantation Society, Rome, Italy, 2000.
63. “Ten years experience with clinical intestinal transplantation,” International Society for Digestive Surgery, Hamburg, Germany, 2000.
64. “Clinical intestinal transplantation: improved long-term survival,” Presidential Plennary Session, American College of Gastroenterology, New York, NY, 2000.
65. “Intestinal transplantation: long-term outcome with special reference to the liver,” AASLD 51st Annual Meeting, Dallas, TX, 2000.
66. “A new therapeutic modality for patients with intractable Crohn’s disease,” Crohn’s & Colitis Foundation of America, Pittsburgh, PA, 2001.
67. “Small bowel transplantation”, UNOS Region 2 OPO and Clinical Forum, Pittsburgh, PA, 2001.
68. “Current status of the management of bile duct injuries, The Minimally Invasive Surgery Center Program, University of Pittsburgh Medical Center, Pittsburgh, PA, 2001.
69. “Clinical Intestinal Transplantation: A decade of a single center experience,” The 121st Annual Meeting, American Surgical Association, Colorado Springs, Colorado, 2001.
70. “A Novel Immunomodulatory Strategy for Clinical Intestinal Transplantation: Ex-Vivo Irradiation with Adjunct Donor Bone Marrow Infusion,” The Second Annual Joint American Society of Transplant Surgeons and the American Society of Transplantation Meeting, Chicago, Illinois, 2001.
71. “Clinical intestinal transplantation: A decade of a single center experience,” VII International Small Bowel Transplant Symposium, Stockholm, Sweden, 2001.
Kareem Abu-Elmagd, M.D., PhD. 63
72. “A decade of experience with intestinal transplantation at the University of Pittsburgh.” 10th Congress of the European Society for Organ Transplantation (ESOT), Lisboa, Portugal, 2001.
73. Surgical Treatment of Varices, Postgraduate Course: Meet-the-Professor Luncheon, 52nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Dallas, TX, 2001.
74. “Induction Immunosuppression,” Small Bowel Lunch Session, The 2nd International Congress on Immunosuppression, San Diego CA, 2001.
75. “Intestinal Failure,” Lecture Session Symposium, World Congress of Gastroenterology, (WCOG), Bangkok, Thailand, 2002.
76. “Graft Immunomodulation and Tolerance Enhancing Strategy for Intestinal Transplantation,” American Transplant Congress (ATC), Washington, DC, 2002.
77. “Intestinal Transplantation,” 10th Annual UNOS Transplant Management Forum, Las Vegas, Nevada, 2002.
78. “Bowel & Intestinal Transplants,” 40th Annual United Ostomy Conference, Philadelphia, PA, 2002.
79. “Intestinal and Multivisceral Transplantation: Long-Term Results and Future Prospects,” State of the Art Symposia – XIX International Congress of the Transplantation Society, Miami, FL, 2002.
80. “Tolerance in Intestinal and Liver Transplant,” Sangstat ITS Symposium, Miami, FL, 2002.
81. “Intestinal Failure,” 2002 ESPEN/BAPEN Satellite Symposium, Glasgow, Scotland, 2002.
82. “A New Tolergenic Immunosuppressive Strategy for Human Intestinal Transplantation,” American Transplant Congress, Washington, DC, 2003.
83. “Liver Protects Bowel Rejection,” VIII International Small Bowel Transplant Symposium, Miami Beach, FL, 2003.
84. “Monotherapy towards Tolerance”, Chair, 11th Congress of the European Society for Organ Transplantation, Venice, Italy, 2003.
85. “Multivisceral and Small Bowel Transplantation, The Pittsburgh Experience,” State of Art Lecture, 7th Annual Mexican Society of Transplantation, AC Meeting Congress, Cancun, Mexico, 2003.
86. “Immunosuppression following Intestinal Transplantation,” State of Art Symposium, XX International Congress of the Transplantation Society; Vienna, Austria, 2004.
87. “The Pittsburgh Tolerance Protocol and Intestinal Transplantation: Current Status,” 5th Annual State of the Art Winter Symposium, 2005.
88. “Transplant Tolerance,” Research Seminar, University of California, San Diego, CA, 2005.
89. “Abdominal Visceral Transplantation and Allograft Tolerance,” Research Lecture Series, John Hopkins Comprehensive Transplant Center, Baltimore, MD, 2005.
90. “Intestinal Rehabilitation: A Multidisciplinary Team Approach,” Serono Speakers Bureau, Digestive Disease Week, Chicago, Illinois, 2005.
91. “Monitoring Immune Function during Tacrolimus Tapering in Small Bowel Transplant Recipients,” American Transplant Congress, Cyclex Satellite Symposium, Seattle, Washington, 2005.
92. “Recipient Pretreatment with Anti-lymphocyte Antibodies and Post-transplant Monotherapy: Success of Weaning and Long-term Graft Function,” American Transplant Congress, Seattle, Washington, 2005.
93. “The Forbidden Organ: Immune-Modulation and Partial Tolerance,” Translational Research Seminar, University of Pittsburgh, Pittsburgh, PA, 2007.
Kareem Abu-Elmagd, M.D., PhD. 64
94. “Recent Achievements at the Intestinal Rehabilitation and Transplantation Center,” STI Scientific Retreat, Seven Springs, PA, 2007. Symposium, Golden Triangle Chapter, International Transplant Nurses Society, Pittsburgh, PA, 2007.
95. “Malignancy after Intestinal and Multivisceral Transplantation,” Workshop on Cancer Risk after Solid Organ Transplantation Coordination, Italian National Transplant Center, Rome, Italy, 2007.
96. “Nomenclature of a Visceral Graft,” Xth International Small Bowel Symposium, Los Angeles, CA, 2007.
97. “Surgical Management of Short Bowel Syndrome,” Surgical Grand Rounds, Strong Memorial Hospital, Rochester, NY, 2007.
98. “Intestinal and Multivisceral Transplantation: Current Indications, Patient Selection, and Outcome Analysis,” Transplant Clinical Conference Cigna Lifesource, Pittsburgh, PA, 2008.
99. “Lymphoproliferative Disorder, De Novo Malignancy, and Tumor Recurrence after Intestinal, Liver-Intestine, and Multivisceral Transplantation: Innovative Strategies with New Outlook,” Joint International Congress of ILTS, ELITA & LICAGE, Paris, France, 2008
100. “Portomesenteric Venous Thrombosis: A New Classification in the Era of Intestinal and Multivisceral Transplantation,” Joint International Congress of ILTS, ELITA & LICAGE, Paris, France, 2008.
101. “Where Do We Need To Focus In Intestinal Transplantation?” Fifth International Pediatric Intestinal Failure and Rehabilitation Symposium, Pittsburgh, PA, 2008.
102. “Intestinal and Multivisceral Transplantation: Indications, Patient Selection and Postoperative Care,” Society of Gastroenterology Nurses and Associates, Philadelphia, PA, 2008.
103. “Intestinal and Multivisceral Transplantation,” Young European Scientist Meeting, Lisbon, Portugal, September 27, 2008.
104. “Intestinal and Multivisceral Transplantation: The Art of Medicine and Love of Humanity,” American Medical Student Association, University of Pittsburgh, October 24, 2008.
105. “Evolution of the Immunosuppressive Strategy for Intestinal and Multivisceral Recipients,” (Plenary Session) Middle Eastern Society of Organ Transplantation (MESOT) 2008, Shiraz, Iran, November 20, 2008.
106. “Liver Transplantation En Bloc with other Abdominal Solid and Visceral Organs,” Egyptian Forum of Liver Disease, Cairo, Egypt, November 26, 2008.
107. “Recent Advances in Hepatocellular Carcinoma,” Egyptian Forum of Liver Disease, Cairo, Egypt, November 27, 2008.
108. “Evolution of Intestinal and Multivisceral Transplantation,” First International Surgical Conference, Jeddah, Saudi Arabia, March 27, 2009.
109. “Small Bowel Transplantation and Organ Donation,” The Center for Organ Donation and Transplant Annual Education Day, Albany, New York, April 1, 2009.
110. “Five Hundred Intestinal and Multivisceral Transplantations at a Single Center,” American Surgical Association (ASA), Indian Wells, California, April 23-25, 2009.
111. “Immunosuppression in Intestinal Transplantation,” IXth Congress of the Polish Transplantation Society, Krakow, Poland, May 14, 2009.
112. “Evolution of Intestinal and Multivisceral Transplantation,” Zurich, Switzerland, May 19, 2009.
113. “Evolution and Minimization of Immunosuppression in Five Hundred Intestinal and Multivisceral Transplantations at a Single Center,” American Transplant Congress, Boston, Massachusetts, May 31, 2009.
Kareem Abu-Elmagd, M.D., PhD. 65
114. “Current Outcomes of Intestinal Transplants,” American Transplant Congress, Boston, Massachusetts, June 1, 2009.
115. “How Much Do You Know About Gut Rehabilitation and Intestinal Transplantation,” UPMC Passavant Grand Rounds, Pittsburgh, PA, July 21, 2009.
116. “Long-term Impact of Tolerogenic Immunosuppression,” Pre-Symposium Workshop, XIth International Small Bowel Transplant Symposium, Bologna, Italy, September 9, 2009.
117. “Early and Long-Term Immunosuppression in Intestinal Transplant,” Plenary Session, XIth International Small Bowel Transplant Symposium, Bologna, Italy, September 11, 2009.
118. “Small Bowel and Multivisceral Transplantation,” Prague, Republic of Czech, September 15, 2009.
119. “Living Related Bowel Transplantation: From Experimental to Standardized,” 11th Congress of the Asia Society of Transplantation (CAST 2009), Beirut, Lebanon, October 3, 2009.
120. “Evolution of Immunosuppression Strategies in the Multivisceral Organ Transplantation,” 11th Congress of the Asia Society of Transplantation (CAST 2009), Beirut, Lebanon, October 3, 2009.
121. “Minimizing Immunosuppression to Monotherapy,” 11th Congress of the Asia Society of Transplantation (CAST 2009), Beirut, Lebanon, October 3, 2009.
122. “How Much Do You Know About Gut Rehabilitation and Intestinal Transplantation,” Medical Grand Rounds, UPMC McKeesport, McKeesport, PA, October 20, 2009.
123. “Innovations in the Management of Short Bowel Syndrome Patients,” Medical Grand Rounds, UPMC Mercy, Pittsburgh, PA, January 28, 2010.
124. “The Current Status of Intestinal and Multivisceral Transplantation: Major Advances and New Challenges,” The First Egyptian Organ Transplant Congress, Cairo, Egypt, March 23, 2010.
125. “Management of Portomesenteric Venous Thrombosis,” Pan-Arab Liver Transplantation Society (PALTS), Tunis, Tunisia, April 2, 2010.
126. “ar,” Pan-Arab Liver Transplantation Society (PALTS), Tunis, Tunisia, April 2, 2010.
127. “Recent Advances in Hepatocellular Carcinoma,” The International Annual Surgical Conference, Jeddah, Saudi Arabia, April 7, 2010.
128. “Liver Transplantation En Bloc with other Abdominal Solid and Visceral Organs,” The International Annual Surgical Conference, Jeddah, Saudi Arabia, April 7, 2010.
129. “Short Gut Syndrome and Intestinal Transplantation,” Surgical Grand Rounds, UPMC Mercy, Pittsburgh, PA, September 29, 2010.
130. “Tumors after Intestinal Transplantation,” The Sixth International Pediatric Intestinal Failure and Rehabilitation Symposium, Chicago, IL, September 11, 2010.
131. “Multivisceral Transplantation,” (Plenary Session) The 12th Congress of the Middle East Society of Organ Transplantation (MESOT), Tunis, Tunisia, October 19, 2010.
132. “The Many Faces of Chimerism: A Double-Edged Sword,” Transplantation Innovations: 30 Years of Transforming Lives, May 20, 2011.
133. “Ischemia in Small Bowel Transplantaton,” KFO Farewell Symposium, Bonn, Germany, June 16, 2011.
134. “Management of Adult Gut Failure,” XII International Small Bowel Symposium, Washington, DC, September 15, 2011.
Kareem Abu-Elmagd, M.D., PhD. 66
135. “RATG Versus Alemtuzumab Single Dose Pretreatment for Visceral Allograft Recipients,” XII International Small Bowel Symposium, Washington, DC, September 16, 2011.
136. “Portomesenteric Venous Thrombosis: A New Classification in the Era of Visceral Transplantation,”
XII International Small Bowel Symposium, Washington, DC, September 18, 2011.
137. “Long-Term Survival, Nutritional Autonomy, and Quality of Life after Intestinal and Multivisceral Transplantation,” American Surgical Association, San Francisco, CA, April 27, 2012.
138. “Organ Transplantation: The Many Faces of Chimerism,” The First Congress of Kasr Al-Ainy Liver Transplantation Unit, Cairo, Egypt, May 10, 2012.
139. “Immunologic Challenges in Intestinal Failure and Transplant - Chronic Rejection.” The 7th International Pediatric Intestinal Failure and Rehabiliatation Symposium, Children’s Hospital of Pittsburgh of UPMC, September 7, 2012
140. “Gut Elongation Surgeries.” UMPC Recent Advances in Digestive Diseases. Pittsburgh, PA, September 28, 2012
141. “Gut Rehabilitation and Intestinal Transplantation.” Cleveland Clinic, Digestive Diease Institute Grand Rounds, Cleveland, OH, October 3, 2012.
142. “Surgical Management of Intestinal Failure.” Egyptian Society of Surgeons 30th Annual Meeting 2012, October 5, 2012.
143. “Management of Short Gut Patients.” The 2nd Kuwait Conference on Hepato-Pancreato-Biliary Surgery and Transplantation, Kuwait, November 4-6, 2012.
144. “Update in Intestinal and MVT treatment.” The 2nd Kuwait Conference on Hepato-Pancreato-Biliary Surgery and Transplantation, Kuwait, November 4-6, 2012.
145. “Surgical Management of Portal Hypertension.” The 2nd Kuwait Conference on Hepato-Pancreato-Biliary Surgery and Transplantation, Kuwait, November 4-6, 2012.
146. “The Many Faces of Organ Transplantation”. DDI Liver Transplant Education Didactic Series, Cleveland Clinic, Cleveland, Ohio, April 4, 2013.
147. “Current Trends in Management of Gut Rehabilitation and and Transplantation.” Metro Hospital, Surgical Grand Rounds, Cleveland, OH, August 1, 2013.
148. “The New Paradigms in the Managament of Intestinal Failure”. Cigna Insurance Company- Webinar, Cleveland, Ohio, March 26, 2014.
149. “Indication, techniques, and outcomes for Small Bowel Transplantation”. 15th Annual Surgery of the Foregut Symposium DDSI Week, Florida, February 6th, 2016
150. “Gut Failure and indications for autologous transplantation in patients with catastophes after bariatric
Procedures”, 15th Annual Surgery of the Foregut Symposium, Florida, February 7th, 2016
151. “Multivisceral Organ Transplant Therapeutics” Baylor University, Dallas Texas, April 7th, 2016
152. “Surgical Management of Gut Failure with Special Reference to Bariatric Surgery” , Baylor University, Dalas
Texas November 8th 2016
153. “Intestinal and Multivisceral Transplantation in the New Era of Gut Rehabilitation”, Transplantation: Complecity vs. Chaos, Lake Como, Italy, June 29th, 2016.
154. “Managing Antibody Mediated Rejection in Intestine Transplant”, 9th Annual International Pediatric Intestinal Failure and Rehabilitation Symposium, UCLA, October 29th, 2016.
Kareem Abu-Elmagd, M.D., PhD. 67
155. “The Field of Intestine Transplantation Teaching the Next Generation” 9th Annual International Pediatric Intestinal Failure and Rehabilitation Symposium, UCLA, October 29th, 2016.
156. “Intestinal and Multivisceral Transplantation in the New Era of Gut Rehabilitation”, Children’s Hospital,
Israel, June 2016.
157. “Intestinal Transplantation: Challeges in Clinical Practice” Sunrise Symposium. American Transplant Congress, Boston, June 2016
158. “Normothermic Ex-vivo perfusion of the Intestine: The Introduction of Innovative physiologic model with novel biomarkers.” Oral presentation, small bowel session, American Transplant Congress, Boston, June 2016.
159. “Evolution of intestinal, multivisceral transplant.” and “Surgical Management of Gut Failure after Bariatric Surgery.” II International Surgical Conference Surgical Vision 2020 King Fahad Armed Forces Hospital lectures Jeddah, Saudi Arabia January 18, 2017
160. “Farouk the Surgeon, Mentor, Father and Legend” 35th Annual Meeting of the Egyptian Society of Surgeons Fairmont Heliopolis Hotel Giza, Egypt March 22nd 2017
161. “What is the future of visceral transplantion in Egypt and Middle East?” 35th Annual Meeting of the Egyptian Society of Surgeons Fairmont Heliopolis Hotel Giza, Egypt March 23rd 2017
162. “What could go seriously wrong with bariatric surgery?” 35th Annual Meeting of the Egyptian Society of Surgeons Fairmont Heliopolis Hotel Giza, Egypt March 24th 2017
163. “Gut Failure and Surgical Ingenuity” Cleveland Clinic Abu Dhabi Grand Rounds March 29th 2017.
164. Keynote speaker at the Intestinal and Multivisceral Transplantation Seminar, Sheikh Zaid Hospital May 14, 2017
165. “Surgical Management of Complications of Bariatric Surgery” Alsafwa Hospital, Egypt May 15, 2017 9. Cairo University Surgical Grand Rounds Cairo, Egypt May 16, 2017
166. Air Force Specialized Hospital, Cairo, Egypt May 16, 2017 11. Moderator, IBD and PSC: Pre-and Post-Transplant Issues. 2017 PSC Partners Annual Conference. Cleveland Clinic Intercontinental Hotel. June 23, 2017
167. “Intestinal Transplant: Concept to Reality” CIRTA 2017 Pre symposium Roosevelt Hotel New York, NY. Pre-Meeting on Surgical and Medical Management: How Did We Get Here? June 28, 2017
168. “Surgical Management of Gut Failure due to Bariatric Surgery” Cairo University Organ Transplant Seminar, Cairo Universtity Surgical Grand Rounds Cairo, Egypt September 7, 2017
169. “The Future of Gut Rehabilitation in Egypt and the Middle East” Cairo University Organ Transplant Seminar, Cairo Universtity Surgical Grand Rounds Cairo, Egypt September 7, 2017
170. “Management of Short Bowel Syndrome” Cairo University Surgery Department in Faculty of of Medicine Cairo, Egypt Saturday December 16, 2017
171. Cairo University Surgical Grand Rounds Cairo, Egypt Monday December 18, 2017
172. “Surgical Management of Gut Failure” Cairo University, Surgery Department in Faculty of of Medicine Cairo, Egypt December 23, 2017
173. "Management of Five Hundred Patients With Gut Failure at a Single Center: Surgical Innovation Versus Transplantation With a Novel Predictive Model" American Surgical Association 139th Annual Meeting, Fairmont Dallas, Dallas, Texas April 13, 2019.
Kareem Abu-Elmagd, M.D., PhD. 68
174. "Management of Gut Failure” Cleveland Clinic Education 2/9/2023 Page: 5 Annual Professional Review APR Assessment - Kareem Abu-Elmagd, MD, PhD (Ohio Staff) Digestive Disease and Surgery Institute - General Surgery Review Year: 2020 Seminar, US Embassy, Washington D.C., June 14, 2019.
175. “The Journey with No Regrets” University of Alberta City Wide Rounds, Edmonton, Canada June 21, 2019.
176. “Different Transplant Procedures” 16th International Congress of the Intestinal Rehabilitation & Transplant Association, Cordeliers Conference Center, Paris, France July 3, 2019.
177. “Surgical Innovation and gut transplantation for patients with abdominal malignancies” Annual Congress NCI Cairo University, Intercontinental City Stars Hotel, Cairo, Egypt November 7, 2019
178. “Small Bowel Neoplasms: Diagnosis and Treatment Updates”. 19th Annual Surgery of the Foregut Symposium, Biltmore Hotel, Coral Gables, Florida February 15, 2020
179. “Intestinal Failure” 19th Annual Surgery of the Foregut Symposium, Biltmore Hotel, Coral Gables, Florida February 15, 2020
180. .“A Year in Review in Intestinal Transplant” 4th Annual Delta Gastro-Hub conference, Royal Tulip Hotel Alexandria, Alexandria, Egypt November 11, 2021 10.
181. Cairo University Surgical Grand Rounds Cairo, Egypt October 6, 2021
182. “Multivisceral Transplant: Is it Ever Necessary for Patients with Well Compensated Cirrhosis and Hepatic Fibrosis” American Transplant Congress, Virtual June 9, 2021
183. “Management of Five Hundred Patients with Malrotated Gut: Thirty Years of Experience with the Introduction of Novel Surgical Techniques” 141st Annual of the American Surgical Association, Virtual, April 16, 2021
184. " Reconstructive Gut Surgery: Innovative Techniques with Novel Outcome Predictive Model" Cleveland Surgical Society, Virtual, October 2021.
185. "Gut Failure" DDW Egypt 2021, Virtual, October 2021
186. "Intestinal Malrotation" MD Insights Cleveland Clinic, June 8, 2021
187. "CGRT with Matthew Walsh Gut Rehabilitation" CGRT Education Meeting, June 2021
188. "Management of Gut Failure: Medical and Surgical Approaches " Cleveland Clinic Surgery Live, April 2021
189. “Gut Failure” World Nutri-Derm Congress, Virtual, December 3, 2021
SIGNIFICANT ACCOMPLISHMENTS
1. Significant contribution to the field of portal hypertensive surgery.
2. Active participation in the clinical introduction and development of FK-506 (tacrolimus) as a primary immunosuppressive drug therapy for solid organ and multivisceral transplantation.
3. Leading role in the development of intestinal and multivisceral transplantation in humans with standardization of surgical techniques, immunosuppressive strategies and postoperative management.
Kareem Abu-Elmagd, M.D., PhD. 69
4. Approval of the intestinal and multivisceral transplantation by the Center for Medicare/Medicaid Services (CMS) to be the standard of care for patients with irreversible intestinal failure. The personal request for a national coverage policy was submitted in May of 1999 and approved by the Department of Health and Human Services on October 4, 2000.
5. Introduction of the concept of gut rehabilitation with the establishment of centers for gut rehabilitation and transplantation at the University of Pittsburgh (1999-2012) and Cleveland Clinic (2012-present).
6. The clinical introduction of allograft immunmodulation and tolerogenic immunosuppressive protocol with recipient pretreatment and minimal post-transplant immunosuppression.
7. The introduction of novel surgical techniques for the management of patients with gut failure due to complex abdominal pathology and complicated gastric bypass surgery.
8. Establishment of ex-vivo normothermic perfusion unit for organ repair at the Cleveland Clinic.